Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 ___________________________________________________
FORM 10-Q
 ___________________________________________________
 
(Mark One)
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended April 2, 2016
or
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from          to           
Commission File Number: 001-33962  
COHERENT, INC.
Delaware
 
94-1622541
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
 
5100 Patrick Henry Drive, Santa Clara, California 95054
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (408) 764-4000  
___________________________________________________
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No  ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer x
 
Accelerated filer ¨
 
 
 
Non-accelerated filer ¨
 
Smaller reporting company ¨
(do not check if a smaller reporting company)
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨   No  x
 
The number of shares outstanding of registrant’s common stock, par value $.01 per share, on May 9, 2016 was 24,291,591 .



Table of Contents

COHERENT, INC.

INDEX
 
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


2

Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This quarterly report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements included in or incorporated by reference in this quarterly report, other than statements of historical fact, are forward-looking statements. These statements are generally accompanied by words such as “trend,” “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “rely,” “believe,” “estimate,” “predict,” “intend,” “potential,” “continue,” "outlook," “forecast” or the negative of such terms, or other comparable terminology, including without limitation statements made under “Our Strategy,” discussions regarding our bookings and in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements. Actual results of Coherent, Inc. (referred to herein as the Company, we, our or Coherent) may differ significantly from those anticipated in these forward-looking statements as a result of various factors, including those discussed in the sections captioned “Our Strategy,” “Risk Factors,” “Key Performance Indicators,” as well as any other cautionary language in this quarterly report. All forward-looking statements included in the document are based on information available to us on the date hereof. We undertake no obligation to update these forward-looking statements as a result of events or circumstances or to reflect the occurrence of unanticipated events or non-occurrence of anticipated events.


3

Table of Contents

PART I.  FINANCIAL INFORMATION
 
ITEM 1.  FINANCIAL STATEMENTS
 
COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
( Unaudited; in thousands, except per share data) 

 
Three Months Ended
 
Six Months Ended
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
Net sales
$
199,882

 
$
203,721

 
$
390,157

 
$
404,336

 
Cost of sales
111,283

 
120,417

 
217,660

 
238,713

 
Gross profit
88,599

 
83,304

 
172,497

 
165,623

 
Operating expenses:
 

 
 

 


 
 
 
Research and development
20,955

 
21,024

 
40,095

 
40,197

 
Selling, general and administrative
40,940

 
39,482

 
77,714

 
77,623

 
Amortization of intangible assets
700

 
666

 
1,401

 
1,362

 
Total operating expenses
62,595

 
61,172

 
119,210

 
119,182

 
Income from operations
26,004

 
22,132

 
53,287

 
46,441

 
Other income (expense):
 

 
 
 


 
 
 
Interest and dividend income
263

 
161

 
503

 
257

 
Interest expense
(30
)
 
(14
)
 
(45
)
 
(25
)
 
Other—net
(2,013
)
 
1,843

 
(2,460
)
 
1,073

 
Total other income (expense), net
(1,780
)
 
1,990


(2,002
)

1,305

 
Income before income taxes
24,224

 
24,122

 
51,285

 
47,746

 
Provision for income taxes
6,443


5,709


13,218


11,903

 
Net income
$
17,781

 
$
18,413

 
$
38,067

 
$
35,843

 
 

 
 
 

 
 
 
Net income per share:
 

 
 

 


 
 
 
Basic
$
0.74

 
$
0.75

 
$
1.58

 
$
1.44

 
Diluted
$
0.73

 
$
0.74

 
$
1.57

 
$
1.43

 
 

 
 
 

 
 
 
Shares used in computation:
 

 
 

 


 
 
 
Basic
24,137

 
24,709

 
24,066

 
24,823

 
Diluted
24,362

 
24,891

 
24,299

 
25,042

 
 
See Accompanying Notes to Condensed Consolidated Financial Statements.


4

Table of Contents


COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
( Unaudited; in thousands) 

 
Three Months Ended
 
Six Months Ended
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
 
 
 
 
 
 
 
 
 
Net income
$
17,781

 
$
18,413

 
$
38,067

 
$
35,843

 
Other comprehensive income (loss):  (1)
 
 
 
 
 
 
 
 
Translation adjustment, net of taxes (2)
13,568

 
(33,280
)
 
5,062

 
(47,799
)
 
Net gain (loss) on derivatives instruments, net of taxes (3)
2

 
175

 
(28
)
 
550

 
Changes in unrealized gains on available-for-sale securities, net of taxes (4)
2,325

 
274

 
2,463

 
201

 
Other comprehensive income (loss), net of tax
15,895

 
(32,831
)
 
7,497

 
(47,048
)
 
Comprehensive income (loss)
$
33,676

 
$
(14,418
)
 
$
45,564

 
$
(11,205
)
 

(1)
Reclassification adjustments were not significant during the three and six months ended April 2, 2016 and April 4, 2015 .

(2)
Tax expenses of $465 and $119 were provided on translation adjustments during the three and six months ended April 2, 2016 , respectively. Tax benefits of $1,110 and $1,862 were provided on translation adjustments during the three and six months ended April 4, 2015 , respectively. 

(3)
Tax expenses (benefits) of $1 and $(17) were provided on net gains (losses) on derivative instruments during the three and six months ended April 2, 2016 , respectively. Tax expenses of $102 and $319 were provided on net gains (losses) on derivative instruments during the three and six months ended April 4, 2015 , respectively.

(4)
Tax expenses of $1,357 and $1,437 were provided on changes in unrealized gains on available-for-sale securities during the three and six months ended April 2, 2016 , respectively. Tax expenses of $158 and $119 were provided on changes in unrealized gains on available-for-sale securities during the three and six months ended April 4, 2015 , respectively.


See Accompanying Notes to Condensed Consolidated Financial Statements.

5

Table of Contents

COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
( Unaudited; in thousands, except par value)
 
April 2,
2016
 
October 3,
2015
ASSETS
 

 
 

Current assets:
 

 
 

Cash and cash equivalents
$
157,176

 
$
130,607

Short-term investments
203,882

 
194,908

Accounts receivable—net of allowances of $2,955 and $3,015, respectively
150,409

 
142,260

Inventories
179,067

 
156,614

Prepaid expenses and other assets
34,602

 
28,294

Total current assets
725,136

 
652,683

Property and equipment, net
108,575

 
102,445

Goodwill
102,876

 
101,817

Intangible assets, net
18,510

 
22,776

Other assets
93,446

 
89,226

Total assets
$
1,048,543

 
$
968,947

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

Current liabilities:
 

 
 

Short-term borrowings
$
5,000

 
$

Accounts payable
43,458

 
33,379

Income taxes payable
11,545

 
4,279

Other current liabilities
89,808

 
84,932

Total current liabilities
149,811

 
122,590

Other long-term liabilities
49,183

 
49,939

Commitments and contingencies (Note 11)


 


Stockholders’ equity:
 

 
 

Common stock, par value $.01 per share:
 

 
 

Authorized—500,000 shares
 

 
 

Outstanding—24,218 shares and 23,970 shares, respectively
241

 
238

Additional paid-in capital
136,171

 
128,607

Accumulated other comprehensive loss
(2,016
)
 
(9,513
)
Retained earnings
715,153

 
677,086

Total stockholders’ equity
849,549

 
796,418

Total liabilities and stockholders’ equity
$
1,048,543

 
$
968,947


See Accompanying Notes to Condensed Consolidated Financial Statements.

6

Table of Contents

COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
( Unaudited; in thousands)
 
Six Months Ended
 
April 2,
2016
 
April 4,
2015
Cash flows from operating activities:
 

 
 

Net income
$
38,067

 
$
35,843

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 

Depreciation and amortization
12,883

 
12,436

Amortization of intangible assets
4,169

 
4,216

Deferred income taxes
(5,653
)
 
6,483

Stock-based compensation
9,132

 
9,172

Other non-cash (income) expense
(12
)
 
384

Changes in assets and liabilities, net of effect of acquisitions:
 

 
 

Accounts receivable
(5,333
)
 
6,441

Inventories
(21,063
)
 
6,114

Prepaid expenses and other assets
(4,857
)
 
(13,921
)
Other assets
1,984

 
582

Accounts payable
7,516

 
557

Income taxes payable/receivable
5,979

 
(9,871
)
Other current liabilities
3,821

 
21,894

Other long-term liabilities
(1,079
)
 
84

Net cash provided by operating activities
45,554

 
80,414

 
 
 
 
Cash flows from investing activities:
 

 
 

Purchases of property and equipment
(16,256
)
 
(12,210
)
Proceeds from dispositions of property and equipment
180

 
974

Purchases of available-for-sale securities
(84,629
)
 
(177,704
)
Proceeds from sales and maturities of available-for-sale securities
79,470

 
175,436

Net cash used in investing activities
(21,235
)
 
(13,504
)
 
 
 
 
Cash flows from financing activities:
 

 
 

Short-term borrowings
34,792

 
19,485

Repayments of short-term borrowings
(29,792
)
 
(19,485
)
Debt issuance costs
(2,137
)
 

Issuance of common stock under employee stock option and purchase plans
3,686

 
3,701

Repurchase of common stock

 
(25,009
)
Net settlement of restricted common stock
(5,344
)
 
(5,235
)
Net cash provided by (used in) financing activities
1,205

 
(26,543
)
Effect of exchange rate changes on cash and cash equivalents
1,045

 
(16,503
)
Net increase in cash and cash equivalents
26,569

 
23,864

Cash and cash equivalents, beginning of period
130,607

 
91,217

Cash and cash equivalents, end of period
$
157,176

 
$
115,081

 
 
 
 
Noncash investing and financing activities:
 
 
 
Unpaid property and equipment purchases
$
3,800

 
$
828


See Accompanying Notes to Condensed Consolidated Financial Statements.

7

Table of Contents

COHERENT, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
1.    BASIS OF PRESENTATION
 
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements and notes thereto should be read in conjunction with the Coherent, Inc. (referred to herein as the “Company,” “we,” “our,” “us” or “Coherent”) condensed consolidated financial statements and notes thereto filed on Form 10-K for the fiscal year ended October 3, 2015 . In the opinion of management, all adjustments necessary for a fair presentation of financial condition and results of operation as of and for the periods presented have been made and include only normal recurring adjustments. Interim results of operations are not necessarily indicative of results to be expected for the year or any other interim periods. Our fiscal year ends on the Saturday closest to September 30 and our second fiscal quarters include 13 and 14 weeks of operations in fiscal 2016 and 2015, respectively. Fiscal year 2016 includes 52 weeks and fiscal year 2015 includes 53 weeks. Certain reclassifications have been made to the prior period amounts to conform to the current period's presentation related to the reclassification of $28.1 million of current deferred income tax assets to non-current deferred income tax assets and non-current deferred income tax liabilities.
 
2.    RECENT ACCOUNTING STANDARDS
 
Adoption of New Accounting Pronouncements

In November 2015, the FASB issued amended guidance that clarifies that in a classified statement of financial position, an entity shall classify deferred tax liabilities and assets as noncurrent amounts. The new guidance supersedes ASC 740-10-45-5 which required the valuation allowance for a particular tax jurisdiction be allocated between current and noncurrent deferred tax assets for that tax jurisdiction on a pro rata basis. The new standard will become effective for our fiscal year beginning October 2, 2017. We elected to early adopt the standard retrospectively in the first quarter of fiscal 2016, which resulted in the reclassification of $28.1 million from current deferred income tax assets to non-current deferred income tax assets and non-current deferred income tax liabilities as of October 3, 2015.

In April 2015, the FASB issued amended guidance that simplifies the presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amended guidance. The new standard will become effective for our fiscal year beginning October 2, 2016. We elected to early adopt the standard in the second quarter of fiscal 2016 to record the debt issuance costs of $2.1 million in other assets for the debt commitment we entered into in the second quarter of fiscal 2016.

Recently Issued Accounting Pronouncements

In March 2016, the FASB issued amended guidance that simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. Under the new guidance, an entity recognizes all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement. This change eliminates the notion of the APIC pool and significantly reduces the complexity and cost of accounting for excess tax benefits and tax deficiencies. In addition, excess tax benefits and tax deficiencies are considered discrete items in the reporting period they occur and are not included in the estimate of an entity’s annual effective tax rate. The new standard will become effective for our fiscal year beginning October 2, 2017. We are currently assessing the impact of this amended guidance and the timing of adoption.

In February 2016, the FASB issued amended guidance to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The new guidance clarifies the criteria for distinguishing between a finance lease and operating lease, as well as classification between the two types of leases, which is substantially unchanged from the previous lease guidance.
Further, the new guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset, initially measured at the present value of the lease payments. For finance leases, a lessee should recognize interest on the lease liability separately from amortization of the right-of-use

8


asset. For operating leases, a lessee should recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election not to recognize lease assets and lease liabilities. The new standard will become effective for our fiscal year beginning September 29, 2019. We are currently assessing the impact of this amended guidance and the timing of adoption.
 
In January 2016, the FASB issued amended guidance that revises the recognition and measurement of financial instruments. The new guidance requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The new standard will become effective for our fiscal year beginning September 30, 2018. We are currently assessing the impact of this amended guidance and the timing of adoption.

3.     BUSINESS COMBINATIONS
Rofin-Sinar Technologies, Inc.
On March 16, 2016, we entered into a definitive agreement to acquire Rofin-Sinar Technologies, Inc. ("Rofin"), one of the world's leading developers and manufacturers of high-performance industrial laser sources and laser-based solutions and components. The acquisition will be an all-cash transaction at a price of $32.50 per share of Rofin common stock for a total approximate offer value of $942 million before fees and transaction costs. The completion of the acquisition is subject to customary closing conditions, including regulatory approvals.
Fiscal 2015 Acquisitions
Raydiance, Inc.
On July 24, 2015, we acquired certain assets of Raydiance, Inc. ("Raydiance") for approximately $5.0 million , excluding transaction costs. Raydiance manufactured complete tools and lasers for ultrafast processing systems and subsystems in the precision micromachining processing market. The Raydiance assets have been included in our Specialty Lasers and Systems segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets
$
1,048

Goodwill
1,552

Intangible assets:
 
    Existing technology
800

    Customer lists
1,600

Total
$
5,000

The purchase price allocated to goodwill was finalized in the first quarter of fiscal 2016, with an increase of $0.4 million and a corresponding decrease of $0.4 million to tangible assets, and has been updated from the preliminary allocation in the fourth quarter of fiscal 2015.
Results of operations for the business have been included in our consolidated financial statements subsequent to the date of acquisition and pro forma results of operations in accordance with authoritative guidance for prior periods have not been presented because the effect of the acquisition was not material to our prior period consolidated financial results.
The identifiable intangible assets are being amortized over their respective useful lives o f three to five years.
None of the goodwill from this purchase is deductible for tax purposes.
We expensed $0.1 million of acquisition-related costs as selling, general and administrative expenses in our consolidated statements of operations for our fiscal year 2015.
Tinsley Optics

9


On July 27, 2015, we acquired the assets and certain liabilities of the Tinsley Optics ("Tinsley") business from L-3 Communications Corporation for approximately $4.3 million , excluding transaction costs. Tinsley is a specialized manufacturer of high precision optical components and subsystems sold primarily in the aerospace and defense industry. Tinsley manufactures the large form factor optics for our excimer laser annealing systems. Tinsley has been included in our Specialty Lasers and Systems segment.
Our allocation of the purchase price is as follows (in thousands):
Tangible assets:
 
  Inventories
$
2,240

  Accounts receivable
2,263

  Prepaid expenses and other assets
1,132

  Property and equipment
2,451

Liabilities assumed
(1,702
)
Deferred tax liabilities
(768
)
Gain on business combination
(1,316
)
Total
$
4,300

The purchase price was lower than the fair value of net assets purchased, resulting in a gain of $1.3 million recorded as a separate line item in our consolidated statements of operations for our fiscal year 2015. We reassessed the recognition and measurement of identifiable assets acquired and liabilities assumed and concluded that all acquired assets and assumed liabilities were recognized and that the valuation procedures and resulting measures were appropriate.
Results of operations for the business have been included in our consolidated financial statements subsequent to the date of acquisition and pro forma results of operations in accordance with authoritative guidance for prior periods have not been presented because the effect of the acquisition was not material to our prior period consolidated financial results.
The gain from the bargain purchase is not subject to income taxation.
We expensed $0.4 million of acquisition-related costs as selling, general and administrative expenses in our consolidated statements of operations for our fiscal year 2015.

4.      FAIR VALUES
 
We have not changed our valuation techniques in measuring the fair value of any financial assets and liabilities during the period. We recognize transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. As of April 2, 2016 and October 3, 2015 , we did not have any assets or liabilities valued based on Level 3 valuations.

Financial assets and liabilities measured at fair value as of April 2, 2016 and October 3, 2015 are summarized below (in thousands):

10


 
 
Aggregate Fair Value
 
Quoted Prices
in
Active Markets
for Identical
Assets
 
Significant
Other
Observable
Inputs
 
Aggregate Fair Value
 
Quoted Prices
in
Active Markets
for Identical
Assets
 
Significant
Other
Observable
Inputs
 
 
April 2, 2016
 
October 3, 2015
 
 
 
 
(Level 1)
 
(Level 2)
 
 
 
(Level 1)
 
(Level 2)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
Money market fund deposits
 
$
32,184

 
$
32,184

 
$

 
$
8,297

 
$
8,297

 
$

Short-term investments:
 


 
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency obligations (2)
 
$
140,766

 
$

 
$
140,766

 
$
150,748

 
$

 
$
150,748

Corporate notes and obligations (2)
 
35,190

 

 
35,190

 
17,942

 

 
17,942

Commercial paper (2)
 
7,464

 

 
7,464

 
9,740

 

 
9,740

Equity securities (1)
 
20,462

 
20,462

 

 
16,478

 
16,478

 

Prepaid and other assets:
 


 
 
 
 
 
 
 
 
 
 
Foreign currency contracts (3)
 
3,152

 

 
3,152

 
258

 

 
258

Mutual funds — Deferred comp and supplemental plan (4)
 
12,301

 
12,301

 

 
13,891

 
13,891

 

Total
 
$
251,519

 
$
64,947

 
$
186,572

 
$
217,354

 
$
38,666

 
$
178,688

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Other current liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency contracts (3)
 
$
(1,904
)
 
$

 
$
(1,904
)
 
$
(239
)
 
$

 
$
(239
)
Total
 
$
249,615

 
$
64,947

 
$
184,668

 
$
217,115

 
$
38,666

 
$
178,449


 ___________________________________________________

(1)
Valuations are based upon quoted market prices.

(2)
Valuations are based upon quoted market prices in active markets involving similar assets. The market inputs used to value these instruments generally consist of market yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Pricing sources include industry standard data providers, security master files from large financial institutions, and other third party sources which are input into a distribution-curve-based algorithm to determine a daily market value. This creates a “consensus price” or a weighted average price for each security.

(3)
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants usually are large commercial banks. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. At April 2, 2016 , prepaid expenses and other assets include $3,152 non-designated forward contracts; other current liabilities include $1,904 non-designated forward contracts. At October 3, 2015 , prepaid expenses and other assets include $217 non-designated forward contracts and $41 foreign currency contracts designated for cash flow hedges, respectively; other current liabilities include $239 non-designated forward contracts and $0 foreign currency contracts designated for cash flow hedges respectively. See Note 6, "Derivative Instruments and Hedging Activities".

(4)
The fair value of mutual funds is determined based on quoted market prices. Securities traded on a national exchange are stated at the last reported sales price on the day of valuation; other securities traded in over-the-counter markets and listed securities for which no sale was reported on that date are stated as the last quoted bid price.


11


5.               SHORT-TERM INVESTMENTS
 
We consider all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Investments classified as available-for-sale are reported at fair value with unrealized gains and losses, net of related income taxes, recorded as a separate component of other comprehensive income (“OCI”) in stockholders’ equity until realized. Interest and amortization of premiums and discounts for debt securities are included in interest income. Gains and losses on securities sold are determined based on the specific identification method and are included in other income (expense).

Cash, cash equivalents and short-term investments consist of the following (in thousands):
 
 
April 2, 2016
 
Cost Basis
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Cash and cash equivalents
$
157,176

 
$

 
$

 
$
157,176

 
 
 
 

 
 

 
 
Short-term investments:
 

 
 

 
 

 
 

Available-for-sale securities:
 

 
 

 
 

 
 

Commercial paper
$
7,464

 
$

 
$

 
$
7,464

U.S. Treasury and agency obligations
139,943

 
854

 
(31
)
 
140,766

Corporate notes and obligations
35,093

 
104

 
(7
)
 
35,190

Equity Securities
15,269

 
5,193

 

 
20,462

Total short-term investments
$
197,769

 
$
6,151

 
$
(38
)
 
$
203,882

 
 
October 3, 2015
 
Cost Basis
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Cash and cash equivalents
$
130,607

 
$

 
$

 
$
130,607

 
 
 
 

 
 

 
 
Short-term investments:
 

 
 

 
 

 
 

Available-for-sale securities:
 

 
 

 
 

 
 

Commercial paper
$
9,740

 
$

 
$

 
$
9,740

       U.S. Treasury and agency obligations
149,708

 
1,040

 

 
150,748

Corporate notes and obligations
17,892

 
52

 
(2
)
 
17,942

Equity securities
15,269

 
1,209

 

 
16,478

Total short-term investments
$
192,609

 
$
2,301

 
$
(2
)
 
$
194,908


None of the unrealized losses as of April 2, 2016 or October 3, 2015 were considered to be other-than-temporary impairments.

The amortized cost and estimated fair value of available-for-sale investments in debt securities as of April 2, 2016 and October 3, 2015 classified as short-term investments on our condensed consolidated balance sheet were as follows (in thousands):
 
 
April 2, 2016
 
October 3, 2015
 
Amortized Cost
 
Estimated Fair Value
 
Amortized Cost
 
Estimated Fair Value
Investments in available-for-sale debt securities due in less than one year
$
163,210

 
$
164,061

 
$
148,088

 
$
149,100

Investments in available-for-sale debt securities due in one to five years (1)
$
19,290

 
$
19,359

 
$
29,252

 
$
29,330

 

12


(1) Classified as short-term investments because these securities are highly liquid and can be sold at any time.

During the three and six months ended April 2, 2016 , we received proceeds totaling $13.5 million and $28.6 million , respectively, from the sale of available-for-sale securities and realized gross gains of less than $0.1 million and $0.1 million , respectively. During the three and six months ended April 4, 2015 , we received proceeds totaling $48.3 million and $77.8 million , respectively, from the sale of available-for-sale securities and realized gross gains of less than $0.1 million and $0.1 million , respectively.

6.     DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 
We maintain operations in various countries outside of the United States and have foreign subsidiaries that manufacture and sell our products in various global markets. The majority of our sales are transacted in U.S. dollars. However, we do generate revenues in other currencies, primarily the Euro, Japanese Yen, South Korean Won and Chinese Renminbi (RMB). As a result, our earnings, cash flows and cash balances are exposed to fluctuations in foreign currency exchange rates. We attempt to limit these exposures through financial market instruments. We utilize derivative instruments, primarily forward contracts with maturities of two months or less, to manage our exposure associated with anticipated cash flows and net asset and liability positions denominated in foreign currencies. Gains and losses on the forward contracts are mitigated by gains and losses on the underlying instruments. We do not use derivative financial instruments for speculative or trading purposes. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date.
 
For derivative instruments that are not designated as hedging instruments, gains and losses are recognized in other income (expense).

Non-Designated Derivatives
The outstanding notional contract and fair value asset (liability) amounts of non-designated hedge contracts, with maximum maturity of two months, are as follows (in thousands):
 
U.S. Notional Contract Value
 
U.S. Fair Value
 
April 2, 2016
 
October 3, 2015
 
April 2, 2016
 
October 3, 2015
Euro currency hedge contracts
 

 
 

 
 

 
 

Purchase
$
63,507

 
$
52,699

 
$
2,919

 
$
33

 
 
 
 
 
 
 
 
Japanese Yen currency hedge contracts
 
 
 
 
 
 
 
  Purchase
$
2,000

 
$
558

 
$
66

 
$
8

  Sell
$
(36,480
)
 
$
(15,804
)
 
$
(406
)
 
$
(84
)
 
 
 
 
 
 
 
 
South Korean Won currency hedge contracts
 
 
 
 
 
 
 
  Purchase
$

 
$
253

 
$

 
$

  Sell
$
(15,872
)
 
$
(17,747
)
 
$
(1,154
)
 
$
30

 
 
 
 
 
 
 
 
Chinese RMB currency hedge contracts
 
 
 
 
 
 
 
  Sell
$
(10,538
)
 
$
(10,900
)
 
$
(193
)
 
$
(106
)
 
 
 
 
 
 
 
 
Other foreign currency hedge contracts
 

 
 

 
 

 
 

Purchase
$
4,313

 
$
3,283

 
$
167

 
$
(49
)
Sell
$
(2,070
)
 
$
(5,835
)
 
$
(151
)
 
$
146


Designated Derivatives
Cash flow hedges related to anticipated transactions are designated and documented at the inception of the hedge when we enter into contracts for specific future transactions. Cash flow hedges are evaluated for effectiveness quarterly. The

13


effective portion of the gain or loss on these hedges is reported as a component of OCI in stockholder's equity and is reclassified into earnings when the underlying transaction affects earnings. We had no cash flow hedges outstanding at April 2, 2016 . Changes in the fair value of currency forward contracts due to changes in time value are excluded from the assessment of effectiveness and recognized in other income (expense) as incurred. We classify the cash flows from the foreign exchange forward contracts that are accounted for as cash flow hedges in the same section as the underlying item, primarily within cash flows from operating activities since we do not designate our cash flow hedges as investing or financing activities.

The outstanding notional contract and fair value asset (liability) amounts of designated cash flow hedge contracts, with maximum maturity of thirteen months, are as follows (in thousands):
 
U.S. Notional Contract Value
 
U.S. Fair Value
 
April 2, 2016
 
October 3, 2015
 
April 2, 2016
 
October 3, 2015
Japanese Yen currency hedge contracts

 
 
 
 
 
 
 
Sell
$

 
$
(2,093
)
 
$

 
$
41


We have entered into certain derivative forward contracts to sell Japanese Yen and buy Euro to hedge revenue exposures related to our photonics-based solutions in Asia. In order to facilitate the hedge, we transact with counterparties in the U.S. directly and then allocate the hedge contracts to our affiliates through a back-to-back relationship with our German subsidiary. The German subsidiary designates these hedge contracts as cash flow hedges under ASC 815, none of which were outstanding at April 2, 2016 .
 
The fair value of our derivative instruments is included in prepaid expenses and other assets and in other current liabilities in our Condensed Consolidated Balance Sheets (see Note 4 "Fair Values").

The locations and amounts of designated and non-designated derivative instruments' gains and losses in the condensed consolidated financial statements for the indicated periods were as follows (in thousands):
 
 
Location in financial statements
Three Months Ended
 
Six Months Ended
 
April 2, 2016
 
April 4, 2015
 
April 2, 2016
 
April 4, 2015
Derivatives designated as hedging instruments
 

 

 
 

 
 

 
 

Gains(losses) in OCI on derivatives (effective portion), after tax
 
OCI
$
2

 
$
175

 
$
(28
)
 
$
550

Losses reclassified from OCI into income (effective portion)
 
Cost of sales
$

 
$
(1,106
)
 
$

 
$
(1,720
)
Gains(losses) reclassified from OCI into income (effective portion)
 
Revenue
$
(58
)
 
$
(92
)
 
$
(58
)
 
$
208

Losses recognized in income on derivatives (ineffective portion and amount excluded from effectiveness testing)
 
Other income(expense)
$
(1
)
 
$
(77
)
 
$
(30
)
 
$
(112
)
Derivatives not designated as hedging instruments
 



 


 


 


Losses recognized in income
 
Other income(expense)
$
(180
)
 
$
(5,413
)
 
$
(2,511
)
 
$
(6,125
)
 
During the first quarter of fiscal 2016 we recognized a loss of $31 in other income (expense) as ineffectiveness related to a portion of an anticipated hedged transaction that failed to occur within the original hedge period plus two months. During the three and six months ended April 4, 2015 we recognized a loss of $106 in other income (expense) as ineffectiveness related to a portion of an anticipated hedged transaction that failed to occur within the original hedge period plus two months. The remainder of the hedged transactions occurred as expected and effective amounts were recognized in revenue as disclosed in the above table.

The amounts that are reclassified from OCI to earnings are generally offset by the recognition of the hedged transactions (e.g., anticipated cost of sales) in earnings, thereby achieving the realization of prices contemplated by the underlying risk

14


management strategies and vary from the expected amounts presented above as a result of changes in foreign exchange rates.

To mitigate credit risk in derivative transactions, we enter into master netting arrangements that allow each counterparty in the arrangements to net settle amounts of multiple and separate derivative transactions under certain conditions. We present the fair value of derivative assets and liabilities within our condensed consolidated balance sheet on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. Our derivative contracts do not contain any credit risk related contingent features and do not require collateral or other security to be furnished by us or the counterparties.

Offsetting of Financial Assets/Liabilities under Master Netting Agreements with Derivative Counterparties as of April 2, 2016 and October 3, 2015 (in thousands):
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
 
 
Gross Amounts of Recognized Derivative Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts of Derivative Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments (1)
 
Cash Collateral Received
 
Net Amounts
 
As of April 2, 2016:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
3,152

 
$

 
$
3,152

 
$
(1,186
)
 
$

 
$
1,966

 
As of October 3, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
258

 
$

 
$
258

 
$
(116
)
 
$

 
$
142

 
(1) The balances at April 2, 2016 and October 3, 2015 were related to derivative liabilities which are allowed to be net settled against derivative assets in accordance with the master netting agreements.

 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
 
 
Gross Amounts of Recognized Derivative Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts of Derivative Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments (1)
 
Cash Collateral Paid
 
Net Amounts
 
As of April 2, 2016:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
(1,904
)
 
$

 
$
(1,904
)
 
$
1,186

 
$

 
$
(718
)
 
As of October 3, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
(239
)
 
$

 
$
(239
)
 
$
116

 
$

 
$
(123
)
 
(1) The balances at April 2, 2016 and October 3, 2015 were related to derivative assets which are allowed to be net settled against derivative liabilities in accordance with the master netting agreements.

7.    GOODWILL AND INTANGIBLE ASSETS

15


 
During the six months ended April 2, 2016 , we noted no indications of impairment or triggering events to cause us to review goodwill for potential impairment. We will conduct our annual goodwill testing during the fourth fiscal quarter.
 
The changes in the carrying amount of goodwill by segment for the period from October 3, 2015 to April 2, 2016 are as follows (in thousands):
 
Specialty
Lasers and
Systems
 
Commercial
Lasers and
Components
 
Total
Balance as of October 3, 2015
$
95,454

 
$
6,363

 
$
101,817

Translation adjustments and other
1,059

 

 
1,059

Balance as of April 2,2016
$
96,513

 
$
6,363

 
$
102,876

 
Components of our amortizable intangible assets are as follows (in thousands):

 
April 2, 2016
 
October 3, 2015
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Existing technology
$
71,384

 
$
(58,701
)
 
$
12,683

 
$
71,365

 
$
(55,452
)
 
$
15,913

Customer lists
16,141

 
(10,733
)
 
5,408

 
16,099

 
(9,661
)
 
6,438

Trade name
393

 
(353
)
 
40

 
399

 
(349
)
 
50

In-process research & development
379

 

 
379

 
375

 

 
375

Total
$
88,297

 
$
(69,787
)
 
$
18,510

 
$
88,238

 
$
(65,462
)
 
$
22,776

 
For accounting purposes, when an intangible asset is fully amortized, it is removed from the disclosure schedule.

Amortization expense for intangible assets for the six months ended April 2, 2016 and April 4, 2015 was $4.2 million and $4.2 million , respectively, which includes $3.1 million and $3.3 million , respectively, for amortization of existing technology. The change in the accumulated amortization also includes $0.1 million and $3.5 million of foreign exchange impact for the six months ended April 2, 2016 and April 4, 2015 , respectively.

At April 2, 2016 , estimated amortization expense for the remainder of fiscal 2016 , the next five succeeding fiscal years and all fiscal years thereafter are as follows (in thousands):
 
Estimated
Amortization
Expense
2016 (remainder)
$
3,925

2017
7,136

2018
4,362

2019
2,228

2020
696

2021
54

Thereafter
109

Total
$
18,510


8.     BALANCE SHEET DETAILS
 
Inventories consist of the following (in thousands):
 
April 2,
2016
 
October 3,
2015
Purchased parts and assemblies
$
54,339

 
$
50,182

Work-in-process
70,632

 
56,225

Finished goods
54,096

 
50,207

Total inventories
$
179,067

 
$
156,614

 
Prepaid expenses and other assets consist of the following (in thousands):
 
April 2,
2016
 
October 3,
2015
Prepaid and refundable income taxes
$
9,880

 
$
8,846

Other taxes receivable
7,177

 
6,574

Prepaid expenses and other assets
17,545

 
12,874

Total prepaid expenses and other assets
$
34,602

 
$
28,294

 

16


Other assets consist of the following (in thousands):
 
April 2,
2016
 
October 3,
2015
Assets related to deferred compensation arrangements
$
23,352

 
$
25,131

Deferred tax assets
64,027

 
60,254

Other assets
6,067

 
3,841

Total other assets
$
93,446

 
$
89,226

 
For our $850.0 million debt financing commitment with Barclays (See Note 9 "Short-term Borrowings"), we paid $2.1 million of debt issuance costs in the second quarter of fiscal 2016 and recorded it to other assets.

Other current liabilities consist of the following (in thousands):
 
April 2,
2016
 
October 3,
2015
Accrued payroll and benefits
$
37,706

 
$
35,504

Deferred revenue
17,772

 
16,474

Warranty reserve
14,972

 
15,308

Accrued expenses and other
11,908

 
10,965

Other taxes payable
5,586

 
4,888

Customer deposits
1,864

 
1,793

Total other current liabilities
$
89,808

 
$
84,932

 
 
Components of the reserve for warranty costs during the first six months of fiscal 2016 and 2015 were as follows (in thousands):
 
Six Months Ended
 
April 2,
2016
 
April 4,
2015
Beginning balance
$
15,308

 
$
16,961

Additions related to current period sales
10,412

 
11,618

Warranty costs incurred in the current period
(10,693
)
 
(10,822
)
Adjustments to accruals related to foreign exchange and other
(55
)
 
(1,816
)
Ending balance
$
14,972

 
$
15,941

 
Other long-term liabilities consist of the following (in thousands):
 
April 2,
2016
 
October 3,
2015
Long-term taxes payable
$
7,823

 
$
7,651

Deferred compensation
24,938

 
26,691

Deferred tax liabilities
2,259

 
2,717

Deferred income
3,722

 
3,149

Asset retirement obligations liability
2,726

 
2,654

Other long-term liabilities
7,715

 
7,077

Total other long-term liabilities
$
49,183

 
$
49,939

 
9.     SHORT-TERM BORROWINGS
 
We have several lines of credit which allow us to borrow in the applicable local currency. We have a total of $13.7 million of unsecured foreign lines of credit as of April 2, 2016 . At April 2, 2016 , we had used $2.0 million of these available foreign lines of credit as guarantees. These credit facilities were used in Europe and Japan during the second fiscal quarter of 2016 . In addition, our domestic line of credit consists of a $50.0 million unsecured revolving credit account. The agreement will expire on May 31, 2017. The line of credit is subject to covenants related to financial ratios and tangible net worth with which we are currently in compliance.  We have an outstanding balance of $5.0 million and have used $1.1 million for letters of credit against our domestic line of credit as of April 2, 2016 .

On March 16, 2016, we entered into a debt commitment letter with Barclays Bank PLC ("Barclays") and on April 5, 2016, entered into an amended and restated debt commitment letter with Barclays and both Bank of America, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (together, "BAML"). Pursuant to the commitment letter, among other things, Barclays and BAML have committed to provide us with debt financing in an aggregate principal amount of up to $850.0 million to finance the acquisition of Rofin. The obligations of Barclays and BAML under the commitment letter are subject to certain conditions, including the consummation of the acquisition in accordance with the terms and conditions of the definitive agreement and other customary closing obligations. For our $850.0 million debt financing commitment with Barclays and BAML, we paid $2.1 million of debt issuance costs in the second quarter of fiscal 2016 and recorded it to other assets on our condensed consolidated balance sheets. The debt issuance cost will be reclassified when there is an outstanding debt.

10.  STOCK-BASED COMPENSATION
 
Fair Value of Stock Compensation
 
We recognize compensation expense for all share based payment awards based on the fair value of such awards. The expense is recognized on a straight-line basis over the respective requisite service period of the awards.
 
Determining Fair Value
 
The fair values of shares purchased under the Employee Stock Purchase Plan (“ESPP”) for the three and six months ended April 2, 2016 and April 4, 2015 , respectively, were estimated using the following weighted-average assumptions:
 
 
Employee Stock Purchase Plan
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
Expected life in years
 
0.5

 
0.5

 
0.5

 
0.5

 
Expected volatility
 
26.0
%
 
24.8
%
 
27.4
%
 
24.8
%
 
Risk-free interest rate
 
0.3
%
 
0.1
%
 
0.2
%
 
0.1
%
 
Expected dividend yield
 
%
 
%
 
%
 
%
 
Weighted average fair value per share
 
$
12.50

 
$
14.26

 
$
12.89

 
$
14.11

 

There were no stock options granted during the three and six months ended April 2, 2016 and April 4, 2015 .


17


We grant performance restricted stock units to officers and certain employees. The performance restricted stock unit agreements provide for the award of performance restricted stock units with each unit representing the right to receive one share of our common stock to be issued after the applicable award vesting period. The final number of units awarded, if any, for these performance grants will be determined as of the vesting dates, based upon our total shareholder return over the performance period compared to the Russell 2000 Index and could range from no units to a maximum of twice the initial award units. The weighted average fair value for these performance units was determined using a Monte Carlo simulation model incorporating the following weighted average assumptions:
 
 
Six Months Ended
 
 
April 2, 2016
 
April 4, 2015
Risk-free interest rate
 
1.20
%
 
0.96
%
Volatility
 
27.0
%
 
28.7
%
Weighted average fair value
 
$
74.48

 
$
70.57


We recognize the estimated cost of these awards, as determined under the simulation model, over the related service period, with no adjustment in future periods based upon the actual shareholder return over the performance period.
 
Stock-Based Compensation Expense
 
The following table shows total stock-based compensation expense and related tax benefits included in the condensed consolidated statements of operations for the three and six months ended April 2, 2016 and April 4, 2015 (in thousands):
 
Three Months Ended
 
Six Months Ended
 
 
April 2, 2016
 
April 4, 2015
 
April 2, 2016
 
April 4, 2015
 
Cost of sales
$
594

 
$
676

 
$
1,199

 
$
1,273

 
Research and development
610

 
556

 
1,036

 
886

 
Selling, general and administrative
4,183

 
3,550

 
6,897

 
7,013

 
Income tax benefit
(1,511
)
 
(1,303
)
 
(1,862
)
 
(1,733
)
 
 
$
3,876

 
$
3,479

 
$
7,270

 
$
7,439

 

During the three and six months ended April 2, 2016 , $0.7 million and $1.3 million was capitalized into inventory for all stock plans, $0.6 million and $1.2 million was amortized to cost of sales and $0.8 million remained in inventory at April 2, 2016 . During the three and six months ended April 4, 2015 , $0.7 million and $1.4 million was capitalized into inventory for all stock plans, $0.7 million and $1.3 million was amortized to cost of sales and $0.8 million remained in inventory at April 4, 2015
 
At April 2, 2016 , the total compensation cost related to unvested stock-based awards granted to employees under the Company’s stock plans but not yet recognized was approximately $31.0 million , net of estimated forfeitures of $1.4 million . This cost will be amortized on a straight-line basis over a weighted-average period of approximately 1.6 years and will be adjusted for subsequent changes in estimated forfeitures.

At April 2, 2016 , total compensation cost related to options to purchase common shares under the ESPP but not yet vested was approximately $0.1 million , which will be recognized over the six month offering period.
 
Stock Awards Activity
  
The following table summarizes the activity of our time-based and performance restricted stock units for the first six months of fiscal 2016 (in thousands, except per share amounts):


18


 
Time Based Restricted Stock Units
 
Market-Based Performance Restricted Stock Units
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Nonvested stock units at October 3, 2015
394

 
$
65.17

 
199

 
$
67.09

Granted
269

 
64.30

 
65

 
74.48

Vested (1)
(190
)
 
61.15

 
(57
)
 
48.48

Forfeited
(11
)
 
63.72

 
(38
)
 
48.48

Nonvested stock at April 2, 2016
462

 
$
66.35

 
169

 
$
74.10


__________________________________________
(1) Service-based restricted stock vested during each fiscal year. Performance-based awards and units included at 100% of target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the award.

11.       COMMITMENTS AND CONTINGENCIES
 

19


We are subject to legal claims and litigation arising in the ordinary course of business, such as product liability, employment or intellectual property claims, including, but not limited to, the matters described below. On May 14, 2013, IMRA America (“Imra”) filed a complaint for patent infringement against two of our subsidiaries in the Regional Court of Düsseldorf, Germany, captioned In re IMRA America Inc. versus Coherent Kaiserslautern GmbH et. al. 4b O 38/13. The complaint alleges that the use of certain of the Company’s lasers infringes upon EP Patent No. 754,103, entitled “Method For Controlling Configuration of Laser Induced Breakdown and Ablation,” issued November 5, 1997. The patent, now expired in all jurisdictions, is owned by the University of Michigan and licensed to Imra. The complaint seeks unspecified compensatory damages, the cost of court proceedings and seeks to permanently enjoin the Company from infringing the patent in the future. Following the filing of the infringement suit, our subsidiaries filed a separate nullity action with the Federal Patent Court in Munich, Germany requesting that the court hold that the Patent was invalid based on prior art. On October 1, 2015, the Federal Patent Court ruled that the German portion of the Patent was invalid. Imra has filed a notice to appeal this decision to the Federal Court of Justice, the highest civil jurisdiction court in Germany. The infringement action is currently stayed pending the outcome of such appeal. Management has made an accrual with respect to this matter and has determined, based on its current knowledge, that the amount or range of reasonably possible losses in excess of the amounts already accrued is not reasonably estimable. Although we do not expect that such legal claims and litigation will ultimately have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows, an adverse result in one or more matters could negatively affect our results in the period in which they occur.
The United States and many foreign governments impose tariffs and duties on the import and export of certain products we sell. From time to time our duty calculations and payments are audited by government agencies. During the second quarter of fiscal 2016, we concluded an audit in South Korea for customs duties and value added tax for the period March 2009 to March 2014. We paid $1.6 million related to this matter and have no remaining accrual at April 2, 2016 .

On March 16, 2016, we entered into a debt commitment letter with Barclays Bank PLC ("Barclays") and on April 5, 2016, entered into an amended and restated debt commitment letter with Barclays and both Bank of America, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (together, "BAML"). Pursuant to the commitment letter, among other things, Barclays and BAML have committed to provide us with debt financing in an aggregate principal amount of up to $850.0 million to finance the acquisition of Rofin. The obligations of Barclays and BAML under the commitment letter are subject to certain conditions, including the consummation of the acquisition in accordance with the terms and conditions of the definitive agreement and other customary closing obligations. For our $850.0 million debt financing commitment with Barclays and BAML, we paid $2.1 million of debt issuance costs in the second quarter of fiscal 2016 and recorded it to other assets on our condensed consolidated balance sheets.

We have an agreement with a financial advisor, Barclays, in relation to the pending acquisition of Rofin. We have agreed to pay Barclays a fee of approximately $10.5 million , $1.0 million of which was paid upon delivery of the fairness opinion in the second quarter of fiscal 2016, and was recorded in the selling, general and administrative line of the condensed consolidated statements of operations, and the remaining portion of which will be paid upon, and subject to, consummation of the acquisition. We have also agreed to pay to Barclays approximately $17.0 million and $7.5 million for underwriting and upfront fees, respectively, upon the close of the financing. In addition, the acquisition agreement contains certain termination rights for Coherent and further provides that we may be required to pay a termination fee of $ 65.0 million to Rofin and $2.4 million to Barclays.

12. STOCK REPURCHASE

On July 25, 2014, the Board of Directors authorized a buyback program whereby we were authorized to repurchase up to $25.0 million of our common stock from time to time through July 31, 2015. During the first quarter of fiscal 2015, we repurchased and retired 300,441 shares of outstanding common stock at an average price of $57.55 per share for a total of $17.3 million , excluding expenses. During the second quarter of fiscal 2015, we repurchased and retired 133,673 shares of outstanding common stock under this plan at an average price of $57.66 per share for a total of $7.7 million , completing the repurchase program.

On January 21, 2015, our Board of Directors authorized an additional stock repurchase program to repurchase up to $25.0 million of our outstanding common stock from time to time through January 31, 2016. During the fourth quarter of fiscal 2015, we repurchased and retired 430,675 shares of outstanding common stock under this plan at an average price of $58.05 per share for a total of $25.0 million .


20


On August 25, 2015, our Board of Directors authorized an additional stock repurchase program to repurchase up to $25.0 million of our outstanding common stock from time to time through August 31, 2016. During the fourth quarter of fiscal 2015, we repurchased and retired 437,534 shares of outstanding common stock under this plan at an average price of $57.14 per share for a total of $25.0 million .

13.  EARNINGS PER SHARE
 
Basic earnings per share is computed based on the weighted average number of shares outstanding during the period, excluding unvested restricted stock. Diluted earnings per share is computed based on the weighted average number of shares outstanding during the period increased by the effect of dilutive employee stock awards, including stock options, restricted stock awards and stock purchase plan contracts, using the treasury stock method.
 
The following table presents information necessary to calculate basic and diluted earnings per share (in thousands, except per share data): 
 
Three Months Ended
 
Six Months Ended
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
Weighted average shares outstanding —basic
24,137

 
24,709

 
24,066

 
24,823

 
Dilutive effect of employee stock awards
225

 
182

 
233

 
219

 
Weighted average shares outstanding—diluted
24,362

 
24,891

 
24,299

 
25,042

 
 
 
 
 
 
 
 
 
 
Net income
$
17,781

 
$
18,413

 
$
38,067

 
$
35,843

 
 
 
 
 
 
 
 
 
 
Net income per basic share
$
0.74

 
$
0.75

 
$
1.58

 
$
1.44

 
Net income per diluted share
$
0.73

 
$
0.74

 
$
1.57

 
$
1.43

 
 
A total of 7,078 and 9,451 potentially dilutive securities have been excluded from the diluted share calculation for the three and six months ended April 2, 2016 as their effect was anti-dilutive. A total of 1,333 and 41,559 potentially dilutive securities have been excluded from the diluted share calculation for the three and six months ended April 4, 2015 as their effect was anti-dilutive.
 
14.   OTHER INCOME (EXPENSE)
 
Other income (expense) is as follows (in thousands): 
 
Three Months Ended
 
Six Months Ended
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
Foreign exchange gain (loss)
$
(198
)
 
$
1,080

 
$
(1,520
)
 
$
(81
)
 
Gain (loss) on deferred compensation investments, net
(1,877
)
 
671

 
(1,002
)
 
1,055

 
Other
62

 
92

 
62

 
99

 
Other - net
$
(2,013
)
 
$
1,843

 
$
(2,460
)
 
$
1,073

 

15.  INCOME TAXES
 
Income tax expense includes a provision for federal, state and foreign taxes based on the annual estimated effective tax rate applicable to us and our subsidiaries, adjusted for items which are considered discrete to the period. Our effective tax rates for the three and six months ended April 2, 2016 were 26.6% and 25.8% , respectively. Our effective tax rates for the three and six months ended April 2, 2016 were lower than the statutory rate of 35.0% primarily due to differences related to the benefit of income subject to foreign tax rates that are lower than U.S. tax rates including the Singapore tax exemption, the benefit of foreign tax credits and the benefit of federal research and development tax credits including renewal of the federal research and development tax credits for fiscal 2015. These amounts are partially offset by deemed dividend inclusions under the Subpart F tax rules, stock-based compensation not deductible for tax purposes and limitations on the deductibility of compensation under IRC Section 162(m).

Our effective tax rates for the three and six months ended April 4, 2015 were 23.7% and 24.9% , respectively. Our effective tax rates for the three and six months ended April 4, 2015 were lower than the statutory rate of 35.0% primarily due to differences related to the benefit of income subject to foreign tax rates that are lower than U.S. statutory tax rates including South Korea and Singapore tax exemptions, the benefit of foreign tax credits and the benefit of the federal research and development tax credits including renewal of the federal research and development tax credits for fiscal 2014. These

21


amounts are partially offset by deemed dividend inclusions under the Subpart F tax rules, stock-based compensation not deductible for tax purposes and limitations on the deductibility of compensation under IRC Section 162(m).

Determining the consolidated provision for income taxes, income tax liabilities and deferred tax assets and liabilities involves judgment. We calculate and provide for income taxes in each of the tax jurisdictions in which we operate, which involves estimating current tax exposures as well as making judgments regarding the recoverability of deferred tax assets in each jurisdiction. The estimates used could differ from actual results, which may have a significant impact on operating results in future periods.

We are subject to taxation and file income tax returns in the U.S. federal jurisdiction and in many state and foreign jurisdictions. For U.S. federal income tax purposes, all years prior to 2011 are closed. In our major foreign jurisdictions and our major state jurisdictions, the years prior to 2006 and 2011, respectively, are closed to examination. Earlier years in our various jurisdictions may remain open for adjustment to the extent that we have tax attribute carryforwards from those years. In March 2016, the Internal Revenue Service (IRS) issued an audit notice and Information Documentation Requests (IDRs) for fiscal year 2013. We have responded to the IDRs and the IRS field work will begin soon. In December 2011 and January 2012, three of our German subsidiaries received notices of tax audits for the fiscal years 2006 through 2010. In fiscal year 2013, we received a preliminary assessment for two of the German subsidiaries and the amount is immaterial. In September 2015, the German tax authorities issued preliminary tax findings for Coherent GmbH for the years 2006 to 2010 and Coherent management met with the German tax authorities in December 2015 to discuss the preliminary assessments. Coherent Management anticipates that the German tax authorities will issue the final audit assessment in the third quarter of fiscal 2016. In July 2015 and March 2016, Coherent Kaiserslautern GmbH (formerly Lumera Laser GmbH) received tax audit notices for the years 2010 to 2014. The audit began in August 2015. We acquired the shares of Lumera Laser GmbH in December 2012 and we should not have responsibility for any assessments related to the pre-acquisition period. In March 2016, Coherent Japan KK received a tax audit notice for the years 2013 to 2015. The audit will begin in July 2016.

Management believes that it has adequately provided reserves for any adjustments that may result from tax examinations. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that certain federal, foreign and state tax matters may be concluded in the next 12 months.

The Consolidated Appropriations Act of 2016 (“the Act”), was enacted on December 18, 2015. Under the Act, the federal research and development tax credit was retroactively extended for amounts paid or incurred after December 31, 2014
through December 31, 2015 and the credit was made permanent. The effects of the change in the tax law are recognized in our first quarter of fiscal 2016, which is the quarter that the law was enacted. Accordingly, prior year research and development tax credits of approximately $1.2 million , after netting with appropriate reserves, were recognized in the first quarter of fiscal 2016.

Coherent Korea received approval for an additional High-Tech tax exemption in April 2016 from the Korean authorities and must make a capital contribution for the exemption to be effective. We anticipate making a capital contribution of approximately $4.0 million by the end of fiscal year 2016.


22


16.  SEGMENT INFORMATION
 
The following table provides net sales and income from operations for our operating segments and a reconciliation of our total income from operations to net income (in thousands):

 
Three Months Ended
 
Six Months Ended
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
Net sales:
 
 
 
 
 
 
 
Specialty Laser Systems
$
143,353

 
$
140,016

 
$
279,304

 
$
285,107

Commercial Lasers and Components
56,529

 
63,705

 
110,853

 
119,229

Total net sales
$
199,882

 
$
203,721

 
$
390,157

 
$
404,336

 
 
 
 
 
 
 
 
Income(expense) from operations:
 
 
 
 
 
 
 
Specialty Laser Systems
$
37,635

 
$
32,078

 
$
73,430

 
$
66,632

Commercial Lasers and Components
1,584

 
2,279

 
3,399

 
2,982

Corporate and other
(13,215
)
 
(12,225
)
 
(23,542
)
 
(23,173
)
Total income from operations
$
26,004

 
$
22,132

 
$
53,287

 
$
46,441

Total other income (expense), net
(1,780
)
 
1,990

 
(2,002
)
 
1,305

Income before income taxes
24,224

 
24,122

 
51,285

 
47,746

Provision for income taxes
6,443

 
5,709

 
13,218

 
11,903

Net Income
$
17,781

 
$
18,413

 
$
38,067

 
$
35,843


Major Customers

We had one major customer during the three and six months ended April 2, 2016 who accounted for 17.3% and 17.5% , respectively, of consolidated revenue. This same customer accounted for 17.4% and 18.0% , respectively, of consolidated revenue for the three and six months ended April 4, 2015 . We had another major customer during the six months ended April 2, 2016 who accounted for 10.2% of consolidated revenue. These customers purchased primarily from our SLS segment.

We had one major customer who accounted for 19.3% of accounts receivable at April 2, 2016 . We had another major customer who accounted for 15.3% and 21.4% of accounts receivable at April 2, 2016 and October 3, 2015 , respectively. Both customers purchased primarily from our SLS segment.


23


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
COMPANY OVERVIEW
 
BUSINESS BACKGROUND
 
We are one of the world’s leading providers of lasers and laser-based technology in a broad range of scientific, commercial and industrial applications. We design, manufacture, service and market lasers and related accessories for a diverse group of customers. Since inception in 1966, we have grown through internal expansion and through strategic acquisitions of complementary businesses, technologies, intellectual property, manufacturing processes and product offerings.

We are organized into two operating segments: Specialty Lasers and Systems (“SLS”) and Commercial Lasers and Components (“CLC”). This segmentation reflects the go-to-market strategies for various products and markets. While both segments deliver cost-effective photonics solutions, SLS develops and manufactures configurable, advanced performance products largely serving the microelectronics, scientific research and government programs and original equipment manufacturer ("OEM") components and instrumentation markets. The size and complexity of many of the SLS products require service to be performed at the customer site by factory trained field service engineers. CLC focuses on higher volume products that are offered in set configurations. The product architectures are designed for easy exchange at the point of use such that substantially all product service and repairs are based upon advanced replacement and depot (i.e., factory) repair. CLC’s primary markets include materials processing, OEM components and instrumentation and microelectronics.

Income from operations is the measure of profit and loss that our chief operating decision maker (“CODM”) uses to assess performance and make decisions. Income from operations represents the sales less the cost of sales and direct operating expenses incurred within the operating segments as well as allocated expenses such as shared sales and manufacturing costs. We do not allocate to our operating segments certain operating expenses, which we manage separately at the corporate level. These unallocated costs include stock-based compensation and corporate functions (certain advanced research and development, management, finance, legal and human resources) and are included in Corporate and other. Management does not consider unallocated Corporate and other costs in its measurement of segment performance.

MARKET APPLICATIONS
 
Our products address a broad range of applications that we group into the following markets: Microelectronics, Scientific Research and Government Programs, OEM Components and Instrumentation and Materials Processing.
 
OUR STRATEGY
We strive to develop innovative and proprietary products and solutions that meet the needs of our customers and that are based on our core expertise in lasers and optical technologies. In pursuit of our strategy, we intend to:
Leverage our technology portfolio and application engineering to lead the proliferation of photonics into broader markets —We will continue to identify opportunities in which our technology portfolio and application engineering can be used to offer innovative solutions and gain access to new markets. We plan to utilize our expertise to increase our market share in the mid to high power material processing applications.
Optimize our leadership position in existing markets —There are a number of markets where we have historically been at the forefront of technological development and product deployment and from which we have derived a substantial portion of our revenues. We plan to optimize our financial returns from these markets.
Maintain and develop additional strong collaborative customer and industry relationships —We believe that the Coherent brand name and reputation for product quality, technical performance and customer satisfaction will help us to further develop our loyal customer base. We plan to maintain our current customer relationships and develop new ones with customers who are industry leaders and work together with these customers to design and develop innovative product systems and solutions as they develop new technologies.
Develop and acquire new technologies and market share —We will continue to enhance our market position through our existing technologies and develop new technologies through our internal research and development efforts, as well as through the acquisition of additional complementary technologies, intellectual property, manufacturing processes and product offerings.

24

Table of Contents

Streamline our manufacturing structure and improve our cost structure —We will focus on optimizing the mix of products that we manufacture internally and externally. We will utilize vertical integration where our internal manufacturing process is considered proprietary and seek to leverage external sources when the capabilities and cost structure are well developed and on a path towards commoditization.
Focus on long-term improvement of adjusted EBITDA, in dollars and as a percentage of net sales —We define adjusted EBITDA as operating income adjusted for depreciation, amortization, stock-based compensation expense, major restructuring costs and certain other non-operating income and expense items. Key initiatives to reach our goals for EBITDA improvements include utilization of our Asian manufacturing locations, rationalizing our supply chain and continued leveraging of our infrastructure.


APPLICATION OF CRITICAL ACCOUNTING POLICIES
 
Our discussion and analysis of financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the SEC. The preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, accounting for long-lived assets (including goodwill and intangible assets), inventory valuation, warranty reserves, stock-based compensation and accounting for income taxes. See Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for our fiscal year ended October 3, 2015 .
 

KEY PERFORMANCE INDICATORS
 
Below is a summary of some of the quantitative performance indicators (as defined below) that are evaluated by management to assess our financial performance. Some of the indicators are non-GAAP measures and should not be considered as an alternative to any other measure for determining operating performance or liquidity that is calculated in accordance with generally accepted accounting principles.
 
Three Months Ended
 
 
 
 
 
April 2, 2016
 
April 4, 2015
 
Change
 
% Change
 
(Dollars in thousands)
 
 
 
 
 
 
 
 
Bookings
$
496,442

 
$
220,552

 
$
275,890

 
125.1
 %
Book-to-bill ratio
2.48

 
1.08

 
1.4

 
129.6
 %
Net sales—Specialty Lasers and Systems
$
143,353

 
$
140,016

 
$
3,337

 
2.4
 %
Net sales—Commercial Lasers and Components
$
56,529

 
$
63,705

 
$
(7,176
)
 
(11.3
)%
Gross profit as a percentage of net sales—
Specialty Lasers and Systems
47.7
%
 
44.2
%
 
3.5
 %
 
7.9
 %
Gross profit as a percentage of net sales—Commercial Lasers and Components
36.8
%
 
34.7
%
 
2.1
 %
 
6.1
 %
Research and development as a percentage of net sales
10.5
%
 
10.3
%
 
0.2
 %
 
1.9
 %
Income before income taxes
$
24,224

 
$
24,122

 
$
102

 
0.4
 %
Net cash provided by operating activities
$
31,292

 
$
49,363

 
$
(18,071
)
 
(36.6
)%
Days sales outstanding in receivables
67.7

 
54.9

 
12.8

 
23.3
 %
Annualized second quarter inventory turns
2.5

 
3.1

 
(0.6
)
 
(19.4
)%
Capital spending as a percentage of net sales
5.7
%
 
3.5
%
 
2.2
 %
 
62.9
 %
Net income as a percentage of net sales
8.9
%
 
9.0
%
 
(0.1
)%
 
(1.1
)%
Adjusted EBITDA as a percentage of net sales
20.9
%
 
17.6
%
 
3.3
 %
 
18.8
 %
 

25

Table of Contents

 
Six Months Ended
 
 
 
 
 
April 2, 2016
 
April 4, 2015
 
Change
 
% Change
 
(Dollars in thousands)
 
 
 
 
 
 
 
 
Bookings
$
769,446

 
$
383,076

 
$
386,370

 
100.9
 %
Book-to-bill ratio
1.97

 
0.95

 
1.02

 
107.4
 %
Net sales—Specialty Lasers and Systems
$
279,304

 
$
285,107

 
$
(5,803
)
 
(2.0
)%
Net sales—Commercial Lasers and Components
$
110,853

 
$
119,229

 
$
(8,376
)
 
(7.0
)%
Gross profit as a percentage of net sales—
Specialty Lasers and Systems
47.7
%
 
44.1
%
 
3.6
%
 
8.2
 %
Gross profit as a percentage of net sales—Commercial Lasers and Components
36.6
%
 
34.7
%
 
1.9
%
 
5.5
 %
Research and development as a percentage of net sales
10.3
%
 
10.0
%
 
0.3
%
 
3.0
 %
Income before income taxes
$
51,285

 
$
47,746

 
$
3,539

 
7.4
 %
Net cash provided by operating activities
$
45,554

 
$
80,414

 
$
(34,860
)
 
(43.4
)%
Capital spending as a percentage of net sales
4.2
%
 
3.0
%
 
1.2
%
 
40.0
 %
Net income as a percentage of net sales
9.8
%
 
8.9
%
 
0.9
%
 
10.1
 %
Adjusted EBITDA as a percentage of net sales
21.1
%
 
18.2
%
 
2.9
%
 
15.9
 %

Definitions and analysis of these performance indicators are as follows:

Bookings and Book-to-Bill Ratio
 
Bookings represent orders received during the current period for products and services to be provided pursuant to service contracts. While we generally have not experienced a significant rate of cancellation, bookings are generally cancelable by our customers without substantial penalty and, therefore, we cannot assure all bookings will be converted to net sales.

The book-to-bill ratio is calculated as quarterly bookings divided by quarterly net sales. This is an indication of the strength of our business but can sometimes be impacted by a single large order or a single large shipment. A ratio of greater than 1.0 indicates that demand for our products is greater than what we supply in the quarter whereas a ratio of less than 1.0 indicates that demand for our products is less than what we supply in the quarter.

In the second quarter of fiscal 2016, Coherent set another new quarterly bookings record, including records in the microelectronics, OEM components and instrumentation and materials processing markets. Bookings increased 125.1% in the second quarter of fiscal 2016 compared to the same quarter one year ago, with the increase led by a significant increase in the microelectronics market. Compared to the first quarter of fiscal 2016 , bookings increased 81.8% with significant increases in the microelectronics, OEM components and instrumentation and materials processing markets partially offset by a decrease in the scientific and government programs market. The book-to-bill ratio was 2.48 in the second quarter of fiscal 2016 .

Backlog represents orders which we expect to be shipped within 12 months and the current portion of service contracts. For a discussion of backlog, see "RESULTS OF OPERATIONS - BACKLOG".

Microelectronics
 
Microelectronics bookings were a new quarterly record and increased 248.8% compared to the same quarter one year ago and increased 94.7% from bookings in the first quarter of fiscal 2016 . The book-to-bill ratio for the second quarter of fiscal 2016 was 3.76 .
 
Record flat panel display orders in the second quarter of fiscal 2016 increased 411.2% from orders in the second quarter of fiscal 2015 and 115.9% from orders in the first quarter of fiscal 2016, primarily due to the timing of order placement by customers, with orders received from multiple customers for large format Linebeam systems to be used in organic light-emitting diode (OLED) production. The buildout of OLED capacity generated more than $300 million of orders for Linebeam 1000, Linebeam 1500 and UV Blade systems in the second quarter of fiscal 2016. These systems have been ordered with

26

Table of Contents

delivery to end customers in South Korea, Japan and China. We believe there is an additional large tranche of orders in excess of $100 million remaining in our customer's current buildout phase that we expect to book before the end of fiscal 2016.

Orders in the advanced packaging (API) market decreased 31.5% from orders in the second quarter of fiscal 2015 and increased 12.5% from orders in the first quarter of fiscal 2016. The API market continues to demonstrate variability based on project specific activity.

Orders from semiconductor capital equipment OEMs increased 10.9% from the second quarter of fiscal 2015 but decreased 6.6% from the first quarter of fiscal 2016. The outlook for semiconductor capital spending is flat to slightly up in 2016. Semiconductor service revenue is also increasing as chip inventories have decreased and utilization rates have increased.

Materials Processing
 
Record materials processing orders increased 36.6% compared to the same quarter one year ago and increased 112.4% from the first quarter of fiscal 2016 . The book-to-bill ratio for the second quarter of fiscal 2016 was 1.54 .

The bookings performance was led by strong demand from cutting and converting of metals and non-metals. We also received record orders from automotive manufacturing OEMs and had very strong results for additive manufacturing applications. While Chinese customers contributed to these results, the broader Chinese market remained volatile as low-power marking and engraving, a staple of the Chinese market, recovered from a weak first quarter of fiscal 2016, but is still soft. The sheet metal market, which has also been slow for the past couple of quarters, appears to be improving. Our second generation fiber laser platform has been qualified by an OEM for welding and cutting including copper.
 
OEM Components and Instrumentation
 
Record OEM Components and Instrumentation orders increased 3.2% compared to the same quarter one year ago and increased 95.9% from the first quarter of fiscal 2016 , with the sequential increase reflecting both the timing of certain OEM orders as well as key design wins. The book-to-bill ratio for the second quarter of fiscal 2016 was 1.41 .

Instrumentation orders increased 3.4% compared to the same quarter one year ago and 76.0% compared to the first quarter of fiscal 2016 due to several large orders from core accounts, record demand for integrated subsystems and increased adoption of clinical applications from cytometry to DNA sequencing. We believe our products are well-positioned for future orders given recent design wins in clinical applications.

Orders for medical OEM products were 10.4% higher in the second quarter of fiscal 2016 compared to the same quarter one year ago and 286.7% higher than orders in the first quarter of fiscal 2016 . We saw improved customer confidence in market conditions when placing longer-term orders for ophthalmic applications, predominantly in vision correction, and for aesthetic products for hair removal. Demand for medical consumables was also strong due to market share gains leading to an increased number of procedures on the part of our customers.

Scientific and Government Programs
 
Scientific and government programs orders increased 0.6% compared to the same quarter one year ago and seasonally decreased 21.1% from the first quarter of fiscal 2016 . The book-to-bill for the second quarter of fiscal 2016 was 0.82 .
 
Several factors affected scientific bookings in the second quarter of fiscal 2016 including seasonal effects, a slow start to China’s new five-year investment plan and a delay in increased National Institutes of Health ("NIH") funding reaching researchers. Ultrafast applications continue to compete favorably in the research markets, with the two largest areas in multiphoton imaging and time-resolved spectroscopy, where the lasers serve as cameras with very short shutter speeds. Historically, research lasers have been in their own class, but the emergence of short pulse processing in materials processing, medical therapeutics and microelectronics is starting to drive a convergence of research and commercial platforms. For example, we recently introduced the Monaco™, an all fiber, ultrafast laser with selectable processing performance in a wide range of applications. The Monaco has now been paired with a new optical parametric amplifier, the Opera-F™, to produce tunable wavelengths for use in multi-photon excitation and spectroscopy. At the same time, it brings products built to commercial standards into the research market, which should improve reliability and lower operating costs for the scientific community.

Net Sales
 

27

Table of Contents

Net sales include sales of lasers, laser tools, related accessories and service. Net sales for the second fiscal quarter increased 2.4% in our SLS segment from the same quarter one year ago and decreased 11.3% in our CLC segment from the same quarter one year ago. Net sales for the first six months decreased 2.0% in our SLS segment from the same period one year ago and decreased 7.0% in our CLC segment from the same period one year ago. For a description of the reasons for changes in net sales refer to the “Results of Operations” section of this quarterly report.

Gross Profit as a Percentage of Net Sales
 
Gross profit as a percentage of net sales (“gross profit percentage”) is calculated as gross profit for the period divided by net sales for the period.  Gross profit percentage in the second quarter increased from 44.2% to 47.7% in our SLS segment and increased from 34.7% to 36.8% in our CLC segment from the same quarter one year ago. Gross profit percentage in the first six months increased from 44.1% to 47.7% in our SLS segment and increased from 34.7% to 36.6% in our CLC segment from the same period one year ago. For a description of the reasons for changes in gross profit refer to the “Results of Operations” section of this quarterly report.
 
Research and Development as a Percentage of Net Sales
 
Research and development as a percentage of net sales (“R&D percentage”) is calculated as research and development expense for the period divided by net sales for the period.  Management considers R&D percentage to be an important indicator in managing our business as investing in new technologies is a key to future growth.  R&D percentage increased to 10.5% from 10.3% in our second fiscal quarter and increased to 10.3% from 10.0% for the first six months of fiscal 2016 compared to the same periods one year ago.  For a description of the reasons for changes in R&D spending refer to the “Results of Operations” section of this quarterly report.
 
Net Cash Provided by Operating Activities
 
Net cash provided by operating activities as reflected on our Condensed Consolidated Statements of Cash Flows primarily represents the excess of cash collected from billings to our customers and other receipts over cash paid to our vendors for expenses and inventory purchases to run our business.  We believe that cash flows from operations is an important performance indicator because cash generation over the long term is essential to maintaining a healthy business and providing funds to help fuel growth.  For a description of the reasons for changes in Net Cash Provided by Operating Activities refer to the “Liquidity and Capital Resources” section of this quarterly report.
 
Days Sales Outstanding in Receivables
 
We calculate days sales outstanding (“DSO”) in receivables as net receivables at the end of the period divided by net sales during the period and then multiplied by the number of days in the period, using 90 days for quarters.  DSO in receivables indicates how well we are managing our collection of receivables, with lower DSO in receivables resulting in higher working capital availability.  The more money we have tied up in receivables, the less money we have available for research and development, acquisitions, expansion, marketing and other activities to grow our business.  Our DSO in receivables for the second quarter of fiscal 2016 increased from 54.9 to 67.7 days compared to the same quarter one year ago primarily due to timing of large dollar flat panel display system sales towards the end of the quarter in Asia, a higher concentration of receivables in Japan where DSOs are typically higher, slower collections in the U.S. and Europe and the unfavorable impact of foreign exchange rates.
 
Annualized Second Quarter Inventory Turns
 
We calculate annualized second quarter inventory turns as the cost of sales during the second quarter annualized and divided by net inventories at the end of the second quarter. This indicates how well we are managing our inventory levels, with higher inventory turns resulting in more working capital availability and a higher return on our investments in inventory. The more money we have tied up in inventory, the less money we have available for research and development, acquisitions, expansion, marketing and other activities to grow our business. Our annualized inventory turns for the second quarter of fiscal 2016 decreased from 3.1 to 2.5 turns compared to the same quarter one year ago primarily due to the planned build-up of inventory levels in certain business units, primarily in microelectronics, to support increased demand and the unfavorable impact of foreign exchange rates.

Capital Spending as a Percentage of Net Sales
 

28

Table of Contents

Capital spending as a percentage of net sales (“capital spending percentage”) is calculated as capital expenditures for the period divided by net sales for the period.  Capital spending percentage indicates the extent to which we are expanding or improving our operations, including investments in technology and equipment. Management monitors capital spending levels as this assists management in measuring our cash flows, net of capital expenditures. Our capital spending percentage increased to 5.7% from 3.5% for the second quarter and to 4.2% from 3.0% for the first six months of fiscal 2016 compared to the same periods one year ago primarily due to higher investments to expand our manufacturing capacity in Göttingen, Germany, upgrade certain of our production facilities in California and New Jersey and purchases of production-related assets, partially offset by lower revenues in the second quarter and first six months of fiscal 2016. We expect higher capital spending in the remainder of fiscal 2016 to expand our manufacturing capacity in Göttingen, Germany and add optics fabrication capacity at our site in Richmond, California.
 
Adjusted EBITDA as a Percentage of Net Sales

We define adjusted EBITDA as operating income adjusted for depreciation, amortization, stock-based compensation, major restructuring costs and certain other non-operating income and expense items, such as costs related to the acquisition of Rofin. Key initiatives to reach our goals for EBITDA improvements include utilization of our Asian manufacturing locations, rationalizing our supply chain and continued leveraging of our infrastructure.

We utilize a number of different financial measures, both GAAP and non-GAAP, such as adjusted EBITDA as a percentage of net sales, in analyzing and assessing our overall business performance, for making operating decisions and for forecasting and planning future periods. We consider the use of non-GAAP financial measures helpful in assessing our current financial performance and ongoing operations. While we use non-GAAP financial measures as a tool to enhance our understanding of certain aspects of our financial performance, we do not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. We provide adjusted EBITDA in order to enhance investors' understanding of our ongoing operations. This measure is used by some investors when assessing our performance.
Below is the reconciliation of our net income as a percentage of net sales to our adjusted EBITDA as a percentage of net sales:

 
Three Months Ended
 
Six Months Ended
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
Net income as a percentage of net sales
8.9
%
 
9.0
 %
 
9.8
%
 
8.9
%
Income tax expense
3.2
%
 
2.8
 %
 
3.4
%
 
2.9
%
Interest and other income (expense), net
%
 
(0.6
)%
 
0.3
%
 
%
Depreciation and amortization
4.3
%
 
4.1
 %
 
4.4
%
 
4.1
%
Costs related to acquisition of Rofin
1.8
%
 
 %
 
0.9
%
 
%
Stock-based compensation
2.7
%
 
2.3
 %
 
2.3
%
 
2.3
%
Adjusted EBITDA as a percentage of net sales
20.9
%
 
17.6
 %
 
21.1
%
 
18.2
%


 
SIGNIFICANT EVENTS

On March 16, 2016, we entered into a definitive agreement to acquire Rofin-Sinar Technologies, Inc. ("Rofin"), one of the world's leading developers and manufacturers of high-performance industrial laser sources and laser-based solutions and components. The acquisition will be an all-cash transaction at a price of $32.50 per share of Rofin common stock for a total approximate offer value of $942 million before fees and transaction costs. The completion of the acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to close in six to nine months from the date of the definitive agreement.

On March 16, 2016, we entered into a debt commitment letter with Barclays Bank PLC ("Barclays") and on April 5, 2016, entered into an amended and restated debt commitment letter with Barclays and both Bank of America, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (together, "BAML"). Pursuant to the commitment letter, among other things, Barclays and BAML have committed to provide us with debt financing in an aggregate principal amount of up to $850.0 million to finance the acquisition of Rofin. The obligations of Barclays and BAML under the commitment letter are subject to

29

Table of Contents

certain conditions, including the consummation of the acquisition in accordance with the terms and conditions of the definitive agreement and other customary closing obligations.

RESULTS OF OPERATIONS


CONSOLIDATED SUMMARY
 
The following table sets forth, for the periods indicated, the percentage of total net sales represented by the line items reflected in our condensed consolidated statements of operations:
 
 
Three Months Ended
 
Six Months Ended
 
 
April 2,
2016
 
April 4,
2015
 
April 2,
2016
 
April 4,
2015
 
Net sales
100.0
 %
 
100.0
%
 
100.0
 %
 
100.0
%
 
Cost of sales
55.7
 %
 
59.1
%
 
55.8
 %
 
59.0
%
 
Gross profit
44.3
 %
 
40.9
%
 
44.2
 %
 
41.0
%
 
Operating expenses:
 
 
 
 
 
 
 
 
Research and development
10.5
 %
 
10.3
%
 
10.3
 %
 
10.0
%
 
Selling, general and administrative
20.5
 %
 
19.4
%
 
19.9
 %
 
19.2
%
 
Amortization of intangible assets
0.3
 %
 
0.3
%
 
0.4
 %
 
0.3
%
 
Total operating expenses
31.3
 %
 
30.0
%
 
30.6
 %
 
29.5
%
 
Income from operations
13.0
 %
 
10.9
%
 
13.6
 %
 
11.5
%
 
Other income (expense), net
(0.9
)%
 
0.9
%
 
(0.5
)%
 
0.3
%
 
Income before income taxes
12.1
 %
 
11.8
%
 
13.1
 %
 
11.8
%
 
Provision for income taxes
3.2
 %
 
2.8
%
 
3.3
 %
 
2.9
%
 
Net income
8.9
 %
 
9.0
%
 
9.8
 %
 
8.9
%
 

Net income for the second quarter of fiscal 2016 was $17.8 million ( $0.73 per diluted share) including $3.9 million of after-tax stock-related compensation expense, $1.4 million amortization of intangible assets and $2.3 million of after-tax costs related to the acquisition of Rofin. Net income for the second quarter of fiscal 2015 was $18.4 million ( $0.74 per diluted share) including $3.5 million of after-tax stock-related compensation expense and $1.5 million amortization of intangible assets. Net income for the first six months of fiscal 2016 was $38.1 million ( $1.57 per diluted share) including $7.3 million of after-tax stock-related compensation expense, $2.9 million amortization of intangible assets, $2.3 million of after-tax costs related to the acquisition of Rofin and a benefit of $1.2 million related to the renewal of the federal research and development tax credits for fiscal 2015. Net income for the first six months of fiscal 2015 was $35.8 million ( $1.43 per diluted share) including $7.4 million of after-tax stock-related compensation expense, $3.1 million amortization of intangible assets and a benefit of $1.1 million related to the renewal of the federal research and development tax credits for fiscal 2014.
 
BACKLOG

Backlog represents orders which we expect to be shipped within 12 months and the current portion of service contracts. Orders used to compute backlog are generally cancelable and subject to rescheduling by our customers without substantial penalties. Historically, we have not experienced a significant rate of cancellation or rescheduling, though we cannot guarantee that the rate of cancellations or rescheduling will not increase in the future. We have a backlog of orders shippable within 12 months of $469.3 million at April 2, 2016, including a significant concentration in the flat panel display market (48%) for customers which are primarily in Asia.

NET SALES
 
Market Application
 
The following tables set forth, for the periods indicated, the amount of net sales and their relative percentages of total net sales by market application (dollars in thousands):

30


 
Three Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage
of total
 net sales
 
Amount
 
Percentage
 of total
 net sales
Consolidated:
 
 
 
 
 
 
 
Microelectronics
$
97,724

 
48.9
%
 
$
101,769

 
50.0
%
OEM components and instrumentation
41,800

 
20.9
%
 
43,992

 
21.6
%
Materials processing
28,024

 
14.0
%
 
29,352

 
14.4
%
Scientific and government programs
32,334

 
16.2
%
 
28,608

 
14.0
%
   Total
$
199,882

 
100.0
%
 
$
203,721

 
100.0
%

 
Six Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage
of total
 net sales
 
Amount
 
Percentage
 of total
 net sales
Consolidated:
 
 
 
 
 
 
 
Microelectronics
$
194,230

 
49.8
%
 
$
201,080

 
49.7
%
OEM components and instrumentation
81,133

 
20.8
%
 
85,281

 
21.1
%
Materials processing
51,058

 
13.1
%
 
58,110

 
14.4
%
Scientific and government programs
63,736

 
16.3
%
 
59,865

 
14.8
%
   Total
$
390,157

 
100.0
%
 
$
404,336

 
100.0
%

  Quarterly

Net sales for the second quarter of fiscal 2016 decreased by $3.8 million , or 1.9% , compared to the second quarter of fiscal 2015 including decreases due to the unfavorable impact of foreign exchange rates.  Sales decreases in the microelectronics, OEM components and instrumentation and materials processing markets were partially offset by increases in the scientific and government programs market.
 
The decrease in the microelectronics market of $4.0 million , or 4.0% , was primarily due to lower shipments for advanced packaging and solar panel manufacturing applications partially offset by higher shipments for semiconductor applications; sales for flat panel display applications were essentially flat. Sales in the OEM components and instrumentation market decreased $2.2 million , or 5.0% , primarily due to lower shipments for medical applications partially offset by higher shipments for military and bio-instrumentation applications. The decrease in the materials processing market of $1.3 million , or 4.5% , was primarily due to lower shipments for non-metal drilling, non-metal cutting and rapid prototyping applications partially offset by higher shipments for marking and metal cutting applications. Sales in the scientific and government programs market increased $3.7 million , or 13.0% , primarily due to higher demand for advanced research applications used by university and government research groups in Europe and the U.S.

Year-to-date

Net sales for the first six months of fiscal 2016 decreased by $14.2 million , or 3.5% compared to the first six months of fiscal 2015 , including decreases due to the unfavorable impact of foreign exchange rates. Sales decreases in the materials processing, microelectronics and OEM components and instrumentation markets were partially offset by increases in the scientific and government programs market. Sales in the material processing market decreased $7.1 million , or 12.1% , primarily due to lower shipments for non-metal drilling, non-metal cutting and rapid prototyping applications partially offset by higher shipments for marking and metal cutting applications. The decrease in the microelectronics market of $6.9 million , or 3.4% , was primarily due to lower shipments for advanced packaging, solar panel production and micromaterials processing applications partially offset by higher shipments for semiconductor applications; sales for flat panel display applications were essentially flat. The decrease in the OEM components and instrumentation market of $4.1 million , or 4.9% , was due primarily to lower shipments for medical and machine vision applications partially offset by higher shipments for military and bio-instrumentation applications. Sales in the scientific and government programs market increased $3.9 million , or 6.5% , primarily due to higher demand for advanced research applications used by university and government research groups in Europe and the U.S.

31

Table of Contents

The timing for shipments of our higher average selling price excimer products in the flat panel display market have historically fluctuated and are in the future expected to fluctuate from quarter-to-quarter due to customer scheduling, our ability to manufacture these products and/or availability of supplies. As a result, the timing to convert orders for these products to sales will likely fluctuate from quarter-to-quarter.

Segments
 
We are organized into two reportable operating segments: SLS and CLC. SLS develops and manufactures configurable, advanced-performance products largely serving the microelectronics, scientific research and government programs and OEM components and instrumentation markets. CLC focuses on higher volume products that are offered in set configurations. CLC’s primary markets include materials processing, OEM components and instrumentation and microelectronics.
 
The following tables set forth, for the periods indicated, the amount of net sales and their relative percentages of total net sales by segment (dollars in thousands):
 
Three Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage
of total
net sales
 
Amount
 
Percentage
of total
net sales
Consolidated:
 
 
 
 
 
 
 
Specialty Lasers and Systems (SLS)
$
143,353

 
71.7
%
 
$
140,016

 
68.7
%
Commercial Lasers and Components (CLC)
56,529

 
28.3
%
 
63,705

 
31.3
%
   Total
$
199,882

 
100.0
%
 
$
203,721

 
100.0
%

 
Six Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage
of total
net sales
 
Amount
 
Percentage
of total
net sales
Consolidated:
 
 
 
 
 
 
 
Specialty Lasers and Systems (SLS)
$
279,304

 
71.6
%
 
$
285,107

 
70.5
%
Commercial Lasers and Components (CLC)
110,853

 
28.4
%
 
119,229

 
29.5
%
   Total
$
390,157

 
100.0
%
 
$
404,336

 
100.0
%

Quarterly

Net sales for the second quarter of fiscal 2016 decreased by $3.8 million , or 1.9% , compared to the second quarter of fiscal 2015 , with decreases of $7.2 million , or 11.3% , in our CLC segment partially offset by increases of $3.3 million , or 2.4% , in our SLS segment. Both the decrease and increase in CLC and SLS segment sales, respectively, included decreases due to the unfavorable impact of foreign exchange rates.
 
The decrease in our CLC segment sales was primarily due to lower shipments for medical, materials processing and advanced packaging applications. The increase in our SLS segment sales was primarily due to higher shipments for scientific and government research programs as well as higher shipments for semiconductor, military and bio-instrumentation applications partially offset by lower shipments for advanced packaging, medical and solar panel production applications.

Year-to-date

Net sales for the first six months of fiscal 2016 decreased by $14.2 million , or 3.5% , compared to the first six months of fiscal 2015 , with decreases of $8.4 million , or 7.0% , in our CLC segment and decreases of $5.8 million , or 2.0% , in our SLS segment. The decreases in both SLS and CLC segment sales included decreases due to the unfavorable impact of foreign exchange rates.
 
The decrease in our CLC segment sales was primarily due to lower materials processing, medical and machine vision application sales as well as lower sales for scientific and government research programs partially offset by higher bio-instrumentation application sales. The decrease in our SLS segment sales was primarily due to lower shipments for advanced

32

Table of Contents

packaging, medical and materials processing applications partially offset by higher shipments for semiconductor applications, scientific and government research programs and military applications.

GROSS PROFIT
 
Consolidated
 
Our gross profit rate increased to 44.3% in the second quarter of fiscal 2016 from 40.9% and increased to 44.2% from 41.0% in the first six months of fiscal 2016 compared to the same periods one year ago.

The 3.4% second quarter increase in the gross profit rate was primarily due to favorable product margins (3.2%) as a result of favorable mix for systems in the microelectronics market, particularly in flat panel display applications, favorable mix in the OEM components and instrumentation and materials processing markets, the impact of higher volumes in certain business units and the favorable impact from foreign currency fluctuations partially offset by the impact of lower service revenues in the microelectronics market. Also contributing to the increase in gross profit rate were lower warranty costs (0.2%) due to fewer warranty events.

The 3.2% increase in the gross profit rate during the first six months of fiscal 2016 was primarily due to favorable product margins (3.0%) as a result of favorable mix for systems in the microelectronics market, particularly in flat panel display applications, the favorable impact from foreign currency fluctuations, favorable mix in the OEM components and instrumentation and materials processing markets and the impact of higher volumes in certain business units. Also contributing to the increase in gross profit rate were lower warranty costs (0.2%) due to fewer warranty events.

Our gross profit rate has been and will continue to be affected by a variety of factors including market and product mix, pricing on volume orders, shipment volumes, our ability to manufacture advanced and more complex products, manufacturing efficiencies, excess and obsolete inventory write-downs, warranty costs, amortization of intangibles, pricing by competitors or suppliers, new product introductions, production volume, customization and reconfiguration of systems, commodity prices and foreign currency fluctuations, particularly the recent volatility in the Euro and to a lesser extent, the Japanese Yen and the Korean Won.

  Specialty Lasers and Systems
 
The gross profit rate in our SLS segment increased to 47.7% in the second quarter of fiscal 2016 from 44.2% and increased to 47.7% from 44.1% in the first six months of fiscal 2016 compared to the same periods one year ago.

The 3.5% second quarter increase in the gross profit rate was primarily due to favorable product margins (3.4%) as a result of favorable mix for systems in the microelectronics market, particularly in flat panel display applications, the impact of higher volumes in certain business units and the favorable impact from foreign currency fluctuations partially offset by the impact of lower service revenues in the microelectronics market and unfavorable mix in the bio-instrumentation market. Also contributing to the increase in gross profit rate were lower warranty costs (0.1%) due to fewer warranty events.

The 3.6% increase in the gross profit rate during the first six months of fiscal 2016 was primarily due to favorable product margins (3.3%) as a result of favorable mix for systems in the microelectronics market, particularly in flat panel display applications, and the favorable impact from foreign currency fluctuations partially offset by the impact of lower service revenues in the microelectronics and materials processing markets and unfavorable mix in the bio-instrumentation market. Also contributing to the increase in gross profit rate were lower warranty costs (0.3%) due to fewer warranty events.

Commercial Lasers and Components

The gross profit rate in our CLC segment increased to 36.8% in the second quarter of fiscal 2016 from 34.7% and increased to 36.6% from 34.7% in the first six months of fiscal 2016 compared to the same periods one year ago.

The 2.1% second quarter increase in the gross profit rate was primarily due to favorable product costs (1.9%) and lower warranty costs (0.6%) due to fewer warranty events partially offset by higher other costs (0.4%) as a percentage of sales due to higher inventory provisions in certain business units and higher freight costs. The 1.9% product margin improvement results primarily from favorable mix in the OEM components and instrumentation and materials processing markets.

The 1.9% increase in the gross profit rate during the first six months of fiscal 2016 was primarily attributable to favorable product costs (2.0%) partially offset by higher other costs (0.1%) as a percentage of sales due to higher inventory provisions in

33

Table of Contents

certain business units. The 2.0% product margin improvement results primarily from favorable mix in the OEM components and instrumentation and materials processing markets.


OPERATING EXPENSES:
 
 
Three Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage of
total net sales
 
Amount
 
Percentage of
total net sales
 
(Dollars in thousands)
Research and development
$
20,955

 
10.5
%
 
$
21,024

 
10.3
%
Selling, general and administrative
40,940

 
20.5
%
 
39,482

 
19.4
%
Amortization of intangible assets
700

 
0.3
%
 
666

 
0.3
%
Total operating expenses
$
62,595

 
31.3
%
 
$
61,172

 
30.0
%

 
Six Months Ended
 
April 2, 2016
 
April 4, 2015
 
Amount
 
Percentage of
total net sales
 
Amount
 
Percentage of
total net sales
 
(Dollars in thousands)
Research and development
$
40,095

 
10.3
%
 
$
40,197

 
10.0
%
Selling, general and administrative
77,714

 
19.9
%
 
77,623

 
19.2
%
Amortization of intangible assets
1,401

 
0.4
%
 
1,362

 
0.3
%
Total operating expenses
$
119,210

 
30.6
%
 
$
119,182

 
29.5
%

Research and development

Quarterly

Research and development (“R&D”) expenses decreased $0.1 million , or 0.3% , during the second fiscal quarter ended April 2, 2016 compared to the same quarter one year ago. The decrease was primarily due to lower project spending of $0.4 million due to the favorable impact of foreign exchange rates and $0.4 million lower charges for increases in deferred compensation plan liabilities partially offset by $0.7 million due to incremental spending from the acquisitions of Tinsley and Raydiance in the fourth quarter of fiscal 2015. On a segment basis as compared to the prior year period, SLS research and development spending increased $0.9 million primarily due to the acquisitions of Tinsley and Raydiance partially offset by lower project spending due to the favorable impact of foreign exchange rates net of lower customer reimbursements. CLC spending decreased $0.6 million primarily due to lower project spending and higher customer reimbursements. Corporate and other spending decreased $0.4 million primarily due to lower charges for increases in deferred compensation plan liabilities.

Year-to-date

R&D expenses decreased $0.1 million , or 0.3% , during the six months ended April 2, 2016 compared to the same period one year ago. The decrease for the first six months was primarily due to lower project spending of $1.3 million including the favorable impact of foreign exchange rates and lower spending on labor net of lower customer reimbursements as well as $0.4 million lower charges for increases in deferred compensation plan liabilities. The decreases were partially offset by increases of $1.5 million due to incremental spending from the acquisitions of Tinsley and Raydiance in the fourth quarter of fiscal 2015 and $0.1 million higher stock-based compensation expense.

On a segment basis as compared to the prior year period, SLS research and development spending increased $0.8 million primarily due to the acquisitions of Tinsley and Raydiance partially offset by lower project spending including the favorable impact of foreign exchange rates and lower spending net of lower customer reimbursements. CLC spending decreased $0.6

34

Table of Contents

million primarily due to lower project spending including higher customer reimbursements. Corporate and other spending decreased $0.3 million due to lower charges for increases in deferred compensation plan liabilities partially offset by higher stock-based compensation expense.

Selling, general and administrative

Quarterly

Selling, general and administrative (“SG&A”) expenses increased $1.5 million , during the second fiscal quarter ended April 2, 2016 compared to the same quarter one year ago. The increase was primarily due to $2.8 million higher consulting and legal costs related to acquisitions, of which $3.6 million was related to the acquisition of Rofin, and $0.6 million higher stock-based compensation expense due to lower estimated forfeitures. In addition, the increase included $0.2 million higher other variable spending including incremental spending from the acquisitions of Tinsley and Raydiance in the fourth quarter of fiscal 2015 net of the favorable impact of foreign exchange rates. The increases were partially offset by $2.1 million lower charges for increases in deferred compensation plan liabilities.

On a segment basis as compared to the prior year period, SLS segment expenses were flat with the impact due to the acquisitions of Tinsley and Raydiance and higher payroll spending offset by the favorable impact of foreign exchange rates and lower other variable spending. CLC spending was flat with higher payroll spending offset by the favorable impact of foreign exchange rates. Spending for Corporate and other increased $1.4 million primarily due to higher consulting and legal costs related to acquisitions and higher stock-based compensation expense partially offset by lower charges for increases in deferred compensation plan liabilities.

Year-to-date

SG&A expenses increased $0.1 million , or 0.1% , during the six months ended April 2, 2016 compared to the same period one year ago. The increase for the first six months was primarily due to $2.8 million higher consulting and legal costs related to acquisitions, of which $3.6 million was related to the acquisition of Rofin, and $0.2 million higher other variable spending including incremental spending from the acquisitions of Tinsley and Raydiance in the fourth quarter of fiscal 2015 net of the favorable impact of foreign exchange rates. The increases were partially offset by $1.8 million lower charges for increases in deferred compensation plan liabilities and $1.1 million lower payroll spending primarily due to the favorable impact of foreign exchange rates. On a segment basis as compared to the prior year period, SLS segment expenses decreased $0.2 million primarily due to lower payroll and other variable spending resulting from the favorable impact of foreign exchange rates partially offset by the impact due to the acquisitions of Tinsley and Raydiance. CLC spending decreased $0.5 million primarily due to lower payroll resulting from the favorable impact of foreign exchange rates. Spending for Corporate and other increased $0.8 million primarily due to higher consulting and legal costs related to acquisitions partially offset by lower charges for increases in deferred compensation plan liabilities.

Amortization of intangible assets
 
Amortization of intangible assets was flat in both the three and six months ended April 2, 2016 compared to the same periods last year. Increases due to the acquisition of Raydiance in the fourth quarter of fiscal 2015 were offset by the completion of amortization of certain intangibles from prior acquisitions.
 
OTHER INCOME (EXPENSE) — NET
 
Other income, net of other expense, decreased $3.8 million and $3.3 million during the three and six months ended April 2, 2016 , respectively, compared to the same periods one year ago. The second fiscal quarter decrease was primarily due to higher losses, including expenses, on our deferred compensation plan assets ($2.5 million) and higher net foreign exchange losses ($1.3 million). The increase in net foreign exchange losses for the quarter was due to lower gains from favorable changes in foreign exchange rates, primarily the weakening of the Euro, coupled with the timing of placement of hedges that occurred in the second quarter of fiscal 2015. The decrease for the six months ended April 2, 2016 was primarily due to higher losses, including expenses, on our deferred compensation plan assets ($2.1 million) and higher net foreign exchange losses ($1.4 million) partially offset by $0.2 million higher interest income. The increase in net foreign exchange losses for the six months ended April 2, 2016 was due to higher unhedged exposures and larger realized losses on cash conversions due to the significant movement of the Euro, Chinese RMB and Korean Won against the U.S. dollar in first six months of fiscal 2016.
 
INCOME TAXES
 

35

Table of Contents

The effective tax rate on income before income taxes for the second quarter of fiscal 2016 of 26.6% and the effective tax rate on income before income taxes for the first six months of fiscal 2016 of 25.8% were lower than the statutory rate of 35.0% primarily due to differences related to the benefit of income subject to foreign tax rates that are lower than U.S. tax rates including the Singapore tax exemption, the benefit of foreign tax credits and the benefit of federal research and development tax credits including renewal of the federal research and development credits for fiscal 2015. These amounts are partially offset by deemed dividend inclusions under the Subpart F tax rules, stock-based compensation not deductible for tax purposes and limitations on the deductibility of compensation under IRC Section 162(m).
 
The effective tax rate on income before income taxes for the second quarter of fiscal 2015 of 23.7% and the effective tax rate on income before income taxes for the first six months of fiscal 2015 of 24.9% were lower than the statutory rate of 35.0% primarily due to differences related to the benefit of income subject to foreign tax rates that are lower than U.S. tax rates including South Korea and Singapore tax exemptions, the benefit of foreign tax credits and the benefit of the federal research and development tax credits including renewal of the federal research and development tax credits for fiscal 2014. These amounts are partially offset by deemed dividend inclusions under the Subpart F tax rules, stock-based compensation not deductible for tax purposes and limitations on the deductibility of compensation under IRC Section 162(m).


LIQUIDITY AND CAPITAL RESOURCES
 
At April 2, 2016 , we had assets classified as cash and cash equivalents and short-term investments, in an aggregate amount of $361.1 million , compared to $325.5 million at October 3, 2015 . At April 2, 2016 , approximately $323.2 million of this cash and securities was held in certain of our foreign subsidiaries, $109.1 million of which was denominated in currencies other than the U.S. dollar. We currently have approximately $308.8 million of cash held by foreign subsidiaries where we intend to permanently reinvest our accumulated earnings in these entities and our current plans do not demonstrate a need for these funds to support our domestic operations. If, however, a portion of these funds were needed for and distributed to our operations in the United States, we would be subject to additional U.S. income taxes and foreign withholding taxes. The amount of the taxes due would depend on the amount and manner of repatriation, as well as the location from where the funds are repatriated. We actively monitor the third-party depository institutions that hold these assets, primarily focusing on the safety of principal and secondarily maximizing yield on these assets. We diversify our cash and cash equivalents and investments among various financial institutions, money market funds, sovereign debt and other securities in order to reduce our exposure should any one of these financial institutions or financial instruments fail or encounter difficulties. To date, we have not experienced any material loss or lack of access to our invested cash, cash equivalents or short-term investments. However, we can provide no assurances that access to our invested cash, cash equivalents or short-term investments will not be impacted by adverse conditions in the financial markets.
In the first quarter of fiscal 2016, the second quarter of fiscal 2015 and the fourth quarter of fiscal 2014, we converted $33.0 million, $42.3 million and $62.7 million, respectively, of cash and securities held in certain of our foreign subsidiaries to U.S. dollars and invested those funds within a European subsidiary whose functional currency is the U.S. dollar. At April 2, 2016 , this subsidiary had $203.6 million of U.S. dollar denominated investments primarily in U.S. Treasury Securities, corporate notes and commercial paper. In April 2016, we converted an additional $22.6 million of cash and securities held in certain of our foreign subsidiaries to U.S. dollars and invested those funds within a European subsidiary whose functional currency is the U.S. dollar. Accordingly, there is no translation expense arising from this entity holding U.S. dollar denominated investments. The converted funds are not intended to be repatriated to the U.S. and no U.S. tax was triggered on the transfer of these funds to the European subsidiary. See ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK below for more information about risks and trends related to foreign currencies.

Sources and Uses of Cash
 
Historically, our primary source of cash has been provided by operations. Other sources of cash in the past three fiscal years include proceeds received from the sale of our stock through our employee stock purchase plan as well as borrowings under our domestic line of credit. Our historical uses of cash have primarily been for the repurchase of our common stock, capital expenditures and acquisitions of businesses and technologies. Supplemental information pertaining to our historical sources and uses of cash is presented as follows and should be read in conjunction with our condensed consolidated statements of cash flows and the notes to condensed consolidated financial statements:

36

Table of Contents

 
 
Six Months Ended
 
April 2,
2016
 
April 4,
2015
 
(in thousands)
Net cash provided by operating activities
$
45,554

 
$
80,414

Sales of shares under employee stock plans
3,686

 
3,701

Repurchases of common stock

 
(25,009
)
Capital expenditures
(16,256
)
 
(12,210
)
Short-term borrowings, net of repayments
5,000

 

Debt issuance costs
(2,137
)
 

 
Net cash provided by operating activities decreased by $34.9 million for the first six months of fiscal 2016 compared to the same period one year ago. The decrease in cash provided by operating activities was primarily due to lower cash flows from the timing of shipments of large systems from inventory and lower cash flows from accounts receivable. We believe that our existing cash, cash equivalents and short term investments combined with cash to be provided by operating activities, amounts available under our lines of credit and the access to financing contemplated by the debt commitment letter from Barclays and BAML will be adequate to cover our working capital needs and planned capital expenditures for at least the next 12 months to the extent such items are known or are reasonably determinable based on current business and market conditions. However, we may elect to finance certain of our capital expenditure requirements through borrowings under our bank credit facilities or other sources of capital. We continue to follow our strategy to further strengthen our financial position by using available cash flow to fund operations.
 
We intend to continue pursuing acquisition opportunities at valuations we believe are reasonable based upon market conditions. However, we cannot accurately predict the timing, size and success of our acquisition efforts or our associated potential capital commitments. Furthermore, we cannot assure you that we will be able to acquire businesses on terms acceptable to us. We expect to fund future acquisitions through additional borrowings (as in our pending acquisition of Rofin), existing cash balances and cash flows from operations. If required, we will consider the issuance of securities. The extent to which we will be willing or able to use our common stock to make acquisitions will depend on its market value at the time and the willingness of potential sellers to accept it as full or partial payment.
 
On March 16, 2016, we entered into a debt commitment letter with Barclays Bank PLC ("Barclays") and on April 5, 2016, entered into an amended and restated debt commitment letter with Barclays and both Bank of America, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (together, "BAML"). Pursuant to the commitment letter, among other things, Barclays and BAML have committed to provide us with debt financing in an aggregate principal amount of up to $850.0 million to finance the acquisition of Rofin. The obligations of Barclays and BAML under the commitment letter are subject to certain conditions, including the consummation of the acquisition in accordance with the terms and conditions of the definitive agreement and other customary closing obligations.

Additional sources of cash available to us were domestic and international currency lines of credit and bank credit facilities totaling $63.7 million as of April 2, 2016 , of which $55.6 million was unused and available. These unsecured credit international facilities were used in Europe and Japan during the first six months of fiscal 2016 . Our domestic line of credit consists of a $50 million unsecured revolving credit account, which expires on May 31, 2017 and is subject to covenants related to financial ratios and tangible net worth. We were in compliance with these covenants as of April 2, 2016 . As of April 2, 2016 , we have drawn $5.0 million and have used $1.1 million for letters of credit against our domestic line of credit.

In fiscal 2015, under plans authorized by the Board of Directors, we repurchased and retired 1,302,323 shares of outstanding common stock under this plan at an average price of $57.59 per share for a total of $75.0 million.
 
Our ratio of current assets to current liabilities was 4.8 :1 at April 2, 2016 compared to 5.3 :1 at October 3, 2015 . The decrease in our ratio is primarily due to increases in accounts payable, income taxes payable, short-term borrowings and other current liabilities partially offset by increases in cash and short-term investments and inventories. Our cash and cash equivalents, short-term investments and working capital are as follows:
 

37

Table of Contents

 
April 2, 2016
 
October 3, 2015
 
(in thousands)
Cash and cash equivalents
$
157,176

 
$
130,607

Short-term investments
203,882

 
194,908

Working capital
575,325

 
530,093

 
Contractual Obligations and Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements as defined under Regulation S-K of the Securities Act of 1933. Information regarding our long-term debt payments, operating lease payments, asset retirement obligations, purchase commitments with suppliers and purchase obligations is provided in Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended October 3, 2015 . There have been no material changes in contractual obligations outside of the ordinary course of business, other than noted in "Merger-related Commitment and Fees" below, since October 3, 2015 . Information regarding our other financial commitments at April 2, 2016 is provided in the notes to the condensed consolidated financial statements in this report.

Merger-related Commitment and Fees

We have an agreement with a financial advisor, Barclays, in relation to the pending acquisition of Rofin. We have agreed to pay Barclays a fee of approximately $10.5 million , $1.0 million of which was paid upon delivery of the fairness opinion in the second quarter of fiscal 2016, and was recorded in the selling, general and administrative line of the condensed consolidated statements of operations, and the remaining portion of which will be paid upon, and subject to, consummation of the acquisition. For our $850.0 million debt financing commitment with Barclays and BAML, we paid $2.137 million of debt issuance costs in the second quarter of fiscal 2016 and recorded it to other assets on our condensed consolidated balance sheets. We have also agreed to pay to Barclays and BAML together approximately $17.0 million and $7.5 million for underwriting and upfront fees, respectively, upon the close of the financing. In addition, the acquisition agreement contains certain termination rights for Coherent and further provides that we, as applicable, may be required to pay a termination fee of $ 65.0 million to Rofin and $2.4 million to Barclays.

Changes in Financial Condition
 
Cash provided by operating activities during the first six months of fiscal 2016 was $45.6 million , which included net income of $38.1 million , depreciation and amortization of $17.1 million and stock-based compensation expense of $9.1 million partially offset by cash used by operating assets and liabilities of $13.0 million and net increases in deferred taxes of $5.7 million . Cash provided by operating activities during the first six months of fiscal 2015 was $80.4 million, which included net income of $35.8 million, depreciation and amortization of $16.7 million, cash provided by operating assets and liabilities of $11.9 million, stock-based compensation expense of $9.2 million, net decreases in deferred taxes of $6.5 million and other net of $0.3 million.

Cash used in investing activities during the first six months of fiscal 2016 was $21.2 million , which included $16.1 million net used to acquire property and equipment and improve buildings net of proceeds from dispositions and $5.1 million net purchases of available-for-sale securities. Cash used in investing activities during the first six months of fiscal 2015 was $13.5 million, which included $11.2 million net used to acquire property and equipment and improve buildings net of proceeds from dispositions and $2.3 million net purchases of available-for-sale securities.
 
Cash provided by financing activities during the first six months of fiscal 2016 was $1.2 million , which included $5.0 million net short-term borrowings and $3.7 million generated from our employee stock option and stock purchase plans partially offset by $5.4 million net settlement of restricted stock and $2.1 million of debt issuance costs. Cash used in financing activities during the first six months of fiscal 2015 was $26.5 million, which included $25.0 million repurchases of common stock and $5.2 million net settlement of restricted stock partially offset by $3.7 million generated from our employee stock option and stock purchase plans.
 
Changes in exchange rates during the first six months of fiscal 2016 decreased our cash balances by $1.0 million . Changes in exchange rates during the first six months of fiscal 2015 increased our cash balances by $3.1 million.
 
RECENT ACCOUNTING STANDARDS
 

38

Table of Contents

See Note 2. “Recent Accounting Standards” in the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption or expected adoption and effects on our condensed consolidated financial position, results of operations and cash flows.

39

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Market risk disclosures
 
We are exposed to market risk related to changes in interest rates and foreign currency exchange rates. We do not use derivative financial instruments for speculative or trading purposes.
 
Interest rate sensitivity
 
A portion of our investment portfolio is composed of fixed income securities. These securities are subject to interest rate risk and will fall in value if market interest rates increase. If market interest rates were to increase immediately (whether due to changes in overall market rates or credit worthiness of the issuers of our individual securities) and uniformly by 10% from levels at April 2, 2016 , the fair value of the portfolio, based on quoted market prices in active markets involving similar assets, would decline by an immaterial amount due to their short-term maturities. We have the ability to generally hold our fixed income investments until maturity and therefore we would not expect our operating results or cash flows to be affected to any significant degree by the effect of a sudden change in market interest rates on our securities portfolio. If necessary, we may sell short-term investments prior to maturity to meet our liquidity needs.
 
At April 2, 2016 , the fair value of our available-for-sale debt securities was $183.4 million , all of which was classified as short-term investments.  Gross unrealized gains and losses on available-for-sale debt securities were $1.0 million and less than $0.1 million , respectively, at April 2, 2016 .
 
Foreign currency exchange risk
 
We maintain operations in various countries outside of the United States and have foreign subsidiaries that manufacture and sell our products in various global markets. The majority of our sales are transacted in U.S. dollars. However, we do generate revenues in other currencies, primarily the Euro, the Japanese Yen, the South Korean Won and the Chinese RMB. Additionally we have operations in different countries around the world with costs incurred in other local currencies, such as British Pound Sterling, Singapore Dollars and Malaysian Ringgit. As a result, our earnings, cash flows and cash balances are exposed to fluctuations in foreign currency exchange rates. For example, we have significant manufacturing operations in Europe so that a weakening Euro is advantageous to the Company’s financial results. We attempt to limit these exposures through financial market instruments. We utilize derivative instruments, primarily forward contracts with maturities of two months or less, to manage our exposure associated with anticipated cash flows and net asset and liability positions denominated in foreign currencies. Gains and losses on the forward contracts are mitigated by gains and losses on the underlying instruments. We do not use derivative financial instruments for trading purposes.
 
On occasion, we enter into currency forward exchange contracts to hedge specific anticipated foreign currency denominated transactions generally expected to occur within the next 12 months. These cash flow hedges are designated for hedge accounting treatment and gains and losses on these contracts are recorded in accumulated other comprehensive income in stockholder's equity and reclassified into earnings at the time that the related transactions being hedged are recognized in earnings. See Note 6 "Derivative Instruments and Hedging Activities".

We do not anticipate any material adverse effect on our condensed consolidated financial position, results of operations or cash flows resulting from the use of these instruments. There can be no assurance that these strategies will be effective or that transaction losses can be minimized or forecasted accurately. While we model currency valuations and fluctuations, these may not ultimately be accurate. If a financial counterparty to any of our hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience material financial losses. In the current economic environment, the risk of failure of a financial party remains high.

At April 2, 2016 , approximately $323.2 million of our cash, cash equivalents and short-term investments were held outside the U.S. in certain of our foreign operations, $109.1 million of which was denominated in currencies other than the U.S. dollar.

A hypothetical 10% change in foreign currency rates on our forward contracts would not have a material impact on our results of operations, cash flows or financial position.
 
The following table provides information about our foreign exchange forward contracts at April 2, 2016 . The table presents the weighted average contractual foreign currency exchange rates, the value of the contracts in U.S. dollars at the contract exchange rate as of the contract maturity date and fair value. The U.S. fair value represents the fair value of the contracts valued at April 2, 2016 rates.

40

Table of Contents

 
Forward contracts to sell (buy) foreign currencies for U.S. dollars (in thousands, except contract rates):
 
 
Average Contract
Rate
 
U.S. Notional
Contract Value
 
U.S. Fair Value
Non-Designated - For US Dollars:
 
 
 
 
 
Euro
1.0894

 
$
(63,507
)
 
$
(2,919
)
Japanese Yen
112.9137

 
$
33,550

 
$
293

South Korean Won
1,238.0000

 
$
15,872

 
$
1,154

Chinese RMB
6.5760

 
$
10,538

 
$
193

Singaporean Dollar
1.4010

 
$
(4,313
)
 
$
(167
)
Malaysian Ringgit
4.1720

 
$
2,070

 
$
151

 
 
 
 
 
 
Non-Designated - For Euros:
 
 
 
 
 
Japanese Yen
117.5996

 
$
930

 
$
47


41

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES
 
Management’s Evaluation of Disclosure Controls and Procedures
 
We have evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as of April 2, 2016 (“Evaluation Date”).  The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective in providing reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.
 
Changes in Internal Control over Financial Reporting
 
There were no changes in our internal control over financial reporting that occurred during the quarter ended April 2, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
Inherent Limitations over Internal Control
 
Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles ("GAAP"). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:
 
(i)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
(ii)
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
(iii)
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 


42

Table of Contents

PART II. OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
Information with respect to this item may be found in Note 11 to our condensed consolidated financial statements in Part I, Item 1 of this report and is incorporated herein by reference.

ITEM 1A. RISK FACTORS

You should carefully consider the followings risks when considering an investment in our Common Stock. These risks could materially affect our business, results of operations or financial condition, cause the trading price of our Common Stock to decline materially or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by us. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Forward-Looking Statements” and the risk of our businesses described elsewhere in this annual report. Additionally, these risks and uncertainties described herein are not the only ones facing us. Other events that we do not currently anticipate or that we currently deem immaterial also may affect our business, results of operations or financial condition.

As we discuss more fully under the section entitled, RISKS RELATED TO THE PROPOSED MERGER WITH ROFIN, any of our identified risks herein will likely be impacted by completing our acquisition of Rofin and integrating its operations.

BUSINESS ENVIRONMENT AND INDUSTRY TRENDS
 
Our operating results, including net sales, net income (loss) and adjusted EBITDA in dollars and as a percentage of net sales, as well as our stock price have varied in the past, and our future operating results will continue to be subject to quarterly and annual fluctuations based upon numerous factors, including those discussed in this Item 1A and throughout this report. Our stock price will continue to be subject to daily variations as well. Our future operating results and stock price may not follow any past trends or meet our guidance and expectations.
 
Our net sales and operating results, such as adjusted EBITDA percentage, net income (loss) and operating expenses, and our stock price have varied in the past and may vary significantly from quarter to quarter and from year to year in the future. We believe a number of factors, many of which are outside of our control, could cause these variations and make them difficult to predict, including:
 
general economic uncertainties in the macroeconomic and local economies facing us, our customers and the markets we serve;
 
fluctuations in demand for our products or downturns in the industries that we serve;
  
the ability of our suppliers, both internal and external, to produce and deliver components and parts, including sole or limited source components, in a timely manner, in the quantity, quality and prices desired;

the timing of receipt and conversion of bookings to net sales;

the concentration of a significant amount of our backlog, and resultant net sales, with a few customers;
 
rescheduling of shipments or cancellation or orders by our customers;
 
fluctuations in our product mix;
 
the ability of our customers' other suppliers to provide sufficient material to support our customers' products;
 
currency fluctuations and stability, in particular the Euro, the Japanese Yen, the South Korean Won, the Chinese RMB and the US dollar as compared to other currencies;
 
commodity pricing;
 

43

Table of Contents

introductions of new products and product enhancements by our competitors, entry of new competitors into our markets, pricing pressures and other competitive factors;
 
our ability to develop, introduce, manufacture and ship new and enhanced products in a timely manner without defects;
 
our ability to successfully expand our manufacturing capacity in Göttingen, Germany and add optics fabrication capacity at our site in Richmond, California;

our ability to manage our manufacturing capacity and that of our suppliers;
 
our reliance on contract manufacturing;
 
the rate of market acceptance of our new products;
 
the ability of our customers to pay for our products;
 
expenses associated with acquisition-related activities;
 
seasonal sales trends;

access to applicable credit markets by us, our customers and their end customers;
 
delays or reductions in customer purchases of our products in anticipation of the introduction of new and enhanced products by us or our competitors;
 
our ability to control expenses;
 
the level of capital spending of our customers;
 
potential excess and/or obsolescence of our inventory;
 
costs and timing of adhering to current and developing governmental regulations and reviews relating to our products and business;
 
costs related to acquisitions of technology or businesses;
 
impairment of goodwill, intangible assets and other long-lived assets;
 
our ability to meet our expectations and forecasts and those of public market analysts and investors;
  
the availability of research funding by governments with regard to our customers in the scientific business, such as universities;
 
continued government spending on defense-related projects where we are a subcontractor;
  
maintenance of supply relating to products sold to the government on terms which we would prefer not to accept;
 
changes in policy, interpretations, or challenges to the allowability of costs incurred under government cost accounting standards;

damage to our reputation as a result of coverage in social media, Internet blogs or other media outlets;

managing our and other parties' compliance with contracts in multiple languages and jurisdictions;

managing our internal and third party sales representatives and distributors, including compliance with all applicable laws;

impact of government economic policies on macroeconomic conditions;

44

Table of Contents


costs and expenses from litigation;

costs associated with designing around or payment of licensing fees associated with issued patents in our fields of business;

government support of alternative energy industries, such as solar;
 
the future impact of legislation, rulemaking, and changes in accounting, tax, defense procurement, or export policies; and
 
distraction of management related to acquisition or divestment activities.

In addition, we often recognize a substantial portion of our sales in the last month of our fiscal quarters. Our expenses for any given quarter are typically based on expected sales and if sales are below expectations in any given quarter, the adverse impact of the shortfall on our operating results may be magnified by our inability to adjust spending quickly enough to compensate for the shortfall. We also base our manufacturing on our forecasted product mix for the quarter. If the actual product mix varies significantly from our forecast, we may not be able to fill some orders during that quarter, which would result in delays in the shipment of our products. Accordingly, variations in timing of sales, particularly for our higher priced, higher margin products, can cause significant fluctuations in quarterly operating results.
 
Due to these and other factors, such as varying product mix, we believe that quarter-to-quarter and year-to-year comparisons of our historical operating results may not be meaningful. You should not rely on our results for any quarter or year as an indication of our future performance. Our operating results in future quarters and years may be below public market analysts' or investors' expectations, which would likely cause the price of our stock to fall. In addition, over the past several years, U.S. and global equity markets have experienced significant price and volume fluctuations that have affected the stock prices of many technology companies both in and outside our industry. There has not always been a direct correlation between this volatility and the performance of particular companies subject to these stock price fluctuations. These factors, as well as general economic and political conditions or investors' concerns regarding the credibility of corporate financial statements, may have a material adverse effect on the market price of our stock in the future.
 
We depend on sole source or limited source suppliers, both internal and external, for some of our key components and materials, including exotic materials, certain cutting-edge optics and crystals, in our products, which make us susceptible to supply shortages or price fluctuations that could adversely affect our business, particularly our ability to meet our customers' delivery requirements.
 
We currently purchase several key components and materials used in the manufacture of our products from sole source or limited source suppliers, both internal and external. In particular, from time-to-time our customers require us to ramp up production and/or accelerate delivery schedules of our products. Our key suppliers may not have the ability to increase their production in line with our customers’ demands. This can become acute during times of high growth in our customers’ businesses. Our failure to timely receive these key components and materials would likely cause delays in the shipment of our products, which would likely negatively impact both our customers and our business. Some of these suppliers are relatively small private companies that may discontinue their operations at any time and which may be particularly susceptible to prevailing economic conditions. Some of our suppliers are located in regions which may be susceptible to natural disasters, such as the flooding in Thailand and the earthquake, tsunami and resulting nuclear disaster in Japan and severe flooding and power loss in the Eastern part of the United States in recent years. Some may be vulnerable to man-made disasters, such as the recent worldwide shortage of neon gas as a result of the conflict in Ukraine. We typically purchase our components and materials through purchase orders or agreed upon terms and conditions and we do not have guaranteed supply arrangements with many of these suppliers. For certain long-lead time supplies or in order to lock-in pricing, we may be obligated to place purchase orders which are not cancelable or otherwise assume liability for a large amount of the ordered supplies, which limit our ability to adjust down our inventory liability in the event of market downturns or other customer cancellations or rescheduling of their purchase orders for our products. Some of our products, particularly in the flat panel display industry, require designs and specifications which are at the cutting-edge of available technologies. Our and our customers' designs and specifications frequently change to meet rapidly evolving market demands. Accordingly, certain of our products require components and supplies which may be technologically difficult and unpredictable to manufacture. By their very nature, these types of components may only be available by a single supplier. These characteristics further pressure the timely delivery of such components. We may fail to obtain these supplies in a timely manner in the future. We may experience difficulty identifying alternative sources of supply for certain components used in our products and may have to incur expenses and management distraction in assisting our current and future suppliers to meet our and our customers' technical requirements. We

45

Table of Contents

would experience further delays while identifying, evaluating and testing the products of these potential alternative suppliers. Furthermore, financial or other difficulties faced by these suppliers or significant changes in demand for these components or materials could limit their availability. We continue to consolidate our supply base and move supplier locations. When we transition locations we may increase our inventory of such products as a “safety stock” during the transition, which may cause the amount of inventory reflected on our balance sheet to increase. Additionally, many of our customers rely on sole source suppliers. In the event of a disruption of our customers' supply chain, orders from our customers could decrease or be delayed.

Any interruption or delay in the supply of any of these components or materials, or the inability to obtain these components and materials from alternate sources at acceptable prices and within a reasonable amount of time, or our failure to properly manage these moves, would impair our ability to meet scheduled product deliveries to our customers and could cause customers to cancel orders. We have historically relied exclusively on our own production capability to manufacture certain strategic components, crystals, semiconductor lasers, lasers and laser-based systems and recently acquired the capability to manufacture certain large format optics. Because we manufacture, package and test these components, products and systems at our own facilities, and such components, products and systems are not readily available from other sources, any interruption in manufacturing would adversely affect our business. Since many of our products have lengthy qualification periods, our ability to introduce multiple suppliers for parts may be limited. In addition, our failure to achieve adequate manufacturing yields of these items at our manufacturing facilities may materially and adversely affect our operating results and financial condition.

We participate in the microelectronics market, which requires significant research and development expenses to develop and maintain products and a failure to achieve market acceptance for our products could have a significant negative impact on our business and results of operations.
 
The microelectronics market is characterized by rapid technological change, frequent product introductions, the volatility of product supply and demand, changing customer requirements and evolving industry standards. The nature of this market requires significant research and development expenses to participate, with substantial resources invested in advance of material sales of our products to our customers in this market. Additionally, our product offerings may become obsolete given the frequent introduction of alternative technologies. In the event either our customers' or our products fail to gain market acceptance, or the microelectronics market fails to grow, it would likely have a significant negative effect on our business and results of operations.

We participate in the flat panel display market, which has a relatively limited number of end customer manufacturers.  Our backlog, timing of net sales and results of operations could be negatively impacted in the event our customers reschedule or cancel orders.

In the flat panel display market, there are a relatively limited number of manufacturers who are the end customers for our annealing products. In the first six months of fiscal 2016, Advanced Process Systems Corporation, an integrator in the flat panel display market based in South Korea, and Japanese Steel Works, Ltd., an integrator in the flat panel display market based in Japan, have contributed more than 10% of our revenue. Given macroeconomic conditions, varying consumer demand and technical process limitations at manufacturers, our customers may seek to reschedule or cancel orders. This was recently seen with a requested expedited shipment of a Linebeam 1500 product for our third fiscal quarter of 2015, which delivery date was then changed at the customer’s request back to its originally scheduled date in the fourth fiscal quarter of 2015. These larger flat panel-related systems have large average selling prices. Any rescheduling or canceling of such orders by our customers will likely have a significant impact on our quarterly or annual net sales and results of operations and could negatively impact inventory values and backlog. Additionally, challenges in meeting evolving technological requirements for these complex products by us and our suppliers could also result in delays in shipments, rescheduled or canceled orders by our customers. This could negatively impact our backlog, timing of net sales and results of operations. 
 
As of April 2, 2016 , flat panel display systems represented 48% of our backlog. Since our backlog includes higher average selling price flat panel display systems, any delays or cancellation of shipments could have a material adverse effect on our financial results.

Some of our laser systems are complex in design and may contain defects that are not detected until deployed by our customers, which could increase our costs and reduce our net sales.
 
Lasers and laser systems are inherently complex in design and require ongoing regular maintenance. The manufacture of our lasers, laser products and systems involves a highly complex and precise process. As a result of the technological complexity of our products, in particular the flat panel annealing systems, changes in our or our suppliers' manufacturing processes or the inadvertent use of defective materials by us or our suppliers could result in a material adverse effect on our ability to achieve acceptable manufacturing yields and product reliability. To the extent that we do not achieve and maintain our projected yields

46

Table of Contents

or product reliability, our business, operating results, financial condition and customer relationships would be adversely affected. We provide warranties on a majority of our product sales, and reserves for estimated warranty costs are recorded during the period of sale. The determination of such reserves requires us to make estimates of failure rates and expected costs to repair or replace the products under warranty. We typically establish warranty reserves based on historical warranty costs for each product line. If actual return rates and/or repair and replacement costs differ significantly from our estimates, adjustments to cost of sales may be required in future periods which could have an adverse effect on our results of operations.
 
Our customers may discover defects in our products after the products have been fully deployed and operated, including under the end user's peak stress conditions. In addition, some of our products are combined with products from other vendors, which may contain defects. As a result, should problems occur, it may be difficult to identify the source of the problem. If we are unable to identify and fix defects or other problems, we could experience, among other things:
 
loss of customers or orders;
 
increased costs of product returns and warranty expenses;
 
damage to our brand reputation;
 
failure to attract new customers or achieve market acceptance;
 
diversion of development, engineering and manufacturing resources; and
 
legal actions by our customers and/or their end users.
 
The occurrence of any one or more of the foregoing factors could seriously harm our business, financial condition and results of operations.

Continued volatility in the advanced packaging and semiconductor manufacturing markets could adversely affect our business, financial condition and results of operations.
 
A portion of our net sales in the microelectronics market depends on the demand for our products by advanced packaging applications and semiconductor equipment companies. These markets have historically been characterized by sudden and severe cyclical variations in product supply and demand, which have often severely affected the demand for semiconductor manufacturing equipment, including laser-based tools and systems. The timing, severity and duration of these market cycles are difficult to predict, and we may not be able to respond effectively to these cycles. The continuing uncertainty in these markets severely limits our ability to predict our business prospects or financial results in these markets.
 
During industry downturns, our net sales from these markets may decline suddenly and significantly. Our ability to rapidly and effectively reduce our cost structure in response to such downturns is limited by the fixed nature of many of our expenses in the near term and by our need to continue our investment in next-generation product technology and to support and service our products. In addition, due to the relatively long manufacturing lead times for some of the systems and subsystems we sell to these markets, we may incur expenditures or purchase raw materials or components for products we cannot sell. Accordingly, downturns in the semiconductor capital equipment market may materially harm our operating results. Conversely, when upturns in these markets occur, we must be able to rapidly and effectively increase our manufacturing capacity to meet increases in customer demand that may be extremely rapid, and if we fail to do so we may lose business to our competitors and our relationships with our customers may be harmed.

We are exposed to risks associated with worldwide economic conditions and related uncertainties which could negatively impact demand for our products and results of operations.
 
Volatility and disruption in the capital and credit markets, depressed consumer confidence, government economic policies, negative economic conditions, volatile corporate profits and reduced capital spending could negatively impact demand for our products. In particular, it is difficult to develop and implement strategy, sustainable business models and efficient operations, as well as effectively manage supply chain relationships in the face of such conditions including uncertainty regarding the ability of some of our suppliers to continue operations and provide us with uninterrupted supply flow. Our ability to maintain our research and development investments in our broad product offerings may be adversely impacted in the event that our sales decline and do not increase in the future. Spending and the timing thereof by consumers and businesses have a significant impact on our results and, where such spending is delayed or canceled, it could have a material negative impact on our operating results. Current global economic conditions remain uncertain and challenging. Weakness in our end markets could

47

Table of Contents

negatively impact our net sales, gross margin and operating expenses, and consequently have a material adverse effect on our business, financial condition and results of operations.

Uncertainty in global fiscal policy has likely had an adverse impact on global financial markets and overall economic activity. Should this uncertain financial policy recur, it would likely negatively impact global economic activity. Any weakness in global economies would also likely have negative repercussions on U.S. and global credit and financial markets, and further exacerbate sovereign debt concerns in the European Union.  All of these factors would likely adversely impact the global demand for our products and the performance of our investments, and would likely have a material adverse effect on our business, results of operations and financial condition.

The financial turmoil affecting the banking system and financial markets continues to negatively impact financial institutions and has resulted in tighter credit markets, and lower levels of liquidity in some financial markets. There could be a number of follow-on effects from the tightened credit environment on our business, including the insolvency of key suppliers or their inability to obtain credit to finance development and/or manufacture products resulting in product delays; inability of customers to obtain credit to finance purchases of our products and/or customer insolvencies; and failure of financial institutions negatively impacting our treasury functions. In the event our customers are unable to obtain credit or otherwise pay for our shipped products it could significantly impact our ability to collect on our outstanding accounts receivable. Other income and expense also could vary materially from expectations depending on gains or losses realized on the sale or exchange of financial instruments; impairment charges resulting from revaluations of debt and equity securities and other investments; interest rates; cash balances; and changes in fair value of derivative instruments. Volatility in the financial markets and any overall economic uncertainty increase the risk that the actual amounts realized in the future on our financial instruments could differ significantly from the fair values currently assigned to them. Uncertainty about current global economic conditions could also continue to increase the volatility of our stock price.
 
In addition, political and social turmoil related to international conflicts, terrorist acts, civil unrest and mass migration may put further pressure on economic conditions in the United States and the rest of the world. Unstable economic, political and social conditions make it difficult for our customers, our suppliers and us to accurately forecast and plan future business activities. If such conditions persist, our business, financial condition and results of operations could suffer. Additionally, unstable economic conditions can provide significant pressures and burdens on individuals, which could cause them to engage in inappropriate business conduct. See “Part I, Item 4. CONTROLS AND PROCEDURES.”
 
Our cash and cash equivalents and short-term investments are managed through various banks around the world and volatility in the capital and credit market conditions could cause financial institutions to fail or materially harm service levels provided by such banks, both of which could have an adverse impact on our ability to timely access funds.
 
World capital and credit markets have been and may continue to experience volatility and disruption. In some cases, the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, as well as pressured the solvency of some financial institutions. These financial institutions, including banks, have had difficulty timely performing regular services and in some cases have failed or otherwise been largely taken over by governments. We maintain our cash, cash equivalents and short-term investments with a number of financial institutions around the world. Should some or all of these financial institutions fail or otherwise be unable to timely perform requested services, we would likely have a limited ability to timely access our cash deposited with such institutions, or, in extreme circumstances the failure of such institutions could cause us to be unable to access cash for the foreseeable future. If we are unable to quickly access our funds when we need them, we may need to increase the use of our existing credit lines or access more expensive credit, if available. If we are unable to access our cash or if we access existing or additional credit or are unable to access additional credit, it could have a negative impact on our operations, including our reported net income. In addition, the willingness of financial institutions to continue to accept our cash deposits will impact our ability to diversify our investment risk among institutions.
 
We are exposed to credit risk and fluctuations in the market values of our investment portfolio.
 
Although we have not recognized any material losses on our cash, cash equivalents and short-term investments, future declines in their market values could have a material adverse effect on our financial condition and operating results. Given the global nature of our business, we have investments both domestically and internationally. There has recently been growing pressure on the creditworthiness of sovereign nations, particularly in Europe where a significant portion of our cash, cash equivalents and short-term investments are invested, which results in corresponding pressure on the valuation of the securities issued by such nations. Additionally, our overall investment portfolio is often concentrated in government-issued securities such as U.S. Treasury securities and government agencies, corporate notes, commercial paper and money market funds. Credit ratings and pricing of these investments can be negatively impacted by liquidity, credit deterioration or losses, financial results, or other factors. Additionally, liquidity issues or political actions by sovereign nations could result in decreased values for our

48

Table of Contents

investments in certain government securities. As a result, the value or liquidity of our cash, cash equivalents and short-term investments could decline or become materially impaired, which could have a material adverse effect on our financial condition and operating results. See “Item 3. Quantitative and Qualitative Disclosures about Market Risk.”

Our future success depends on our ability to increase our sales volumes and decrease our costs to offset potential declines in the average selling prices (“ASPs”) of our products and, if we are unable to realize greater sales volumes and lower costs, our operating results may suffer.
 
Our ability to increase our sales volume and our future success depends on the continued growth of the markets for lasers, laser systems and related accessories, as well as our ability to identify, in advance, emerging markets for laser-based systems. We cannot assure you that we will be able to successfully identify, on a timely basis, new high-growth markets in the future. Moreover, we cannot assure you that new markets will develop for our products or our customers' products, or that our technology or pricing will enable such markets to develop. Future demand for our products is uncertain and will depend to a great degree on continued technological development and the introduction of new or enhanced products. If this does not continue, sales of our products may decline and our business will be harmed.
 
We have in the past experienced decreases in the ASPs of some of our products. As competing products become more widely available, the ASPs of our products may decrease. If we are unable to offset any decrease in our ASPs by increasing our sales volumes, our net sales will decline. In addition, to maintain our gross margins, we must continue to reduce the cost of manufacturing our products while maintaining their high quality. From time to time, our products, like many complex technological products, may fail in greater frequency than anticipated. This can lead to further charges, which can result in higher costs, lower gross margins and lower operating results. Furthermore, as ASPs of our current products decline, we must develop and introduce new products and product enhancements with higher margins. If we cannot maintain our gross margins, our operating results could be seriously harmed, particularly if the ASPs of our products decrease significantly.

Our future success depends on our ability to develop and successfully introduce new and enhanced products that meet the needs of our customers.
 
Our current products address a broad range of commercial and scientific research applications in the photonics markets. We cannot assure you that the market for these applications will continue to generate significant or consistent demand for our products. Demand for our products could be significantly diminished by disrupting technologies or products that replace them or render them obsolete. Furthermore, the new and enhanced products in certain markets generally continue to be smaller in size and have lower ASPs, and therefore, we have to sell more units to maintain revenue levels. Accordingly, we must continue to invest in research and development in order to develop competitive products.
 
Our future success depends on our ability to anticipate our customers' needs and develop products that address those needs. Introduction of new products and product enhancements will require that we effectively transfer production processes from research and development to manufacturing and coordinate our efforts with those of our suppliers to achieve volume production rapidly. If we fail to transfer production processes effectively, develop product enhancements or introduce new products in sufficient quantities to meet the needs of our customers as scheduled, our net sales may be reduced and our business may be harmed.

We face risks associated with our foreign operations and sales that could harm our financial condition and results of operations.
 
For the three and six months ended April 2, 2016 , 73% of our net sales were derived from customers outside of the United States. For fiscal 2015, fiscal 2014 and fiscal 2013, 73%, 74%, and 77%, respectively, of our net sales were derived from customers outside of the United States. We anticipate that foreign sales, particularly in Asia, will continue to account for a significant portion of our net sales in the foreseeable future.

A global economic slowdown or a natural disaster could have a negative effect on various foreign markets in which we operate, such as the earthquake, tsunami and resulting nuclear disaster in Japan and the flooding in Thailand in recent years. Such a slowdown may cause us to reduce our presence in certain countries, which may negatively affect the overall level of business in such countries. Our foreign sales are primarily through our direct sales force. Additionally, some foreign sales are made through foreign distributors and representatives. Our foreign operations and sales are subject to a number of risks, including:
 
longer accounts receivable collection periods;
 
the impact of recessions and other economic conditions in economies outside the United States;

49

Table of Contents

 
unexpected changes in regulatory requirements;
 
certification requirements;
 
environmental regulations;
 
reduced protection for intellectual property rights in some countries;
 
potentially adverse tax consequences;
 
political and economic instability;
  
import/export regulations, tariffs and trade barriers;
 
compliance with applicable United States and foreign anti-corruption laws;
 
cultural and management differences;
 
reliance in some jurisdictions on third party sales channel partners;

preference for locally produced products; and
 
shipping and other logistics complications.
 
Our business could also be impacted by international conflicts, terrorist and military activity, civil unrest and pandemic illness which could cause a slowdown in customer orders, cause customer order cancellations or negatively impact availability of supplies or limit our ability to timely service our installed base of products.
 
We are also subject to the risks of fluctuating foreign currency exchange rates, which could materially adversely affect the sales price of our products in foreign markets, as well as the costs and expenses of our foreign subsidiaries. While we use forward exchange contracts and other risk management techniques to hedge our foreign currency exposure, we remain exposed to the economic risks of foreign currency fluctuations.
 
We may not be able to protect our proprietary technology which could adversely affect our competitive advantage.
 
Maintenance of intellectual property rights and the protection thereof is important to our business. We rely on a combination of patent, copyright, trademark and trade secret laws and restrictions on disclosure to protect our intellectual property rights. Our patent applications may not be approved, any patents that may be issued may not sufficiently protect our intellectual property and any issued patents may be challenged by third parties. Other parties may independently develop similar or competing technology or design around any patents that may be issued to us. We cannot be certain that the steps we have taken will prevent the misappropriation of our intellectual property, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. Further, we may be required to enforce our intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial costs and diversion of management's attention. Additionally, there may be existing patents of which we are unaware that could be pertinent to our business and it is not possible for us to know whether there are patent applications pending that our products might infringe upon since these applications are often not publicly available until a patent is issued or published.
 
We may, in the future, be subject to claims or litigation from third parties, for claims of infringement of their proprietary rights or to determine the scope and validity of our proprietary rights or the proprietary rights of competitors or other rights holders. These claims could result in costly litigation and the diversion of our technical and management personnel. Adverse resolution of litigation may harm our operating results or financial condition.
 
In recent years, there has been significant litigation in the United States and around the world involving patents and other intellectual property rights. This has been seen in our industry, for example in the recently concluded patent-related litigation between IMRA America, Inc. ("Imra") and IPG Photonics Corporation and in Imra's recently brought litigation against two of our German subsidiaries. From time to time, like many other technology companies, we have received communications from other parties asserting the existence of patent rights, copyrights, trademark rights or other intellectual property rights which such third parties believe may cover certain of our products, processes, technologies or information. In the future, we may be a

50

Table of Contents

party to litigation to protect our intellectual property or as a result of an alleged infringement of others' intellectual property whether through direct claims or by way of indemnification claims of our customers, as, in some cases, we contractually agree to indemnify our customers against third-party infringement claims relating to our products. These claims and any resulting lawsuit, if successful, could subject us to significant liability for damages or invalidation of our proprietary rights. These lawsuits, regardless of their success, would likely be time-consuming and expensive to resolve and would divert management time and attention. Any potential intellectual property litigation could also force us to do one or more of the following:
 
  stop manufacturing, selling or using our products that use the infringed intellectual property;
 
obtain from the owner of the infringed intellectual property right a license to sell or use the relevant technology, although such license may not be available on reasonable terms, or at all; or
 
redesign the products that use the technology.
 
If we are forced to take any of these actions or are otherwise a party to lawsuits of this nature, we may incur significant losses and our business may be seriously harmed. We do not have insurance to cover potential claims of this type.
 
If our goodwill or intangible assets become impaired, we may be required to record a significant charge to earnings.
 
Under accounting principles generally accepted in the United States, we review our intangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill is required to be tested for impairment at least annually. Factors that may be considered in determining whether a change in circumstances indicating that the carrying value of our goodwill or other intangible assets may not be recoverable include declines in our stock price and market capitalization or future cash flows projections. A decline in our stock price, or any other adverse change in market conditions, particularly if such change has the effect of changing one of the critical assumptions or estimates we used to calculate the estimated fair value of our reporting units, could result in a change to the estimation of fair value that could result in an impairment charge. Any such material charges, whether related to goodwill or purchased intangible assets, may have a material negative impact on our financial and operating results.
 
We depend on skilled personnel to operate our business effectively in a rapidly changing market, and if we are unable to retain existing or hire additional personnel when needed, our ability to develop and sell our products could be harmed.
 
Our ability to continue to attract and retain highly skilled personnel will be a critical factor in determining whether we will be successful in the future. Recruiting and retaining highly skilled personnel in certain functions continues to be difficult. At certain locations where we operate, the cost of living is extremely high and it may be difficult to retain key employees and management at a reasonable cost. We may not be successful in attracting, assimilating or retaining qualified personnel to fulfill our current or future needs. Our failure to attract additional employees and retain our existing employees could adversely affect our growth and our business.
 
Our future success depends upon the continued services of our executive officers and other key engineering, sales, marketing, manufacturing and support personnel, any of whom may leave and our ability to effectively transition to their successors. Our inability to retain or to effectively transition to their successors could harm our business and our results of operations.
 
The long sales cycles for our products may cause us to incur significant expenses without offsetting net sales.
 
Customers often view the purchase of our products as a significant and strategic decision. As a result, customers typically expend significant effort in evaluating, testing and qualifying our products before making a decision to purchase them, resulting in a lengthy initial sales cycle. While our customers are evaluating our products and before they place an order with us, we may incur substantial sales and marketing and research and development expenses to customize our products to the customers' needs. We may also expend significant management efforts, increase manufacturing capacity and order long lead-time components or materials prior to receiving an order. Even after this evaluation process, a potential customer may not purchase our products. As a result, these long sales cycles may cause us to incur significant expenses without ever receiving net sales to offset such expenses.

The markets in which we sell our products are intensely competitive and increased competition could cause reduced sales levels, reduced gross margins or the loss of market share.
 
Competition in the various photonics markets in which we provide products is very intense. We compete against a number of large public and private companies, including CVI Melles Griot, GSI Group, Inc., IPG Photonics Corporation, Lumentum

51

Table of Contents

Holdings Inc., Newport Corporation, Rofin-Sinar Technologies, Inc., and Trumpf GmbH, as well as other smaller companies. Some of our competitors are large companies that have significant financial, technical, marketing and other resources. These competitors may be able to devote greater resources than we can to the development, promotion, sale and support of their products. Some of our competitors are much better positioned than we are to acquire other companies in order to gain new technologies or products that may displace our product lines. Any of these acquisitions could give our competitors a strategic advantage. Any business combinations or mergers among our competitors, forming larger companies with greater resources, could result in increased competition, price reductions, reduced margins or loss of market share, any of which could materially and adversely affect our business, results of operations and financial condition.
 
Additional competitors may enter the markets in which we serve, both foreign and domestic, and we are likely to compete with new companies in the future. We may encounter potential customers that, due to existing relationships with our competitors, are committed to the products offered by these competitors. Further, our current or potential customers may determine to develop and produce products for their own use which are competitive to our products. As a result of the foregoing factors, we expect that competitive pressures may result in price reductions, reduced margins, loss of sales and loss of market share. In addition, in markets where there are a limited number of customers, competition is particularly intense.

If we fail to accurately forecast component and material requirements for our products, we could incur additional costs and incur significant delays in shipments, which could result in a loss of customers.
 
We use rolling forecasts based on anticipated product orders and material requirements planning systems to determine our product requirements. It is very important that we accurately predict both the demand for our products and the lead times required to obtain the necessary components and materials. We depend on our suppliers for most of our product components and materials. Lead times for components and materials that we order vary significantly and depend on factors including the specific supplier requirements, the size of the order, contract terms and current market demand for components. For substantial increases in our sales levels of certain products, some of our suppliers may need at least nine months lead-time. If we overestimate our component and material requirements, we may have excess inventory, which would increase our costs. If we underestimate our component and material requirements, we may have inadequate inventory, which could interrupt and delay delivery of our products to our customers. Any of these occurrences would negatively impact our net sales, business or operating results. 

Our reliance on contract manufacturing and outsourcing may adversely impact our financial results and operations due to our decreased control over the performance and timing of certain aspects of our manufacturing.
 
Our manufacturing strategy includes partnering with contract manufacturers to outsource non-core subassemblies and less complex turnkey products, including some performed at international sites located in Asia and Eastern Europe. Our ability to resume internal manufacturing operations for certain products and components in a timely manner may be eliminated. The cost, quality, performance and availability of contract manufacturing operations are and will be essential to the successful production and sale of many of our products. Our financial condition or results of operation could be adversely impacted if any contract manufacturer or other supplier is unable for any reason, including as a result of the impact of worldwide economic conditions, to meet our cost, quality, performance, and availability standards. We may not be able to provide contract manufacturers with product volumes that are high enough to achieve sufficient cost savings. If shipments fall below forecasted levels, we may incur increased costs or be required to take ownership of the inventory. Also, our ability to control the quality of products produced by contract manufacturers may be limited and quality issues may not be resolved in a timely manner, which could adversely impact our financial condition or results of operations.

If we fail to effectively manage our growth or, alternatively, our spending during downturns, our business could be disrupted, which could harm our operating results.
 
Growth in sales, combined with the challenges of managing geographically dispersed operations, can place a significant strain on our management systems and resources, and our anticipated growth in future operations could continue to place such a strain. The failure to effectively manage our growth could disrupt our business and harm our operating results. Our ability to successfully offer our products and implement our business plan in evolving markets requires an effective planning and management process. In economic downturns, we must effectively manage our spending and operations to ensure our competitive position during the downturn, as well as our future opportunities when the economy improves, remain intact. The failure to effectively manage our spending and operations could disrupt our business and harm our operating results.
 
Historically, acquisitions have been an important element of our strategy. However, we may not find suitable acquisition candidates in the future and we may not be able to successfully integrate and manage acquired businesses. Any acquisitions we make could disrupt our business and harm our financial condition.

52

Table of Contents

 
We have in the past made strategic acquisitions of other corporations and entities, as well as asset purchases, and we continue to evaluate potential strategic acquisitions of complementary companies, products and technologies. In the event of any future acquisitions, we could:
 
issue stock that would dilute our current stockholders' percentage ownership;
 
pay cash that would decrease our working capital;
 
incur debt;
 
assume liabilities; or
 
incur expenses related to impairment of goodwill and amortization.
 
Acquisitions also involve numerous risks, including:
 
problems combining the acquired operations, systems, technologies or products;
 
an inability to realize expected operating efficiencies or product integration benefits;
 
difficulties in coordinating and integrating geographically separated personnel, organizations, systems and facilities;
 
difficulties integrating business cultures;
 
unanticipated costs or liabilities, including the costs associated with improving the internal controls of the acquired company;
 
diversion of management's attention from our core businesses;
 
adverse effects on existing business relationships with suppliers and customers;
 
potential loss of key employees, particularly those of the purchased organizations;
 
incurring unforeseen obligations or liabilities in connection with acquisitions; and
 
the failure to complete acquisitions even after signing definitive agreements which, among other things, would result in the expensing of potentially significant professional fees and other charges in the period in which the acquisition or negotiations are terminated.
 
We cannot assure you that we will be able to successfully identify appropriate acquisition candidates, to integrate any businesses, products, technologies or personnel that we might acquire in the future or achieve the anticipated benefits of such transactions, which may harm our business.

Our market is unpredictable and characterized by rapid technological changes and evolving standards demanding a significant investment in research and development, and, if we fail to address changing market conditions, our business and operating results will be harmed.

The photonics industry is characterized by extensive research and development, rapid technological change, frequent new product introductions, changes in customer requirements and evolving industry standards. Because this industry is subject to rapid change, it is difficult to predict its potential size or future growth rate. Our success in generating net sales in this industry will depend on, among other things:

maintaining and enhancing our relationships with our customers;

the education of potential end-user customers about the benefits of lasers and laser systems; and

our ability to accurately predict and develop our products to meet industry standards.


53

Table of Contents

For the three and six months ended April 2, 2016 , our research and development costs were $21.0 million ( 10.5% of net sales) and $40.1 million ( 10.3% of net sales), respectively. For our fiscal years 2015, 2014 and 2013, our research and development costs were $81.5 million (10.2% of net sales), $79.1 million (10.0% of net sales) and $82.8 million (10.2% of net sales), respectively. We cannot assure you that our expenditures for research and development will result in the introduction of new products or, if such products are introduced, that those products will achieve sufficient market acceptance or to generate sales to offset the costs of development. Our failure to address rapid technological changes in our markets could adversely affect our business and results of operations.

We are exposed to lawsuits in the normal course of business which could have a material adverse effect on our business, operating results, or financial condition.
 
We are exposed to lawsuits in the normal course of our business, including product liability claims, if personal injury, death or commercial losses occur from the use of our products. While we typically maintain business insurance, including directors' and officers' policies, litigation can be expensive, lengthy, and disruptive to normal business operations, including the potential impact of indemnification obligations for individuals named in any such lawsuits. We may not, however, be able to secure insurance coverage on terms acceptable to us in the future. Moreover, the results of complex legal proceedings are difficult to predict. An unfavorable resolution of a particular lawsuit, including a recall or redesign of products if ultimately determined to be defective, could have a material adverse effect on our business, operating results, or financial condition.
 
We use standard laboratory and manufacturing materials that could be considered hazardous and we could be liable for any damage or liability resulting from accidental environmental contamination or injury.
 
Although most of our products do not incorporate hazardous or toxic materials and chemicals, some of the gases used in our excimer lasers and some of the liquid dyes used in some of our scientific laser products are highly toxic. In addition, our operations involve the use of standard laboratory and manufacturing materials that could be considered hazardous. Also, if a facility fire were to occur at our Sunnyvale, California site and were to spread to a reactor used to grow semiconductor wafers, it could release highly toxic emissions. We believe that our safety procedures for handling and disposing of such materials comply with all federal, state and offshore regulations and standards. However, the risk of accidental environmental contamination or injury from such materials cannot be entirely eliminated. In the event of such an accident involving such materials, we could be liable for damages and such liability could exceed the amount of our liability insurance coverage and the resources of our business which could have an adverse effect on our financial results or our business as a whole.
 
Compliance or the failure to comply with current and future environmental regulations could cause us significant expense.
 
We are subject to a variety of federal, state, local and foreign environmental regulations relating to the use, storage, discharge and disposal of hazardous chemicals used during our manufacturing process or requiring design changes or recycling of products we manufacture. If we fail to comply with any present and future regulations, we could be subject to future liabilities, the suspension of production or a prohibition on the sale of products we manufacture. In addition, such regulations could restrict our ability to expand our facilities or could require us to acquire costly equipment, or to incur other significant expenses to comply with environmental regulations, including expenses associated with the recall of any non-compliant product and the management of historical waste.
 
From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, the Registration, Evaluation, Authorization and Restriction of Chemical substances (“REACH”), the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (“RoHS”) and the Waste Electrical and Electronic Equipment Directive (“WEEE”) enacted in the European Union which regulate the use of certain hazardous substances in, and require the collection, reuse and recycling of waste from, certain products we manufacture. This and similar legislation that has been or is in the process of being enacted in Japan, China, South Korea and various states of the United States may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials. These redesigns or alternative materials may detrimentally impact the performance of our products, add greater testing lead-times for product introductions or have other similar effects. We believe we comply with all such legislation where our products are sold and we will continue to monitor these laws and the regulations being adopted under them to determine our responsibilities. In addition, we are monitoring legislation relating to the reduction of carbon emissions from industrial operations to determine whether we may be required to incur any additional material costs or expenses associated with our operations. We are not currently aware of any such material costs or expenses. The SEC has promulgated rules requiring disclosure regarding the use of certain “conflict minerals” mined from the Democratic Republic of Congo and adjoining countries and procedures regarding a manufacturer's efforts to prevent the sourcing of such minerals. The implementation of such rules has required us to incur additional expense and internal resources and may continue to do so in the

54

Table of Contents

future, particularly in the event that only a limited pool of suppliers are available to certify that products are free from “conflict minerals.” Our failure to comply with any of the foregoing regulatory requirements or contractual obligations could result in our being directly or indirectly liable for costs, fines or penalties and third-party claims, and could jeopardize our ability to conduct business in the United States and foreign countries.

Our and our customers' operations would be seriously harmed if our logistics or facilities or those of our suppliers, our customers' suppliers or our contract manufacturers were to experience catastrophic loss.
 
Our operations, logistics and facilities and those of our customers, suppliers and contract manufacturers could be subject to a catastrophic loss from fire, flood, earthquake, volcanic eruption, work stoppages, power outages, acts of war, pandemic illnesses, energy shortages, theft of assets, other natural disasters or terrorist activity. A substantial portion of our research and development activities, manufacturing, our corporate headquarters and other critical business operations are located near major earthquake faults in Santa Clara, California, an area with a history of seismic events. Any such loss or detrimental impact to any of our operations, logistics or facilities could disrupt our operations, delay production, shipments and net sales and result in large expenses to repair or replace the facility. While we have obtained insurance to cover most potential losses, after reviewing the costs and limitations associated with earthquake insurance, we have decided not to procure such insurance. We believe that this decision is consistent with decisions reached by numerous other companies located nearby. We cannot assure you that our existing insurance coverage will be adequate against all other possible losses.

Difficulties with our enterprise resource planning (“ERP”) system and other parts of our global information technology system could harm our business and results of operation. If our network security measures are breached and unauthorized access is obtained to a customer's data or our data or our information technology systems, we may incur significant legal and financial exposure and liabilities.

Like many modern multinational corporations, we maintain a global information technology system, including software products licensed from third parties. Any system, network or Internet failures, misuse by system users, the hacking into or disruption caused by the unauthorized access by third parties or loss of license rights could disrupt our ability to timely and accurately manufacture and ship products or to report our financial information in compliance with the timelines mandated by the SEC. Any such failure, misuse, hacking, disruptions or loss would likely cause a diversion of management's attention from the underlying business and could harm our operations. In addition, a significant failure of our global information technology system could adversely affect our ability to complete an evaluation of our internal controls and attestation activities pursuant to Section 404 of the Sarbanes-Oxley Act of 2002.
Our information systems are subject to attacks, interruptions and failures.
As part of our day-to-day business, we store our data and certain data about our customers in our global information technology system. While our system is designed with access security, if a third party gains unauthorized access to our data, including any regarding our customers, such a security breach could expose us to a risk of loss of this information, loss of business, litigation and possible liability. Our security measures may be breached as a result of third-party action, including intentional misconduct by computer hackers, employee error, malfeasance or otherwise. Additionally, third parties may attempt to fraudulently induce employees or customers into disclosing sensitive information such as user names, passwords or other information in order to gain access to our customers' data or our data, including our intellectual property and other confidential business information, or our information technology systems. Because the techniques used to obtain unauthorized access, or to sabotage systems, change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Any unauthorized access could result in a loss of confidence by our customers, damage our reputation, disrupt our business, lead to legal liability and negatively impact our future sales. Additionally, such actions could result in significant costs associated with loss of our intellectual property, impairment of our ability to conduct our operations, rebuilding our network and systems, prosecuting and defending litigation, responding to regulatory inquiries or actions, paying damages or taking other remedial steps.

Changes in tax rates, tax liabilities or tax accounting rules could affect future results.

As a global company, we are subject to taxation in the United States and various other countries and jurisdictions. Significant judgment is required to determine our worldwide tax liabilities. A number of factors may affect our future effective tax rates including, but not limited to:

changes in the composition of earnings in countries or states with differing tax rates;

changes in the valuations of our deferred tax assets and liabilities;

55

Table of Contents


the resolution of issues arising from tax audits with various tax authorities, and in particular, the outcome of the German tax audits of our tax returns for fiscal years 2006 - 2014, the U.S. tax audit of our tax return for fiscal year 2013 and the Japan tax audit of our tax returns for fiscal years 2013 - 2015;

changes in our global structure that involve acquisitions or an increased investment in technology outside of the United States to better align asset ownership and business functions with revenues and profits;

adjustments to estimated taxes upon finalization of various tax returns;

increases in expenses not deductible for tax purposes, including impairments of goodwill in connection with acquisitions;

our ability to meet the eligibility requirements for tax holidays of limited time tax-advantage status in various jurisdictions;

changes in available tax credits;

changes in share-based compensation;

changes in the tax laws or the interpretation of such tax laws, including the Base Erosion Profit Shifting (“BEPS”) project being conducted by the Organization for Economic Co-operation and Development (“OECD”);

changes in generally accepted accounting principles; and

the repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.

We are also engaged in discussions with various tax authorities regarding the appropriate level of profitability for Coherent entities and this may result in changes to our worldwide tax liabilities. In addition, we are subject to regular examination of our income tax returns by the Internal Revenue Service (“IRS”) and other tax authorities. From time to time the United States, foreign and state governments make substantive changes to tax rules and the application of rules to companies, including various announcements from the United States government potentially impacting our ability to defer taxes on international earnings. We regularly assess the likelihood of favorable or unfavorable outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination will not be materially different than the treatment reflected in our historical income tax provisions and accruals, which could materially and adversely affect our operating results and financial condition.

Changing laws, regulations and standards relating to corporate governance and public disclosure may create uncertainty regarding compliance matters.
 
Federal securities laws, rules and regulations, as well as the rules and regulations of self-regulatory organizations such as NASDAQ and the NYSE, require companies to maintain extensive corporate governance measures, impose comprehensive reporting and disclosure requirements, set strict independence and financial expertise standards for audit and other committee members and impose civil and criminal penalties for companies and their chief executive officers, chief financial officers and directors for securities law violations. These laws, rules and regulations have increased and will continue to increase the scope, complexity and cost of our corporate governance, reporting and disclosure practices, which could harm our results of operations and divert management's attention from business operations. Changing laws, regulations and standards relating to corporate governance and public disclosure may create uncertainty regarding compliance matters. New or changed laws, regulations and standards are subject to varying interpretations in many cases. As a result, their application in practice may evolve over time. We are committed to maintaining high standards of ethics, corporate governance and public disclosure. Complying with evolving interpretations of new or changed legal requirements may cause us to incur higher costs as we revise current practices, policies and procedures, and may divert management time and attention from revenue generating to compliance activities. If our efforts to comply with new or changed laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice, our reputation may also be harmed.
 
Governmental regulations, including duties, affecting the import or export of products could negatively affect our net sales.
 
The United States and many foreign governments impose tariffs and duties on the import and export of products, including some of those which we sell. In particular, given our worldwide operations, we pay duties on certain products when they are

56

Table of Contents

imported into the United States for repair work as well as on certain of our products which are manufactured by our foreign subsidiaries. These products can be subject to a duty on the product value. Additionally, the United States and various foreign governments have imposed tariffs, controls, export license requirements and restrictions on the import or export of some technologies, especially encryption technology. From time to time, government agencies have proposed additional regulation of encryption technology, such as requiring the escrow and governmental recovery of private encryption keys. Governmental regulation of encryption technology and regulation of imports or exports, or our failure to obtain required import or export approval for our products, could harm our international and domestic sales and adversely affect our net sales. From time to time our duty calculations and payments are audited by government agencies. For example, we were audited in South Korea for customs duties and value-added-tax for the period March 2009 to March 2014. We were liable for additional payments, duties, taxes and penalties of $1.6 million, which we paid in the second quarter of fiscal 2016. Any future assessments could have a material adverse effect on our business or financial position, results of operations, or cash flows.
 
In addition, compliance with the directives of the Directorate of Defense Trade Controls (“DDTC”) may result in substantial expenses and diversion of management. Any failure to adequately address the directives of DDTC could result in civil fines or suspension or loss of our export privileges, any of which could have a material adverse effect on our business or financial position, results of operations, or cash flows.

Failure to maintain effective internal controls may cause a loss of investor confidence in the reliability of our financial statements or to cause us to delay filing our periodic reports with the SEC and adversely affect our stock price.
 
The SEC, as directed by Section 404 of the Sarbanes-Oxley Act of 2002, adopted rules requiring public companies to include a report of management on internal control over financial reporting in their annual reports on Form 10-K that contain an assessment by management of the effectiveness of our internal control over financial reporting. In addition, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Although we test our internal control over financial reporting in order to ensure compliance with the Section 404 requirements, our failure to maintain adequate internal controls over financial reporting could result in an adverse reaction in the financial marketplace due to a loss of investor confidence in the reliability of our financial statements or a delay in our ability to timely file our periodic reports with the SEC, which ultimately could negatively impact our stock price.

Provisions of our charter documents and Delaware law, and our Change-of-Control Severance Plan may have anti-takeover effects that could prevent or delay a change in control.
 
Provisions of our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition or make removal of incumbent directors or officers more difficult. These provisions may discourage takeover attempts and bids for our common stock at a premium over the market price. These provisions include:
 
the ability of our Board of Directors to alter our bylaws without stockholder approval;
 
limiting the ability of stockholders to call special meetings; and
 
establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted on by stockholders at stockholder meetings.
 
We are subject to Section 203 of the Delaware General Corporation Law, which prohibits a publicly-held Delaware corporation from engaging in a merger, asset or stock sale or other transaction with an interested stockholder for a period of three years following the date such person became an interested stockholder, unless prior approval of our board of directors is obtained or as otherwise provided. These provisions of Delaware law also may discourage, delay or prevent someone from acquiring or merging with us without obtaining the prior approval of our board of directors, which may cause the market price of our common stock to decline. In addition, we have adopted a change of control severance plan, which provides for the payment of a cash severance benefit to each eligible employee based on the employee's position. If a change of control occurs, our successor or acquirer will be required to assume and agree to perform all of our obligations under the change of control severance plan which may discourage potential acquirers or result in a lower stock price.

RISKS RELATED TO THE PROPOSED MERGER WITH ROFIN

If we are unable to complete our contemplated merger with Rofin, our expected financial results and the market value of our common stock could be adversely affected.


57

Table of Contents

Consummation of the merger with Rofin is subject to customary conditions to closing, including the receipt of required regulatory approvals. If any condition to the merger is not satisfied or waived, the merger may not be completed. We and Rofin may also terminate the merger agreement under certain circumstances. To the extent the merger is not completed for any reason, we would have devoted substantial resources and management attention to the transaction without realizing the accompanying benefits expected by our management, and our financial condition and results of operations and the market value of our stock may be adversely affected. Additional risks and uncertainties associated with the merger include:

the failure to consummate the merger may result in negative publicity and a negative impression of us in the investment community;
 
we and Rofin may become subject to costly litigation related to the merger, and may be subject to additional proceedings in the future;

required regulatory approvals from governmental entities may delay the merger or result in the imposition of conditions that could cause the abandonment of the merger;

the merger agreement may be terminated in circumstances that would require us to pay Rofin a termination fee of up to $65.0 million and a termination fee to Barclays of $2.4 million;

our ability to attract, recruit, retain and motivate current and prospective employees who may be uncertain about their future roles and relationships with us following the completion of the merger may be adversely affected;

the increase in our leverage and debt service obligations as a result of the incurrence of additional financing in connection with the merger may adversely affect the combined company’s financial condition, results of operations and earnings per share; and

the attention of our employees and management may be diverted due to activities related to the merger; and disruptions from the merger, whether completed or not, may harm our relationships with our employees, customers, distributors, suppliers or other business partners, and may result in a loss of or a substantial decrease in purchases by our customers.

Even if the Rofin merger is consummated, we may not be able to integrate the business of Rofin successfully with our own or realize the anticipated benefits of the merger.

The merger involves the combination of two companies that currently operate as independent multinational public companies. The combined company will be required to devote significant management attention and resources to integrating our business practices with those of Rofin. Potential difficulties that the combined company may encounter as part of the integration process include the following:

the inability to successfully combine our business with Rofin in a manner that permits the combined company to achieve the full synergies and other benefits anticipated to result from the merger;

complexities associated with managing the combined businesses, including difficulty addressing possible differences in corporate cultures and management philosophies and the challenge of integrating complex systems, technology, networks and other assets of each of the companies in a seamless manner; and

potential unknown liabilities and unforeseen increased expenses or delays associated with the merger

In addition, we have operated and, until the completion of the merger will continue to operate, independently. It is possible that the integration process could result in:

diversion of the attention of our management; and

the disruption of, or the loss of momentum in, our ongoing business or inconsistencies in standards, controls, procedures or policies, any of which could adversely affect our ability to maintain relationships with customers, suppliers, employees and other constituencies or our ability to achieve the anticipated benefits of the merger, or could reduce our earnings or otherwise adversely affect the business and financial results of the combined company.


58

Table of Contents

The future results of the combined company will suffer if the combined company does not effectively manage its expanded operations following the merger.

Following the merger, the size of the business of the combined company will increase significantly beyond the current size of either our or Rofin’s business. The combined company’s future success depends, in part, upon its ability to manage this expanded business, which will pose substantial challenges for management, including challenges related to the management and monitoring of new operations and associated increased costs and complexity. There can be no assurances that the combined company will be successful or that it will realize the expected synergies and benefits currently anticipated from the merger.

The combined company is expected to incur substantial expenses related to the merger with and the integration of Rofin.

We have and expect to continue to incur substantial expenses in connection with the merger and the integration of Rofin. There are a large number of processes, policies, procedures, operations, technologies and systems that may need to be integrated, including purchasing, accounting and finance, sales, payroll, pricing, marketing and employee benefits. While we have assumed that a certain level of expenses will be incurred, there are many factors beyond our or their control that could affect the total amount or the timing of the integration expenses. Moreover, many of the expenses that will be incurred are, by their nature, difficult to estimate accurately. These expenses could, particularly in the near term, exceed the savings that the combined company expects to achieve from the elimination of duplicative expenses and the realization of economies of scale and cost savings. These integration expenses could result in the combined company taking significant charges against earnings following the completion of the merger, and the amount and timing of such charges are uncertain at present.

Charges to earnings resulting from the application of the purchase method of accounting to the Rofin acquisition may adversely affect our results of operations.

In accordance with generally accepted accounting principles, we will account for the Rofin acquisition using the purchase method of accounting, which will result in charges to earnings that could have a material adverse effect on the market value of our common stock following completion of the acquisition. Under the purchase method of accounting, we will allocate the total purchase price of Rofin’s net tangible and identifiable intangible assets based upon their estimated fair values at the acquisition date. The excess of the purchase price over net tangible and identifiable intangible assets will be recorded as goodwill. We will incur additional depreciation and amortization expense over the useful lives of certain of the net tangible and intangible assets acquired in connection with the acquisition. In addition, to the extent the value of goodwill or intangible assets with indefinite lives becomes impaired, we may be required to incur material charges relating to the impairment of those assets. These depreciation, amortization and potential impairment charges could have a material impact on our results of operations.

There can be no assurance that we will be able to secure the financing we intend to use to pay the cash portion of the consideration for the acquisition of Rofin.

We have entered into a debt commitment letter with Barclays Bank PLC ("Barclays") and both Bank of America, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (together, "BAML"), pursuant to which, among other things, Barclays and BAML have committed to provide us with debt financing in an aggregate principal amount of up to $850.0 million to finance the acquisition of Rofin. The obligations of Barclays and BAML under the commitment letter are subject to certain conditions, including the consummation of the acquisition in accordance with the terms and conditions of the definitive agreement and other customary closing obligations.

We intend to fund the acquisition consideration, the repayment of certain indebtedness of the combined companies and related fees and expenses with a combination of the combined companies’ balance sheet cash and proceeds of approximately $850.0 million under the term loan and the revolving credit agreement.

The availability of the term loan and revolving credit agreement will be subject to certain conditions. Therefore, no assurance can be given that the financing pursuant to the term loan and revolving credit agreement described above will be available. Our obligation to complete the merger is subject to a financing contingency.

In the event that the term loan and revolving credit is not available, other financing may not be available on acceptable terms, in a timely manner, or at all. If we are unable to secure alternative financing, the merger may not be completed.

Our indebtedness following completion of the merger will be substantially greater than our indebtedness on a stand-alone basis and greater than our or Rofin's combined indebtedness existing prior to the merger. This increased level of indebtedness could adversely affect us, including by decreasing our business flexibility, and will increase our borrowing costs.

59

Table of Contents


Our substantially increased indebtedness and higher debt-to-equity ratio following completion of the merger in comparison to that prior to the merger will have the effect, among other things, of reducing our flexibility to respond to changing business and economic conditions and will increase our borrowing costs. In addition, the amount of cash required to service our increased indebtedness levels and thus the demands on our cash resources will be greater than the amount of cash flows required to service our indebtedness or that of Rofin individually prior to the merger. The increased levels of indebtedness could also reduce funds available for our investments in product development as well as capital expenditures, dividends, share repurchases and other activities and may create competitive disadvantages for us relative to other companies with lower debt levels.


ITEM 6. EXHIBITS

Exhibit No.
 
Description
 
 
 
2.1+

 
Merger Agreement, dated as of March 16, 2016, by and among the Company, Rembrandt Merger Sub Corp. and Rofin-Sinar Technologies Inc. (Previously filed as Exhibit 2.1 to Form 8-K filed on March 16, 2016)

 
 
 
10.1+

 
Commitment Letter by and among the Company and Barclays Bank PLC, dated as of March 16, 2016. (Previously filed as Exhibit 10.1 to Form 8-K filed on March 16, 2016)

 
 
 
10.2
 
Amended and Restated Commitment Letter by and among the Company, Barclays Bank PLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Bank of America, N.A., dated as of April 5, 2016.

 
 
 
10.3
 
Transition Service Agreement, dated February 22, 2016, between the Company and Helene Simonet

 
 
 
31.1
 
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
 
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.2
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101.INS*
 
XBRL Instance Document
 
 
 
101.SCH*
 
XBRL Taxonomy Extension Schema
 
 
 
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase
 
 
 
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase
 
 
 
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase
 
 
 
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase

60

Table of Contents

+

These exhibits were previously filed with the Commission as indicated and are incorporated herein by reference.

*
In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections.
Identifies management contract or compensatory plans or arrangements required to be filed as an exhibit.




61

Table of Contents

COHERENT, INC.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
Coherent, Inc.
 
 
(Registrant)
 
 
 
Date:
May 11, 2016
/s/:
JOHN R. AMBROSEO
 
 
 
John R. Ambroseo
 
 
 
President and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
Date:
May 11, 2016
/s/:
KEVIN PALATNIK
 
 
 
Kevin Palatnik
 
 
 
Executive Vice President and Chief Financial Officer
 
 
 
(Principal Financial and Accounting Officer)


62

Table of Contents

EXHIBIT INDEX
 
Exhibit No.
 
Description
 
 
 
2.1+

 
Merger Agreement, dated as of March 16, 2016, by and among the Company, Rembrandt Merger Sub Corp. and Rofin-Sinar Technologies Inc. (Previously filed as Exhibit 2.1 to Form 8-K filed on March 16, 2016)

 
 
 
10.1+

 
Commitment Letter by and among the Company and Barclays Bank PLC, dated as of March 16, 2016. (Previously filed as Exhibit 10.1 to Form 8-K filed on March 16, 2016)

 
 
 
10.2
 
Amended and Restated Commitment Letter by and among the Company, Barclays Bank PLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Bank of America, N.A., dated as of April 5, 2016.

 
 
 
10.3
 
Transition Service Agreement, dated February 22, 2016, between the Company and Helene Simonet

 
 
 
31.1
 
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
 
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.2
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101.INS*
 
XBRL Instance Document
 
 
 
101.SCH*
 
XBRL Taxonomy Extension Schema
 
 
 
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase
 
 
 
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase
 
 
 
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase
 
 
 
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase
+

These exhibits were previously filed with the Commission as indicated and are incorporated herein by reference.

*
In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections.
Identifies management contract or compensatory plans or arrangements required to be filed as an exhibit.



63

EXECUTION VERSION


BARCLAYS  
745 Seventh Avenue
New York, NY 10019
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
BANK OF AMERICA, N.A.
One Bryant Park
New York, NY 10036
 
April 5, 2016
Coherent, Inc.
5100 Patrick Henry Drive

Santa Clara, California 95054
Attention: Kevin Palatnik
Project Rembrandt
Amended and Restated Commitment Letter
Ladies and Gentlemen:
Reference is hereby made to the Commitment Letter, dated as of March 16, 2016 (the “ Original Commitment Letter ”), between Barclays Bank PLC (“ Barclays ”) and you (as defined below). The Original Commitment Letter is hereby amended and restated and superseded in its entirety as follows (and the Original Commitment Letter shall be of no further force and effect):
Coherent, Inc., a Delaware corporation (“ you ” or the “ US Borrower ”) has advised Barclays, Bank of America, N.A. (“ BofA ”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (“ MLPFS ”, which term shall include, in each case, MLPFS’s designated affiliate for any purpose hereunder, and together with BofA and their respective affiliates, “ BAML ”) (BAML, together with Barclays, each a “ Commitment Party ” and together, the “ Commitment Parties ”, “ we ” or “ us ”) that you intend to acquire (the “ Acquisition ”) ROFIN-SINAR Technologies Inc., a Delaware corporation (the “ Acquired Business ”). The Acquisition will be effected through the merger of a newly created wholly-owned subsidiary of yours (“ Merger Sub ”) with and into the Acquired Business, with the Acquired Business surviving such merger as your wholly-owned subsidiary pursuant to the terms of the Agreement and Plan of Merger, dated as of March 16, 2016 (the “ Acquisition Agreement ”), by and among the US Borrower, Merger Sub and the Acquired Business. The US Borrower, the Euro Borrower (as defined in Annex I), the Acquired Business and their respective subsidiaries are sometimes collectively referred to herein as the “ Companies .”
You have also advised us that you intend to finance the Acquisition, the repayment of certain existing indebtedness (to be mutually agreed upon) of the Companies (the “ Refinancing ”), the costs and expenses related to the Transaction (as hereinafter defined) and the ongoing working capital and other general corporate purposes of the Companies after consummation of the Acquisition from the following sources (and that no financing other than the financing described herein will be required in connection with the Transaction): $850,000,000 in senior secured credit facilities of the Borrowers (collectively, the “ Facilities ”), comprised of (i) (a) a term loan B facility of $375,000,000, made available to the US Borrower (the “ US Term Facility ”) and (b) a term loan B facility of the Euro equivalent of $375,000,000, made available to the Euro Borrower (the “ Euro Term Facility ” and together with the US Term Facility, the “ Term Facility ”) and (ii) a revolving credit facility of $100,000,000 (the “ Revolving Credit Facility ”). The Acquisition, the Refinancing, the entering into and funding of the Facilities and all related transactions are hereinafter collectively referred to as the “ Transaction .” The date of consummation of the Acquisition is referred to herein as the “ Closing Date .”
1. Commitments. In connection with the foregoing, (a)(x) Barclays is pleased to advise you of its commitments to provide, severally and not jointly, 60% of the aggregate principal amount of each of the Facilities and (y) BofA is pleased to advise you of its commitments to provide, severally and not jointly, 40% of the aggregate principal amount of each of the Facilities (in such capacity, each an “ Initial Lender ” and collectively, the “ Initial Lenders ”), (b) Barclays’ willingness to act as the syndication agent (in such capacity, the “ Syndication Agent ”) and sole and exclusive administrative agent (in such capacity, the “ Administrative Agent ”) for the Facilities, in each case subject to the conditions set forth in this letter and in Annexes I and II hereto (collectively, the “ Summary of Terms ” and together with this letter, the “ Commitment Letter ”) and (c) each of Barclays’ and MLPFS’s willingness, and you hereby engage each of Barclays and MLPFS, to act as joint lead arrangers and joint bookrunning managers (each, in such capacity, a “ Lead Arranger ” and collectively, the “ Lead Arrangers ”) for the Facilities, and in connection therewith to form a syndicate of lenders for the Facilities (collectively, the “ Lenders ”) reasonably acceptable to you. Notwithstanding anything to the contrary contained herein, the commitment of the Initial Lenders with respect to the initial fundings of the Facilities will be subject only to the satisfaction (or waiver by the Initial Lenders) of the conditions precedent set forth in paragraph 5 hereof. All capitalized terms used and not otherwise defined herein shall have the same meanings as specified therefor in the Summary of Terms.
Except as set forth below, you agree that no other agents, co-agents, arrangers, co-arrangers, bookrunners, managers or co-managers will be appointed, no other titles will be awarded and no compensation (other than as expressly contemplated by this Commitment Letter and the Fee Letters (as hereinafter defined)) will be paid to any Lender as consideration for its participation in the Facilities unless you and we shall agree. You agree further that Barclays will have “lead left” placement on all marketing materials relating to each of the Facilities and will perform the duties and exercise the authority customarily performed and exercised by it in such role, including acting as sole manager of the physical books.
2.      Syndication. The Lead Arrangers intend to commence syndication of the Facilities promptly after your acceptance of the terms of this Commitment Letter and the Fee Letters. Without limiting your obligations to assist with syndication efforts as set forth herein, it is understood that the Initial Lenders’ commitments hereunder are not conditioned upon the syndication of, or receipt of commitments or participations in respect of, the Facilities and in no event shall the commencement or successful completion of syndication of the Facilities constitute a condition to the availability of the Facilities on the Closing Date. You agree, prior to the Syndication Date (as hereinafter defined), to actively assist, and to use your commercially reasonable efforts to cause the Acquired Business and its subsidiaries to actively assist, the Lead Arrangers in achieving a syndication of each Facility that is reasonably satisfactory to the Lead Arrangers and you; provided that, notwithstanding each Lead Arranger’s right to syndicate the Facilities and receive commitments with respect thereto, it is agreed that (i) except in the case of an assignment to which you otherwise agree in writing, (A) no Initial Lender shall be relieved, released or novated from its obligations hereunder (including its obligation to fund the Facilities on the Closing Date) in connection with any syndication, assignment or participation of the Facilities, including its commitments in respect thereof, until after the initial funding of the Facilities has occurred; and (B) no assignment or novation shall become effective with respect to all or any portion of an Initial Lender’s commitments in respect of the Facilities until after the initial funding of the Facilities; and (ii) each Commitment Party shall retain exclusive control over all rights and obligations with respect to its commitments in respect of the Facilities, including all rights with respect to consents, modifications, supplements, waivers and amendments, until the Closing Date has occurred and the initial funding under the Facilities has been made. Notwithstanding anything to the contrary contained herein, any resales or assignments of the Facilities by any Lender (including any Initial Lender) on or following the Closing Date shall be governed by the provisions of the Facilities as set forth in the Summary of Terms. We agree not to syndicate our commitments to (i) competitors of the Companies specified to us by you in writing from time to time, (ii) any persons that are engaged as principals primarily in private equity, mezzanine financing or venture capital and certain banks, financial institutions, other institutional lenders and other entities, in each case that have been specified to us by you in writing on or prior to March 16, 2016 and (iii) as to any entity referenced in each case of clauses (i) and (ii) above (the “ Primary Disqualified Institution ”), any of such Primary Disqualified Institution’s known affiliates readily identifiable by name, but excluding any affiliate that is primarily engaged in, or that advises funds or other investment vehicles that are engaged in, making, purchasing, holding or otherwise investing in commercial loans, bonds and similar extensions of credit or securities in the ordinary course and with respect to which the Primary Disqualified Institution does not, directly or indirectly, possess the power to direct or cause the direction of the investment policies of such entity (clauses (i), (ii) and (iii) above collectively, the “ Disqualified Institutions ”) and that no Disqualified Institutions may become Lenders. Such assistance shall include (a) your providing, and using your commercially reasonable efforts to cause your advisors, the Acquired Business, its subsidiaries and its advisors to provide, the Lead Arrangers and the Lenders promptly upon request with all customary information reasonably deemed necessary by the Lead Arrangers to complete such syndication, including, but not limited to (x) information and evaluations prepared by you, the Acquired Business and your and its advisors, or on your or its behalf, relating to the Transaction (including the Projections (as hereinafter defined)) and (y) customary forecasts prepared by management of the Companies of balance sheets, income statements and cash flow statements for each fiscal quarter for the first twelve months following the Closing Date and for each year commencing with the first fiscal year following the Closing Date and for each of the succeeding seven fiscal years thereafter; (b) your assistance (including the use of commercially reasonable efforts to cause the Acquired Business to assist) in the preparation of a customary information memorandum with respect to each of the Facilities (each, an “ Information Memorandum ”) and other customary marketing materials to be used in connection with the syndication of each Facility (collectively with the Summary of Terms and any additional summary of terms prepared for distribution to Public Lenders (as hereinafter defined), the “ Information Materials ”); (c) using commercially reasonable efforts to ensure that the syndication efforts of the Lead Arrangers benefit from your existing lending relationships and, to the extent practical and appropriate, using commercially reasonable efforts to ensure that the syndication efforts of the Lead Arrangers benefit from the existing banking relationships of the Acquired Business and its subsidiaries; (d) using commercially reasonable efforts to obtain, upon our request, prior to the launch of primary syndication, monitored public corporate credit or family ratings (but no specific rating) for you after giving effect to the Transaction and ratings (but no specific rating) of the Facilities from Moody’s Investors Service, Inc. (“ Moody’s ”) and Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. (“ S&P ”) (collectively, the “ Ratings ”); (e) your ensuring, and with respect to the Acquired Business, using your commercially reasonable efforts to ensure, that none of the Companies shall syndicate or issue, attempt to syndicate or issue, announce or authorize the announcement of the syndication or issuance of any debt of the Companies (other than the Facilities), including any renewals or refinancings of any existing debt, that, in the reasonable judgment of the Lead Arrangers, could reasonably be expected to materially and adversely affect the syndication of the Facilities without the prior written consent of the Lead Arrangers (such consent not to be unreasonably withheld, delayed or conditioned) (it being understood and agreed that the following debt may be issued without the prior written consent of the Lead Arrangers: (i) capital leases and purchase money and equipment financing indebtedness incurred in the ordinary course of business, (ii) intercompany indebtedness and (iii) other indebtedness of the Acquired Business permitted to be incurred or remain outstanding under the Acquisition Agreement); and (f) your otherwise assisting the Lead Arrangers in their syndication efforts, including by making your officers and advisors, and, to the extent practical and appropriate, using your commercially reasonable efforts to make the officers and advisors of the Acquired Business, available from time to time upon reasonable advance notice to attend and make presentations regarding the business and prospects of the Companies and the Transaction at one or more meetings of prospective Lenders. Notwithstanding anything to the contrary contained in this Commitment Letter or the Fee Letters or any other letter agreement or undertaking concerning the financing of the Transaction to the contrary, neither the obtaining of the Ratings referenced above nor the compliance with any of the other provisions set forth in clauses (a) through (f) above or any other provision of this paragraph shall constitute a condition to the commitments hereunder or the funding of the Facilities on the Closing Date. For the avoidance of doubt, the Companies will not be required to provide any information to the extent that the provision thereof would violate any attorney-client privilege, law, rule or regulation or any obligation of confidentiality binding on the Companies; provided that in the event that the Companies do not provide information in reliance on this sentence, the Companies shall provide notice to the Lead Arrangers that such information is being withheld and shall use their commercially reasonable efforts to communicate, to the extent feasible, the applicable information in a way that would not violate the applicable obligation or risk waiver of such privilege.
It is understood and agreed that the Lead Arrangers will manage and control all aspects of the syndication of the Facilities in consultation with you and, as to the selection of Lenders, with your approval (such approval not to be unreasonably withheld or delayed), and, subject to the second paragraph in Section 1 above, any titles offered to prospective Lenders, when commitments will be accepted and the final allocations of the commitments among the Lenders. It is understood that no Lender participating in the Facilities will receive compensation from you in order to obtain its commitment, except on the terms contained herein and in the Summary of Terms. It is also understood and agreed that the amount and distribution of the fees among the Lenders will be at the sole and absolute discretion of the Lead Arrangers.
3.      Information Requirements. You hereby represent, warrant and covenant (with respect to information relating to the Acquired Business made available prior to the Closing Date, to your knowledge) that (a) all written information, other than Projections (as defined below) forward looking information and information of a general economic or industry specific nature, that has been or is hereafter made available to the Lead Arrangers or any of the Lenders by or on behalf of you or any of your representatives in connection with any aspect of the Transaction (including such information relating to the Acquired Business) (the “ Information ”) did not and will not when furnished, taken as a whole, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein, in the light of the circumstances under which they were made, not materially misleading (giving effect to all supplements and updates provided thereto) and (b) all financial projections concerning the Companies that have been or are hereafter made available to the Lead Arrangers or any of the Lenders by or on behalf of you or any of your representatives (the “ Projections ”) have been or will be prepared in good faith based upon reasonable assumptions (it being understood and agreed that the Projections are not to be viewed as a guarantee of financial performance or achievement, that the Projections are subject to significant uncertainties and contingencies, many of which are beyond your control, and that actual results may differ from the Projections and such differences may be material). You agree that if at any time prior to the later of (a) the earlier of (i) the date on which a Successful Syndication (as defined in the Facilities Fee Letter) is achieved and (ii) 60 days following the Closing Date (such earlier date, the “ Syndication Date ”) and (b) the Closing Date any of the representations in the preceding sentence would be incorrect in any material respect if the Information and Projections were being furnished, and such representations were being made, at such time, then you will (and with respect to Information and Projections with respect to the Acquired Business you will use commercially reasonable efforts to cause the Acquired Business to) promptly supplement, or cause to be supplemented, the Information and Projections so that such representations will be correct in all material respects (to your knowledge insofar as it applies to the Information and Projections furnished prior to the Closing Date concerning the Acquired Business) at such time. In issuing this commitment and in arranging and syndicating each of the Facilities, the Commitment Parties are and will be using and relying on the Information and the Projections without independent verification thereof. For the avoidance of doubt, nothing in this paragraph will constitute a condition to the availability of the Facilities on the Closing Date.
You acknowledge that (a) the Lead Arrangers on your behalf will make available Information Materials to the proposed syndicate of Lenders by posting the Information Materials on IntraLinks or another similar electronic system (the “ Platform ”) and (b) certain prospective Lenders (such Lenders, “ Public Lenders ”; all other Lenders, “ Private Lenders ”) may have personnel that do not wish to receive material non-public information (within the meaning of the United States federal securities laws, “ MNPI ”) with respect to the Companies, their respective affiliates or any other entity, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with respect to such entities’ securities. If requested, you will assist the Lead Arrangers in preparing an additional version of the Information Materials not containing MNPI (the “ Public Information Materials ”) to be distributed to prospective Public Lenders.
Before distribution of any Information Materials (a) to prospective Private Lenders, you shall provide the Lead Arrangers with a customary letter authorizing the dissemination of the Information Materials; and (b) to prospective Public Lenders, you shall provide the Lead Arrangers with a customary letter authorizing the dissemination of the Public Information Materials and confirming the absence of MNPI therefrom. In addition, you hereby agree that (x) at the request of the Lead Arrangers (or their respective affiliates), you shall use commercially reasonable efforts to identify that portion of the Information Materials that may be distributed to the Public Lenders by clearly and conspicuously marking the same as “PUBLIC”; (y) all Information Materials marked “PUBLIC” are permitted to be made available through a portion of the Platform designated “Public Investor”; and (z) the Lead Arrangers (and their respective affiliates) shall be entitled to treat any Information Materials that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not designated “Public Investor.”
You agree, subject to the confidentiality and other provisions of this Commitment Letter, that the Lead Arrangers (and their respective affiliates) on your behalf may distribute the following documents to all prospective Lenders, unless you advise the Lead Arrangers in writing (including by email) within a reasonable time prior to their intended distributions that such material should only be distributed to prospective Private Lenders: (a) administrative materials prepared by the Lead Arrangers for prospective Lenders such as lender meeting invitations and funding and closing memoranda, (b) notifications of changes to the terms of the Facilities and (c) other materials intended for prospective Lenders after the initial distribution of the Information Materials, including drafts approved in writing by you and the Lead Arrangers (or their respective affiliates) and final versions of definitive documents with respect to the Facilities. If you advise the Lead Arrangers (or their respective affiliates) that any of the foregoing items should be distributed only to Private Lenders, then the Lead Arrangers (and their respective affiliates) will not distribute such materials to Public Lenders without further discussions with you. You agree (with respect to Information Materials relating to the Acquired Business made available prior to the Closing Date, to your knowledge) that Information Materials made available to prospective Public Lenders in accordance with this Commitment Letter shall not contain MNPI.
4.      Fees and Indemnities .
(a)      You agree to reimburse the Commitment Parties for all reasonable and documented out-of-pocket fees and expenses (including, but not limited to, the reasonable and documented fees, actual disbursements and other out-of-pocket expenses of one primary counsel to the Commitment Parties (it being understood and agreed that Weil, Gotshal & Manges LLP shall act as primary counsel to the Commitment Parties), and of (x) one local counsel in each relevant state and one local counsel in each Material Jurisdiction, in each case, retained by the Lead Arrangers (each such counsel shall be subject to your reasonable consent (such consent not to be unreasonably withheld, delayed or conditioned)) and (y) solely in the case of a conflict of interest, one additional counsel in each relevant jurisdiction to the affected Commitment Parties similarly situated and reasonable due diligence expenses) incurred in connection with the Facilities, the syndication thereof, the preparation of the Credit Documentation (as defined below) therefor and the other transactions contemplated hereby, whether or not the Closing Date occurs or any of the Credit Documentation is executed and delivered or any extensions of credit are made under either of the Facilities. Such amounts shall be paid on the earlier of (i) the Closing Date or (ii) three business days following the termination of this Commitment Letter as provided below. You agree to pay the fees set forth in (x) the separate fee letter addressed to you dated the date hereof from the Commitment Parties (the “ Facilities Fee Letter ”) and (y) the separate agency fee letter addressed to you dated March 16, 2016 from the Administrative Agent (the “ Agency Fee Letter ” and, together with the Facilities Fee Letter, the “ Fee Letters ”).
(b)      You also agree to indemnify and hold harmless each of the Commitment Parties, each other Lender and each of their affiliates, successors and assigns and their respective partners, officers, directors, employees, trustees and agents (in each case, except to the extent acting in their capacity as a financial advisor in connection with the Acquisition) (each, an “ Indemnified Party ”) from and against (and will reimburse each Indemnified Party for) any and all claims, damages, losses, liabilities and expenses (including, without limitation, the reasonable and documented fees, actual disbursements and other out-of-pocket expenses of counsel to any Indemnified Party) that may be incurred by or asserted or awarded against any Indemnified Party, in each case arising out of or in connection with or by reason of (including, without limitation, in connection with any investigation, litigation or proceeding or preparation of a defense in connection therewith) (a) this Commitment Letter, (b) the Fee Letters, (c) any aspect of the Transaction or any of the other transactions contemplated thereby or (d) the Facilities, or any use made or proposed to be made with the proceeds thereof, except to the extent such claim, damage, loss, liability or expense (i) is found in a final non-appealable judgment by a court of competent jurisdiction to have resulted from (x) such Indemnified Party’s bad faith, gross negligence or willful misconduct or (y) a material breach of such Indemnified Party’s obligations hereunder or under the Fee Letters, (ii) arises from a dispute solely among the Indemnified Parties (other than a dispute involving claims against us in our capacity as a Lead Arranger, Syndication Agent, bookrunning manager, co-agent or similar capacity), and in any such event described in this clause (ii) solely to the extent that the underlying dispute does not arise as a result of any action, inaction or representation of, or information provided by or on behalf of, you or any of your subsidiaries or (iii) resulted from any agreement governing any settlement effected without your prior written consent (such consent not to be unreasonably withheld or delayed); provided , however , that the foregoing indemnity will apply to any such settlement in the event that you were offered the ability to assume the defense of the action that was the subject matter of such settlement and elected not to assume such defense. In the case of any claim, litigation, investigation or proceeding (any of the foregoing, a “ Proceeding ”) to which the indemnity in this paragraph applies, such indemnity shall be effective whether or not such Proceeding is brought by you, your equity holders or creditors or an Indemnified Party, whether or not an Indemnified Party is otherwise a party thereto and whether or not any aspect of the Transaction is consummated. You also agree that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to you or your subsidiaries arising out of, related to or in connection with any aspect of the Transaction, except to the extent of direct (as opposed to special, indirect, consequential or punitive) damages determined in a final non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s bad faith, gross negligence, willful misconduct or material breach of this Commitment Letter or the Fee Letters. Notwithstanding any other provision of this Commitment Letter, no Indemnified Party shall be liable for any damages arising from the use by others of information or other materials obtained through electronic telecommunications or other information transmission systems, other than for direct, actual damages resulting from the bad faith, gross negligence or willful misconduct of such Indemnified Party as determined by a final non-appealable judgment of a court of competent jurisdiction. You shall not, without the prior written consent of an Indemnified Party (which consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement of any pending or threatened Proceeding against an Indemnified Party in respect of which indemnity could have been sought hereunder by such Indemnified Party unless (i) such settlement includes an unconditional release of such Indemnified Party from all liability or claims that are the subject matter of such Proceeding and (ii) does not include any statement as to any admission of liability.
You and each Indemnified Party (in consultation with you) shall take all reasonable steps to mitigate any losses, claims, damages, liabilities and expenses and each Indemnified Party shall give such information and assistance to you as you may reasonably request in connection with any Proceeding.
In addition, please note that Barclays Capital Inc. has been retained by you as financial advisor (in such capacity, together with any affiliates, the “ Financial Advisor ”) to you in connection with the Acquisition. You agree to such retention, and further agree not to assert any claim you might allege based on any actual or potential conflicts of interest that might be asserted to arise or result from our and our affiliates’ relationships with you as described and referred to herein.
5.      Conditions to Financing . The commitment of each Initial Lender with respect to the initial funding of the Facilities is subject solely to (a) the satisfaction or waiver by the Commitment Parties of each of the conditions set forth under Annex II hereto and (b) subject to the Funds Certain Provisions (as defined below), the execution and delivery of definitive credit documentation with respect to each Facility consistent with this Commitment Letter and the Fee Letters and, to the extent terms are not provided in this Commitment Letter or the Fee Letters, otherwise satisfactory to you and the Lead Arrangers (the “ Credit Documentation ”) prior to such initial funding.
Notwithstanding anything in this Commitment Letter, the Fee Letters, the Credit Documentation or any other letter agreement or other undertaking concerning the financing of the Transaction to the contrary, (a) the Credit Documentation shall be in a form such that the terms thereof do not impair availability of the Facilities on the Closing Date if the conditions in Annex II and paragraph 5 hereof shall have been satisfied, (b) to the extent any security interest in the Collateral (as defined in Annex I) (other than the Collateral of the Borrowers and the Guarantors (as defined in Annex I) the security interest in which may be perfected by the filing of a UCC financing statement, the filing of short-form security agreements with the United States Patent and Trademark Office or the United States Copyright Office or the delivery of certificates evidencing equity interests (other than any certificates evidencing equity interests in the Acquired Business and its subsidiaries)) is not provided on the Closing Date after your use of commercially reasonable efforts to do so, the provision and/or perfection, as applicable, of any such Collateral shall not constitute a condition precedent to the availability of the Facilities on the Closing Date (it being understood, however, that the Credit Documentation shall provide that such provision and/or perfection occurs not later than 90 days, or in the case of any certificates evidencing equity interests in the Acquired Business and any of its subsidiaries organized in the United States, 10 days (or, in each case such later date as reasonably agreed to by the Administrative Agent) after the Closing Date pursuant to arrangements to be mutually agreed), and (c) subject to appropriate qualifications to reflect the foregoing clause (b), the only representations and warranties the accuracy of which shall be a condition to the availability of the Facilities on the Closing Date shall be those set forth in paragraph (ii) of Annex II hereto. The provisions of this paragraph are referred to herein as the “ Funds Certain Provisions .”
Each of the parties hereto agrees that this Commitment Letter and the Fee Letters is a binding and enforceable agreement (subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization and other similar laws relating to or affecting creditors’ rights generally and general principles of equity (whether considered in a proceeding in equity or law)) with respect to the subject matter contained herein, including an agreement to negotiate in good faith the Credit Documentation by the parties hereto in a manner consistent with this Commitment Letter and, to the extent applicable, the Fee Letters, it being acknowledged and agreed that the funding of the Facilities is subject only to the conditions precedent as provided herein.
6.      Confidentiality and Other Obligations. This Commitment Letter and the Fee Letters and the contents hereof and thereof are confidential and, may not be disclosed in whole or in part to any person or entity without the prior written consent of the Lead Arrangers (not to be unreasonably withheld, conditioned or delayed) except (i) this Commitment Letter and the Fee Letters may be disclosed (A) on a confidential basis to your directors, officers, employees, accountants, attorneys and other representatives and professional advisors and those of your affiliates who need to know such information in connection with the Transaction and are informed of the confidential nature of such information, (B) pursuant to the order of any court or administrative agency in any pending legal or administrative proceeding, or otherwise as required by applicable law or compulsory legal process based on the reasonable advice of your legal counsel (in which case you agree to inform the Lead Arrangers promptly thereof prior to such disclosure to the extent permitted by applicable law), and (C) on a confidential basis to the directors, officers, employees, accountants, attorneys and other representatives and professional advisors of the Acquired Business in connection with their consideration of the Transaction, provided that the Fee Letters are redacted in a manner reasonably satisfactory to the Lead Arrangers, (ii) Annex I and Annex II and the existence of this Commitment Letter and the Fee Letters (but not the contents of the Commitment Letter and the Fee Letters) may be disclosed to Moody’s and S&P and any other rating agency on a confidential basis, (iii) the aggregate amount of the fees (including upfront fees and original issue discount) payable under the Fee Letters may be disclosed as part of generic disclosure regarding sources and uses for closing of the Facilities (but without disclosing any specific fees, market flex or other economic terms set forth therein or to whom such fees or other amounts are owed), (iv) the Commitment Letter and the Fee Letters may be disclosed on a confidential basis to your auditors after the Closing Date for customary accounting purposes, including accounting for deferred financing costs, (v) you may disclose the Commitment Letter (but not the Fee Letters) and its contents in any proxy or other public filing relating to the Acquisition, (vi) the Commitment Letter and the Fee Letters may be disclosed to a court, tribunal or any other applicable administrative agency or judicial authority in connection with the enforcement of your rights hereunder (in which case you agree to inform the Lead Arrangers promptly thereof prior to such disclosure to the extent permitted by applicable law), and (v) you many disclose the existence and contents of the Commitment Letter to potential Lenders and participants in connection with their consideration of the Transaction. This paragraph shall terminate on the earlier of (a) execution and delivery of the Credit Documentation and (b) the date that is twelve months from March 16, 2016.
The Commitment Parties shall use all confidential information provided to them by or on behalf of you hereunder solely for the purpose of providing the services which are the subject of this Commitment Letter and otherwise in connection with the Transaction and shall treat confidentially all such information; provided , however , that nothing herein shall prevent the Commitment Parties from disclosing any such information (i) pursuant to the order of any court or administrative agency or in any pending legal or administrative proceeding, or otherwise as required by applicable law or compulsory legal process (in which case the Commitment Parties agree to inform you promptly thereof to the extent not prohibited by law, rule or regulation), (ii) upon the request or demand of any regulatory authority having jurisdiction over the Commitment Parties or any of their respective affiliates, (iii) to the extent that such information becomes publicly available other than by reason of disclosure in violation of this agreement by the Commitment Parties, (iv) to the Commitment Parties’ affiliates, employees, legal counsel, independent auditors and other experts, professionals or agents who need to know such information in connection with the Transaction and are informed of the confidential nature of such information, (v) for purposes of establishing a “due diligence” defense, (vi) to the extent that such information is received by a Commitment Party from a third party that is not to the applicable Commitment Party’s knowledge subject to confidentiality obligations to you, (vii) to the extent that such information is independently developed by the Commitment Parties, (viii) to potential Lenders, participants, assignees or any direct or indirect contractual counterparties to any swap or derivative transaction relating to you or your obligations under the Facilities (other than Disqualified Institutions), in each case, who agree to be bound by the terms of this paragraph (or language not less restrictive than this paragraph or as otherwise reasonably acceptable to you and each Commitment Party, including as may be agreed in any confidential information memorandum or other marketing material), (ix) to Moody’s and S&P, and to Bloomberg, LSTA and similar market data collectors with respect to the syndicated lending industry; provided that such information is supplied only on a confidential basis and does not include copies of the Fee Letters, or (x) with your prior written consent. This paragraph shall terminate on the earlier of (a) execution and delivery of the Credit Documentation and (b) the date that is twelve months from March 16, 2016.
You acknowledge that the Commitment Parties or their affiliates may be providing financing or other services to parties whose interests may conflict with yours. The Commitment Parties agree that they will not furnish confidential information obtained from you to any of their other customers and will treat confidential information relating to the Companies and their respective affiliates with the same degree of care as they treat their own confidential information. The Commitment Parties further advise you that they will not make available to you confidential information that they have obtained or may obtain from any other customer. In connection with the services and transactions contemplated hereby, you agree that the Commitment Parties are permitted to access, use and share with any of their bank or non-bank affiliates, agents, advisors (legal or otherwise) or representatives any information concerning the Companies or any of their respective affiliates that is or may come into the possession of the Commitment Parties or any of their respective affiliates.
In connection with all aspects of each transaction contemplated by this Commitment Letter, you acknowledge and agree, and acknowledge your affiliates’ understanding, that: (i) each of the Facilities and any related arranging or other services described in this Commitment Letter is an arm’s-length commercial transaction between you and your affiliates, on the one hand, and the Commitment Parties, on the other hand, (ii) the Commitment Parties have not provided any legal, accounting, regulatory or tax advice with respect to any of the transactions contemplated hereby and you have consulted your own legal, accounting, regulatory and tax advisors to the extent you have deemed appropriate, (iii) you are capable of evaluating, and understand and accept, the terms, risks and conditions of the transactions contemplated hereby, (iv) in connection with the financing transactions contemplated hereby and the process leading to such transactions, each of the Commitment Parties has been, is, and will be acting solely as a principal and has not been, is not, and will not be acting as an advisor, agent or fiduciary for you or any of your affiliates, stockholders, creditors or employees or any other party, (v) the Commitment Parties have not assumed and will not assume an advisory, agency or fiduciary responsibility in your or your affiliates’ favor with respect to any of the financing transactions contemplated hereby or the process leading thereto, and the Commitment Parties have no obligation to you or your affiliates with respect to the financing transactions contemplated hereby except those obligations expressly set forth in this Commitment Letter, and (vi) the Commitment Parties and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from yours and those of your affiliates, and the Commitment Parties have no obligation to disclose any of such interests to you or your affiliates. To the fullest extent permitted by law and without limiting the provisions of paragraph 4(b), you hereby waive and release any claims that you may have against the Commitment Parties with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any financing transaction contemplated by this Commitment Letter.
The Commitment Parties hereby notify you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “ U.S.A. Patriot Act ”), each of them is required to obtain, verify and record information that identifies you, the Euro Borrower and the Guarantors, which information includes the name and address of such person and other information that will allow the Commitment Parties, as applicable, to identify such person in accordance with the U.S.A. Patriot Act. This notice is given in accordance with the requirements of the U.S.A. Patriot Act and is effective for the Commitment Parties and each prospective Lender.
7.      Survival of Obligations. The provisions of paragraphs 2, 3, 4, 6 and 8 shall remain in full force and effect regardless of whether any Credit Documentation shall be executed and delivered and notwithstanding the termination of this Commitment Letter or any commitment or undertaking of the Commitment Parties hereunder, provided that (i) the provisions of paragraphs 2 and 3 shall not survive if the commitments and undertakings of the Commitment Parties are terminated by any party hereto prior to the effectiveness of the Facilities, (ii) if the Facilities close and the Credit Documentation is executed and delivered (A) the provisions of paragraphs 2 and 3 shall survive only until the Syndication Date is achieved and (B) the provisions under paragraph 4 and the second paragraph of Section 6 shall be superseded and deemed replaced by the terms of the Credit Documentation governing such matters (solely to the extent such provisions are set forth therein).
8.      Miscellaneous. This Commitment Letter and the Fee Letters may be executed in multiple counterparts and by different parties hereto in separate counterparts, all of which, taken together, shall constitute an original. Delivery of an executed counterpart of a signature page to this Commitment Letter or the Fee Letters by telecopier, facsimile or other electronic transmission (e.g., a “pdf” or “tiff”) shall be effective as delivery of a manually executed counterpart thereof. Headings are for convenience of reference only and shall not affect the construction of, or be taken into consideration when interpreting, this Commitment Letter or the Fee Letters.
This Commitment Letter and the Fee Letters shall be governed by, and construed in accordance with, the laws of the State of New York; provided that (i) the interpretation of whether a Company Material Adverse Effect (as defined in Annex II hereto) has occurred, (ii) the accuracy of the Acquisition Agreement Representations and whether you or any of your affiliates have the right to terminate your (or its) obligations under the Acquisition Agreement or decline to consummate the Acquisition as a result of a breach of such Acquisition Agreement Representations and (iii) whether the Acquisition has been consummated in accordance with the terms of the Acquisition Agreement shall, in each case, be construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to any choice or conflict of law provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Each party hereto hereby irrevocably waives any and all right to trial by jury in any action, proceeding or counterclaim (whether based on contract, tort or otherwise) arising out of or relating to this Commitment Letter, the Fee Letters, the Transaction and the other transactions contemplated hereby and thereby or the actions of the Commitment Parties in the negotiation, performance or enforcement hereof. Each party hereto hereby irrevocably and unconditionally submits to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in the Borough of Manhattan in New York City in respect of any suit, action or proceeding arising out of or relating to the provisions of this Commitment Letter, the Fee Letters, the Transaction and the other transactions contemplated hereby and thereby and irrevocably agrees that all claims in respect of any such suit, action or proceeding may be heard and determined in any such court. The parties hereto agree that service of any process, summons, notice or document by registered mail addressed to you shall be effective service of process against you for any suit, action or proceeding relating to any such dispute. Each party hereto waives, to the fullest extent permitted by applicable law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceedings brought in any such court, and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. A final judgment in any such suit, action or proceeding brought in any such court may be enforced in any other courts to whose jurisdiction the applicable party is or may be subject by suit upon judgment.
This Commitment Letter, together with the Fee Letters, embodies the entire agreement and understanding among the parties hereto and your affiliates with respect to the Facilities and supersedes all prior agreements and understandings relating to the subject matter hereof. No party has been authorized by the Commitment Parties to make any oral or written statements that are inconsistent with this Commitment Letter. Neither this Commitment Letter (including the attachments hereto) nor the Fee Letters may be amended or any term or provision hereof or thereof waived or modified except by an instrument in writing signed by each of the parties hereto.
This Commitment Letter may not be assigned by you without our prior written consent (and any purported assignment without such consent will be null and void), is intended to be solely for the benefit of the parties hereto and is not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto (and the Indemnified Parties). Notwithstanding the foregoing sentence, (i) each Initial Lender may assign its commitment hereunder, in whole or in part, to any of its affiliates or to any Lender (other than to a Disqualified Institution); provided that, other than with respect to an assignment to which you otherwise agree in writing, such Initial Lender shall not be released from the portion of its commitment hereunder so assigned to the extent such assignee fails to fund the portion of the commitment assigned to it on the Closing Date notwithstanding the satisfaction of the conditions to funding set forth herein and (ii) MLPFS may, without notice to you, assign its rights and obligations under this Commitment Letter to any other registered broker-dealer wholly-owned by Bank of America Corporation to which all or substantially all of Bank of America Corporation’s or any of its subsidiaries’ investment banking, commercial lending services or related business may be transferred following the date hereof.
Please indicate your acceptance of the terms of the Facilities set forth in this Commitment Letter and the Fee Letters by returning to Barclays executed counterparts of this Commitment Letter and the Fee Letters not later than 9:00 a.m. (New York City time) on April 6, 2016, whereupon the undertakings of the parties with respect to the Facilities shall become effective to the extent and in the manner provided hereby. This offer shall terminate with respect to the Facilities if not so accepted by you at or prior to that time. Thereafter, all commitments and undertakings of the Commitment Parties hereunder will expire on the earliest of (a) 11:59 p.m. (New York City time) on March 16, 2017 (the “ Commitment Termination Date ”) (provided that to the extent the Termination Date (as defined in the Acquisition Agreement in effect on March 16, 2016) is extended to June 16, 2017 in accordance with the terms of Section 8.1(b) of the Acquisition Agreement (in accordance with the terms thereof as in effect on the date hereof), the Commitment Termination Date shall, upon notice of such extension to the Lead Arrangers from the US Borrower, be automatically extended to 11:59 p.m. (New York City time) on June 16, 2017), (b) the closing of the Acquisition without the use of the Facilities, (c) the termination of the Acquisition Agreement and (d) the public announcement of the abandonment of the Acquisition by you or any of your affiliates in a public statement or filing (such earliest time set forth in clause (a), (b), (c) or (d) above, the “ Expiration Date ”).
[The remainder of this page intentionally left blank.]


We are pleased to have the opportunity to work with you in connection with this important financing.
Very truly yours,
BARCLAYS BANK PLC

By:     /s/ Timothy Broadbent    
Name:    Timothy Broadbent
Title:    Managing Director
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
By:     /s/ Neil Kahrim    
Name:    Neil Kahrim
Title: Director

BANK OF AMERICA, N.A.

By:     /s/ Neil Kahrim    
Name:    Neil Kahrim
Title: Director
  
This Commitment Letter is accepted and agreed
to as of the date first written above:
COHERENT, INC.

By: /s/ Kevin Palatnik
Name: Kevin Palatnik
Title: EVP&CFO
ANNEX I
SUMMARY OF TERMS AND CONDITIONS
FACILITIES
Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Annex I is attached.
Borrowers:
With respect to the US Term Facility and the Revolving Credit Facility, Coherent, Inc. (the “ US Borrower ”).
With respect to the Euro Term Facility and the Revolving Credit Facility, Coherent Holding GmbH, a German company with limited liability (the “ Euro Borrower ” and, together with the US Borrower, the “ Borrowers ”).
Borrower Representative:
The Credit Documentation (as defined below) will permit the US Borrower to act as the borrower representative (in such capacity, the “ Borrower Representative ”), and to act as agent on behalf of the Borrowers for purposes of delivering notices, providing consents, receiving notices and taking other actions permitted or required under the Credit Documentation.
Guarantors:
Subject in all respects to the Security Principles (as defined below), (a) the obligations of the US Borrower under the US Term Facility, the Revolving Credit Facility (as defined below) and, at the Borrower Representative’s option, under any treasury management, interest protection or other hedging arrangements entered into with a Lender (as defined below) or an affiliate thereof (collectively, the “ US Obligations ”) will be guaranteed on a senior basis by each of the US Borrower’s, direct or indirect, wholly-owned restricted subsidiaries that are US Subsidiaries (as defined below) (the entities described in this clause (a), collectively, the “ US Guarantors ”; the US Guarantors together with the US Borrower, the “ US Loan Parties ”) and (b) all obligations of the Euro Borrower under the Euro Term Facility and the Revolving Credit Facility (collectively, the “ Euro Obligations ”) will be unconditionally guaranteed on a senior basis by each US Loan Party and each of the US Borrower’s wholly-owned restricted subsidiaries that are Foreign Subsidiaries (as defined below) (collectively, the “ Euro Guarantors ”; and the Euro Guarantors, together with the US Guarantors, collectively, the “ Guarantors ”; and the Euro Guarantors, together with the Euro Borrower, collectively, the “ Euro Loan Parties ”; and the Euro Loan Parties, together with the US Loan Parties, the “ Loan Parties ”), subject to customary exceptions to be agreed (including, without limitation, no guarantee from (i) with respect to the US Obligations only, any CFC Holdco or Disregarded Domestic Person (each as defined below) and any US Subsidiary that is a subsidiary of a Foreign Subsidiary, (ii) any subsidiary whose provision of a guarantee would (x) be prohibited by applicable law or regulation or any contractual obligation existing on the Closing Date or at the time of acquisition thereof after the Closing Date (so long as such prohibition is not created in contemplation of such transaction) or that would require consent, approval, license or authorization of a governmental authority (unless such consent, approval, license or authorization has been received) or (y) otherwise result in a material adverse tax consequence to either Borrower, in each case, as reasonably determined by such Borrower, (iii) Immaterial Subsidiaries (as defined below), (iv) unrestricted subsidiaries, (v) captive insurance companies, (vi) not-for-profit subsidiaries, (vii) special purpose entities, (viii) any subsidiary where the Borrower Representative and the Administrative Agent reasonably determine that the costs of obtaining a guarantee from such subsidiary are excessive in relation to the value afforded thereby or (ix) other subsidiaries mutually agreed between the Borrower Representative and the Administrative Agent. For the avoidance of doubt and notwithstanding anything to the contrary herein, subsidiaries which are not “eligible contract participants” shall not guarantee swap obligations to the extent not permitted by the Commodity Exchange Act, or any regulation thereunder, by virtue of such subsidiary failing to constitute an “eligible contract participant”.
For purposes of the Credit Documentation, (a) “ US Subsidiary ” means any direct or indirect subsidiary of the US Borrower organized under the laws of the United States, any state thereof or the District of Columbia, (b) “ Foreign Subsidiary ” means any direct or indirect subsidiary of the US Borrower organized in a jurisdiction outside of the United States, any state thereof or the District of Columbia, (c) “ Guarantor Coverage Test ” means, as of the last day of the fiscal quarter of the US Borrower most recently ended for which financial statements have been (or were required to be) delivered pursuant to the Credit Documentation, the Consolidated Total Assets (to be defined in a manner consistent with the Documentation Principles) and Consolidated EBITDA (as defined below) attributable to the Guarantors only is no less than 80% of Consolidated Total Assets and Consolidated EBITDA, respectively, of the US Borrower and its restricted subsidiaries (other than any restricted subsidiaries located in an Excluded Jurisdiction), in each case as of such date for the test period most recently ended, (d) “ Immaterial Subsidiary ” means (i) any Restricted Subsidiary organized under the law of a Non-Material Jurisdiction and (ii) any Restricted Subsidiary organized under the laws of a Material Jurisdiction, taken together with all such Immaterial Subsidiaries organized under the laws of such Material Jurisdiction as of the last day of the fiscal quarter of the US Borrower most recently ended for which financial statements have been (or were required to be) delivered pursuant to the Credit Documentation, did not have assets with a value in excess of 1.0% of Consolidated Total Assets or contribute in excess of 1.0% of Consolidated EBITDA, in each case as of such date for the test period most recently ended; provided , that the Borrower Representative may elect in its sole discretion to exclude as an Immaterial Subsidiary any Restricted Subsidiary that would otherwise meet the definition thereof; provided, further  that a Material Subsidiary organized in any Post-Closing Material Jurisdiction shall not be required to be a Guarantor if the US Borrower has, as of such date for the test period most recently ended, complied with the Guarantor Coverage Test, (e) “ Material Jurisdiction ” means (i) on the Closing Date, the United States, the United Kingdom, Germany, Spain and the Netherlands (the “ Closing Date Material Jurisdictions ”) and (ii) at any time after the Closing Date, the Closing Date Material Jurisdictions and any other jurisdiction where any Restricted Subsidiary organized under the laws of such jurisdiction, taken together with all other Restricted Subsidiaries organized under the laws of such jurisdiction as of the last day of the fiscal quarter of the US Borrower most recently ended for which financial statements have been (or were required to be) delivered pursuant to the Credit Documentation, have assets with a value in excess of 5.0% of Consolidated Total Assets or contribute in excess of 5.0% of Consolidated EBITDA of the US Borrower and its restricted subsidiaries, in each case as of such date for the test period most recently ended (the “ Post-Closing Material Jurisdiction ”); provided  that in no event shall The People’s Republic of China, South Korea or Japan be deemed to be a “Material Jurisdiction” (each such jurisdiction, an “ Excluded Jurisdiction ”), (f) “ Non-Material Jurisdiction ” means any jurisdiction that is not a Material Jurisdiction and (g) “ Material Subsidiary ” means any direct or indirect subsidiary of the US Borrower which is not an Immaterial Subsidiary.
Administrative and Collateral Agent :
Barclays Bank PLC (“ Barclays ”) will act as sole and exclusive administrative and collateral agent for the Lenders (the “ Administrative Agent ”).
Joint Lead Arrangers and Joint Bookrunning Managers:
Barclays and Merrill Lynch, Pierce, Fenner & Smith Incorporated (“ MLPFS ”, which term shall include, in each case, MLPFS’s designated affiliate for any purpose hereunder) will act as joint lead arrangers and joint bookrunning managers for the Facilities (each, in such capacity, a “ Lead Arranger ” and collectively, the “ Lead Arrangers ”).
Syndication Agent:
Barclays will act as syndication agent for the Facilities (in such capacity, the “ Syndication   Agent ”).
Lenders:
Banks, financial institutions and institutional lenders selected by the Lead Arrangers and reasonably acceptable to the Borrower Representative and, after the initial funding of the Facilities, subject to the restrictions set forth in the Assignments and Participations section below (the “ Lenders ”).
Facilities:
An aggregate principal amount of up to $850,000,000 will be available through the following facilities (such facilities, the “ Facilities ”):
 
Term Facility: (i) a $375,000,000 (plus, at the election of the Borrower Representative, an amount sufficient to fund original issue discount (“ OID ”) or upfront fees required to be funded in connection with the “market flex” provisions of the Facilities Fee Letter and not funded under the Revolving Credit Facility) term loan B facility made available to the US Borrower, all of which will be drawn on the Closing Date (the “ US Term Facility ”) and (ii) a term loan B facility in a principal amount equal to the Euro equivalent of $375,000,000 made available to the Euro Borrower, all of which will be drawn on the Closing Date (the “ Euro Term Facility ” and together with the US Term Facility, collectively, the “ Term Facility ”). For the avoidance of doubt, the Euro equivalent shall be determined by the Administrative Agent on the earlier of (x) the allocation of the commitments under the Term Facility in connection with the syndication thereof and (y) the date on which the Borrower Representative submits the borrowing request to the Administrative Agent in connection with the initial funding of the Facilities.
 
Revolving Credit Facility: a $100,000,000 revolving credit facility (the “ Revolving Credit Facility ” and the loans thereunder, the “ Revolving Loans ”), available from time to time on or after the Closing Date until the fifth anniversary of the Closing Date, which will be available to the US Borrower and the Euro Borrower in Euros, U.S. dollars and/or such other currencies as the Administrative Agent and each lender with a commitment under the Revolving Credit Facility agrees. The Revolving Credit Facility shall include a sublimit of $30,000,000 for the issuance of standby letters of credit (each, a “ Letter of Credit ”) and a sublimit of $10,000,000 for swingline loans (each, a “ Swingline Loan ”). Letters of Credit will be initially issued by Barclays and Bank of America, N.A. on a pro rata basis (in such capacity, the “ Issuing Bank ”), and each of the Lenders under the Revolving Credit Facility will purchase an irrevocable and unconditional participation in each Letter of Credit and each Swingline Loan.
Swingline Option:
Barclays, in its capacity as the swingline lender (in such capacity, the “ Swingline Lender ”), will make Swingline Loans available to the US Borrower in U.S. dollars on a same day basis. The US Borrower must repay each Swingline Loan upon demand of the Swingline Lender (and in any event on the fifth anniversary of the Closing Date).
Purpose:
The proceeds of the borrowings under the Term Facility on the Closing Date and cash on of the balance sheet of the Borrowers and the Guarantors, shall be used (i) to finance the Acquisition and the Refinancing and (ii) to pay fees and expenses incurred in connection with the Transaction. The proceeds of the Revolving Credit Facility may be used on the Closing Date to fund any additional upfront fees or OID payable due to an imposition of “market flex” under the Facilities Fee Letter (to the extent no funded by an increase to the US Term Facility) and to backstop, cash collateralize or replace letters of credit outstanding on the Closing Date. The proceeds of the Revolving Credit Facility shall be used after the Closing Date to provide ongoing working capital and for other general corporate purposes of the Borrowers and their subsidiaries.
Interest Rates:
The interest rates per annum applicable to the Facilities will be, at the option of the Borrower Representative (i) LIBOR plus the Applicable Margin (as hereinafter defined) or (ii) the Base Rate plus the Applicable Margin. The Applicable Margin means (a) with respect to the Term Facility, (x) 4.75% per annum, in the case of LIBOR advances, and (y) 3.75% per annum, in the case of Base Rate advances, and (b) with respect to the Revolving Credit Facility, (x) 4.25% per annum, in the case of LIBOR advances, and (y) 3.25% per annum, in the case of Base Rate advances, in each case with two 25 basis point step-downs if the Secured Net Leverage Ratios (as defined below) are less than 0.75x and 1.25x inside the Secured Net Leverage Ratio on the Closing Date, respectively.
 
Each Swingline Loan shall bear interest at the Base Rate plus the Applicable Margin for Base Rate Revolving Loans.
 
The Borrower Representative may select interest periods of one, two, three or six months (and, if agreed to by all relevant Lenders, twelve months) for LIBOR advances. Interest shall be payable in cash at the end of the selected interest period, but no less frequently than quarterly.
 
LIBOR ” and “ Base Rate ” will have meanings customary and appropriate for financings of this type; provided that (x) LIBOR with respect to (i) the Term Facility will be deemed to be not less than 1.00% per annum (the “ LIBOR Floor ”) and (ii) the Revolving Credit Facility will be deemed to be not less than 0.00% per annum and (y) the Base Rate will be deemed to be not less than 100 basis points higher than one-month LIBOR.
 
During the continuance of an event of default for non-payment of principal, interest or any other amount, interest will accrue on such overdue principal, interest or other amount at the Default Rate (as defined below). During the continuance of a bankruptcy event of default, the principal amount of all outstanding obligations will bear interest at the Default Rate. As used herein, “ Default Rate ” means (i) on the principal of any loan at a rate of 2.00% in excess of the rate otherwise applicable to such loan and (ii) on any other overdue amount at a rate of 2.00% in excess of the non-default rate of interest then applicable to Base Rate loans under the Term Facility.
Commitment Fee:
For the period commencing on the Closing Date through the last day of the first fiscal quarter ending thereafter, a commitment fee of 0.50% per annum, with a step down to 0.375% per annum for any fiscal quarterly period thereafter for which the Secured Net Leverage Ratio as of the last day of the most recently completed fiscal quarter is equal to or less than a Secured Net Leverage Ratio that is 1.00x inside the Secured Net Leverage Ratio on the Closing Date, shall be payable on the actual daily unused portions of the Revolving Credit Facility during each such applicable period, such fee to be payable quarterly in arrears and on the date of termination or expiration of the commitments under the Revolving Credit Facility. Swingline Loans will not be considered utilization of the Revolving Credit Facility for purposes of this calculation. No commitment fee shall be paid to any defaulting lender.
Calculation of Interest and Fees:
Other than calculations in respect of interest at the Base Rate (which shall be made on the basis of actual number of days elapsed in a 365/366 day year), all calculations of interest and fees shall be made on the basis of actual number of days elapsed in a 360-day year.
Cost and Yield Protection:
Customary for transactions and facilities of this type, including, without limitation, in respect of breakage or redeployment costs incurred in connection with prepayments, changes in capital adequacy and capital requirements or their interpretation, illegality, unavailability, reserves without proration or offset and payments free and clear of withholding or other taxes, except as required by applicable law (with appropriate gross-up for withholding taxes, subject to customary exceptions); provided that for all purposes of the Credit Documentation, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines and directives promulgated thereunder and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, shall be deemed introduced or adopted after the Closing Date.

Letter of Credit Fees:
Letter of Credit fees equal to the Applicable Margin from time to time on LIBOR advances under the Revolving Credit Facility on a per annum basis will be payable quarterly in arrears and shared proportionately by the Lenders under the Revolving Credit Facility. In addition, a fronting fee equal to 12.5 basis points per annum will be payable to the Issuing Bank for its own account, as well as reasonable customary issuance and documentary fees. Both the Letter of Credit fees and the fronting fees will be calculated on the amount available to be drawn under each outstanding Letter of Credit.
Maturity:
Term Facility: 7 years after the Closing Date.
 
Revolving Credit Facility: 5 years after the Closing Date.
Amendment and Extension:
The Credit Documentation shall provide the right of individual Lenders to agree in their sole discretion to extend the maturity of their loans and commitments under the Facilities upon the request of the Borrower Representative and without the consent of any other Lender (and as further described under “Waivers and Amendments” below).
Incremental Facilities :
The Credit Documentation will permit the Borrower Representative to add one or more incremental term loan facilities to the Facilities (each, an “ Incremental Term Facility ”) and/or increase commitments under the Revolving Credit Facility (any such increase, an “ Incremental Revolving Facility ”; the Incremental Term Facilities and the Incremental Revolving Facilities are collectively referred to as “ Incremental Facilities ”) in an aggregate amount of up to (a) $150,000,000 plus  (b) an additional amount such that, in the case of this clause (b) only, after giving pro forma effect thereto (including use of proceeds), the Senior Secured Net Leverage Ratio (as defined below) does not exceed 2.75:1.00 (and, for purposes of the test in this clause (b) to include all such Incremental Facilities, assuming they were fully drawn, and whether or not secured and whether secured on a first-lien or junior basis (without netting the proceeds thereof), but excluding any substantially simultaneous debt incurrence pursuant to clause (a)) (it being understood that loans may be incurred under both clauses (a) and (b) above, and proceeds from any such incurrence under both clauses (a) and (b) above may be utilized in a single transaction by first calculating the incurrence under clause (b) above and then calculating the incurrence under clause (a) above and, for the avoidance of doubt, any such incurrence under clause (a) shall not be given pro forma effect for purposes of determining Senior Secured Net Leverage Ratio for purposes of effectuating the incurrence under clause (b) in such single transaction); provided that (i) no Lender will be required to participate in any such Incremental Facility, (ii) (x) no event of default (or, in the case of an Incremental Facility the proceeds of which will be used to finance a Permitted Acquisition (as defined below), no payment or bankruptcy event of default) exists or would exist after giving effect thereto and (y) the representations and warranties in the Credit Documentation shall be true and correct in all material respects (except to the extent already qualified by materiality or material adverse effect) ( provided  that any bring-down of representations and warranties shall be limited in the case of any Permitted Acquisition to customary “specified representations” and “acquisition agreement representations”), (iii) the maturity date of any such Incremental Term Facility shall be no earlier than the maturity date for the Term Facility, (iv) the weighted average life to maturity of any Incremental Term Facility shall be no shorter than the weighted average life to maturity of the Term Facility, (v) the interest margins for the Incremental Term Facility shall be determined by the Borrower Representative and the lenders of the Incremental Term Facility; provided that in the event that the interest margins for any Incremental Term Facility incurred less than 18 months after the Closing Date are greater than the Applicable Margin for the Term Facility by more than 50 basis points, then the Applicable Margin for the Term Facility shall be increased to the extent necessary so that the interest margins for the Incremental Term Facility are not more than 50 basis points higher than the Applicable Margin for the Term Facility; provided , further , that in determining the interest margins applicable to the Term Facility and the Applicable Margins for the Incremental Term Facility, (x) OID or upfront fees (which shall be deemed to constitute like amounts of OID) payable by the applicable Borrower for the account of the Lenders of the Term Facility or the Incremental Term Facility in the primary syndication thereof shall be included (with OID being equated to interest based on the shorter of (i) the weighted average life to maturity of such loans and (ii) an assumed four-year life to maturity), (y) customary arrangement, structuring, underwriting, amendment or commitment fees payable solely to the Lead Arrangers (or their respective affiliates) in connection with the Term Facility or to one or more arrangers (or their affiliates) of the Incremental Term Facility shall be excluded, and (z) if the LIBOR or Base Rate floor for the Incremental Term Facility is greater than the LIBOR or Base Rate floor, respectively, for the existing Term Facility, the difference between such floor for the Incremental Term Facility and the existing Term Facility shall be equated to an increase in the Applicable Margin for purposes of this clause (v), (vi) each Incremental Facility may be secured by either a pari passu or junior lien on the Collateral (as hereinafter defined) securing the Facilities in each case on terms and pursuant to documentation reasonably satisfactory to the Administrative Agent, (vii) any Incremental Revolving Facility shall be on terms and pursuant to documentation applicable to the Revolving Credit Facility and any Incremental Term Facility shall be on terms and pursuant to documentation to be determined by the Borrower Representative and the lenders providing such Incremental Facility, provided that, to the extent such terms and documentation are not consistent with the Term Facility (except to the extent permitted by clause (iii), (iv) or (v) above), they shall be reasonably satisfactory to the Administrative Agent and (viii) subject to clause (vii) above, any Incremental Term Facility shall be on terms and pursuant to documentation to be agreed between the Borrower Representative and the applicable lenders providing the Incremental Term Facility; provided  that to the extent such terms and documentation are not consistent with the Term Facility or the Revolving Credit Facility, as the case may be (except to the extent permitted above), such terms may, at the option of the Borrower Representative, be incorporated into the Credit Documentation to the extent all such terms are beneficial to all existing Lenders without further amendment requirements, including, for the avoidance of doubt, any increase in the Applicable Margin relating to the existing Term Facility to bring such Applicable Margin in line with the Incremental Term Facility to achieve fungibility with such existing Term Facility. The Borrower Representative shall seek commitments in respect of any Incremental Facility from existing Lenders or from additional banks, financial institutions and other institutional lenders reasonably acceptable to the Administrative Agent who will become Lenders in connection therewith.
 
The Credit Documentation will permit the Borrower Representative to utilize availability under the Incremental Term Facilities to issue first or junior lien secured notes or junior lien loans (any such notes or loans (including notes issued through a private placement), “ Incremental Equivalent Debt ”), with the amount of such secured notes or loans reducing the aggregate principal amount available for the Incremental Term Facilities, subject to customary terms and conditions to be agreed; provided  that, to the extent any Incremental Equivalent Debt is junior lien indebtedness, such indebtedness shall be permitted to be incurred as Incremental Equivalent Debt to the extent that after giving pro forma effect thereto (include use of proceeds) the Total Gross Leverage Ratio (as defined below) does not exceed 4.50:1.00 regardless of the Senior Secured Net Leverage Ratio then in effect.
Refinancing Facilities:
The Credit Documentation will permit the Borrower Representative to refinance loans under the Term Facility or commitments under the Revolving Credit Facility or loans or commitments under any Incremental Facility (each, “ Refinanced Debt ”) from time to time, in whole or part, with (x) one or more new term facilities (each, a “ Refinancing Term Facility ”) or new revolving credit facilities (each, a “ Refinancing Revolving Facility ”; the Refinancing Term Facilities and the Refinancing Revolving Facilities are collectively referred to herein as “ Refinancing Facilities ”), respectively, under the Credit Documentation with the consent of the Borrower Representative and the institutions providing such Refinancing Facility or (y) other than with respect to a refinancing of the Revolving Credit Facility, one or more series of unsecured notes or loans, notes secured by the Collateral on a pari passu basis with the Facilities or notes or loans secured by the Collateral on a subordinated basis to the Facilities, which will be subject to customary intercreditor terms reasonably acceptable to the Administrative Agent and the Borrower Representative (any such notes or loans, “ Refinancing Notes ” and together with the Refinancing Facilities, the “ Refinancing Indebtedness ”); provided that (i) any Refinancing Term Facility or Refinancing Notes consisting of term loans do not mature prior to the maturity date of, or have a shorter weighted average life than, the applicable Refinanced Debt consisting of term loans, (ii) any Refinancing Notes consisting of notes do not mature prior to the maturity date of the applicable Refinanced Debt or have any scheduled amortization, (iii) the commitments under any Refinancing Revolving Facility do not terminate prior to the termination date of the revolving commitments under the applicable Refinanced Debt, (iv) there shall be no issuers, borrowers or guarantors in respect of any Refinancing Indebtedness that are not a Borrower or a Guarantor, (v) any Refinancing Notes shall not contain any mandatory prepayment provisions (other than related to customary asset sale and change of control offers or events of default) that could result in prepayments of such Refinancing Notes prior to the maturity date of the applicable Refinanced Debt, (vi) the other terms and conditions of such Refinancing Indebtedness (excluding pricing, interest rate margins, rate floors, discounts, fees and prepayment or redemption provisions) shall either, at the option of the Borrower Representative, (x) with respect to Refinancing Notes only, reflect market terms and conditions (taken as a whole) at the time of incurrence or issuance (as determined by the Borrower Representative) or (y) not be materially more favorable (when taken as a whole) to the lenders or investors providing such Refinancing Indebtedness than the terms of the applicable Refinanced Debt unless (1) the holders of the Refinanced Debt being replaced also receive the benefit of such terms or (2) any such provisions apply only after the maturity date of the Refinanced Debt and (vii) the proceeds of such Refinancing Facility or Refinancing Notes (a) shall not be in an aggregate principal amount greater than the aggregate principal amount of the applicable Refinanced Debt plus any fees, premiums, OID and accrued interest associated therewith, and costs and expenses related thereto and (b) shall be immediately applied to permanently prepay (or, in the case of a Refinancing Revolving Facility, replace) in whole or in part the applicable Refinanced Debt.
Documentation Principles:
The Credit Documentation:
(i)      will be negotiated in good faith within a reasonable time period to be determined based on the expected Closing Date and taking into account the timing of the syndication of the Facilities;
(ii)      be in such form that they do not impair the availability of the Term Facility by the Closing Date if the Funds Certain Provisions are satisfied;
(iii)      will contain only those mandatory prepayments, representations, warranties, conditions to borrowing, affirmative, negative and financial covenants and events of defaults set forth herein, in each case applicable to the Borrowers and their restricted subsidiaries; and
(iv)      will contain other terms and provisions substantially consistent with those contained in a documentation precedent (the “ Documentation Precedent ”) to be mutually agreed (as adjusted pursuant to terms of this section, the “ Documentation Principles ”), with such changes and modifications thereto (A) that reflect the terms and provisions set forth in the Commitment Letter, this Summary of Terms and Conditions and the “market flex” provisions of the Facilities Fee Letter, (B) that reflect changes in law or accounting standards and requirements of local law or to cure mistakes or defects, (C) that are reasonably agreed to by the Borrower Representative and the Lead Arrangers, (D) that are reasonably necessary to take into account the operational requirements and strategic requirements of the Borrowers and their restricted subsidiaries (after giving effect to the Transaction) in light of their size, industries, businesses and business practices, geographic location and operations, proposed business plan and financial model, (E) the jurisdiction of organization of the Borrowers and their restricted subsidiaries and (F) that reflect the customary operational and agency provisions of the Administrative Agent.  
For the avoidance of doubt, the Credit Documentation shall include customary EU bail-in provisions.
Scheduled Amortization:
Term Facility : Subject to quarterly amortization of principal equal to 0.25% per quarter of the original aggregate principal amount of the Term Facility, with the balance payable at final maturity of the Term Facility.
 
Revolving Credit Facility : None.
Mandatory Prepayments:
In addition to the amortization set forth above and the next paragraph, mandatory prepayments shall be required:
(i)      in an amount equal to 100% of the net cash proceeds of non-ordinary course asset sales or other dispositions (including insurance and condemnation proceeds) by the Borrowers or any of their restricted subsidiaries (other than a disposition among the Borrowers and any of their restricted subsidiaries), to the extent (A) such proceeds are not reinvested or committed to be reinvested in assets useful in the business of the Borrowers or any of their restricted subsidiaries within 12 months of receipt ( provided  that if so committed, such reinvestment shall in any case occur within 180 days following such twelve-month period) of the date of such disposition and (B) the aggregate amount of such proceeds that are not reinvested in accordance with clause (A) hereof exceeds $10,000,000 in any single transaction or related series of transactions;
(ii)      in an amount equal to 100% of net cash proceeds from the issuance or incurrence after the Closing Date of additional debt of any of the Borrowers or any of their restricted subsidiaries (other than (x) the Incremental Facilities and (y) any other debt permitted under the Credit Documentation other than Refinancing Indebtedness); and
(iii)      in an amount equal to 50.0% of Excess Cash Flow (to be defined in a manner consistent with the Documentation Principles) of the US Borrower and its restricted subsidiaries, on a consolidated basis, with step downs to 25% and 0% if the Total Net Leverage Ratio is less than 0.50x and 1.00x inside the Total Net Leverage Ratio on the Closing Date, respectively, in each case of clauses (i) - (iii), subject to the limitations set forth in the paragraph immediately following, such amounts shall be applied to scheduled installments of principal in the direct order of maturity.
Except as set forth in the following paragraph, prepayments of the Term Facility shall be applied on a pro rata basis across the US Term Facility and the Euro Term Facility.
All prepayments referred to immediately above are subject to there being no material adverse tax consequences and to permissibility (i) under local law ( e.g. , financial assistance, corporate benefit, restrictions on upstreaming of cash intra-group and the fiduciary and statutory duties of directors or the relevant subsidiaries) and (ii) material constituent document restrictions and other material agreements (so long as any such prohibition is not created in contemplation of such prepayment), it being understood and agreed that if the payment of only one tranche of the Term Facility would trigger a material adverse tax consequence or be subject to a local law restriction then such payment shall be applied to the other tranche of the Term Facility on a non-pro rata basis. The non-application of any prepayment amounts as a consequence of the foregoing provisions will not, for the avoidance of doubt, constitute a default or event of default, and such amounts shall be available to the Borrowers and their restricted subsidiaries, subject to terms and conditions substantially consistent with the Documentation Principles.
Any Lender may elect not to accept its pro rata portion of any mandatory prepayment as otherwise required by clauses (i), (ii) and (iii) immediately above (except with respect to the proceeds of Refinancing Facilities and Refinancing Notes) (each a “ Declining Lender ”). Any prepayment amount declined by a Declining Lender (“ Declined Proceeds ”) may be retained by the Borrowers and may be used by the Borrowers in any manner not prohibited by the Credit Documentation and any such retained amounts will not thereafter be counted as excess cash flow or net cash proceeds in any subsequent measurement period.
Optional Prepayments and Commitment Reductions:
The Facilities may be prepaid at any time in whole or in part without premium or penalty, upon written notice, at the option of the Borrower Representative, together with accrued and unpaid interest thereon, to the date of prepayment, except (x) that any prepayment of LIBOR advances other than at the end of the applicable interest periods therefor shall be made with reimbursement for any funding losses and redeployment costs of the Lenders resulting therefrom and (y) as set forth in “Repayment Premium” below. Each optional prepayment of the Term Facility shall be applied as directed by the Borrower Representative. The unutilized portion of any commitment under the Revolving Credit Facilities may be reduced permanently or terminated by the Borrower Representative at any time without penalty.
Repayment Premium:
In the event that all or any portion of the Term Facility is (i) repaid, prepaid, refinanced or replaced or (ii) repriced or effectively refinanced through any waiver, consent or amendment (in each case, in connection with any waiver, consent or amendment to the Term Facility directed at, or the result of which would be, the lowering of the effective interest cost or the weighted average yield of the Term Facility or the incurrence of any term facility having an effective interest cost or weighted average yield that is less than the effective interest cost or weighted average yield of the Term Facility (or portion thereof) so repaid, prepaid, refinanced, replaced or repriced (other than a refinancing of the Term Facility in connection with any transaction that would, if consummated, constitute a change of control) (a “ Repricing Transaction ”)) occurring on or prior to the date that is six months after the Closing Date, such repayment, prepayment, refinancing, replacement or repricing will be made at 101.0% of the principal amount so repaid, prepaid, refinanced, replaced or repriced (it being understood and agreed that the US Borrower shall be responsible for the repayment premium of 1.0%). If all or any portion of the Term Facility held by any Lender is repaid, prepaid, refinanced or replaced pursuant to a “yank-a-bank” or similar provision in the Credit Documentation as a result of, or in connection with, such Lender not agreeing or otherwise consenting to any waiver, consent or amendment referred to in clause (ii) above (or otherwise in connection with a Repricing Transaction), such repayment, prepayment, refinancing or replacement will be made at 101.0% of the principal amount so repaid, prepaid, refinanced or replaced (it being understood and agreed that the US Borrower shall be responsible for the repayment premium of 1.0%). Notwithstanding the foregoing, no prepayment premium shall apply in the case of any repayment, prepayment, refinancing, replacement or amendment if in connection with a change of control or any acquisition or transaction not otherwise permitted under the Credit Documentation.
Security:
Subject to the Funds Certain Provisions and the provisions of the immediately following paragraphs (the provisions set forth in the immediately following paragraphs, collectively, the “ Security Principles ”), the obligations of each US Loan Party and each Euro Loan Party shall be secured by valid and perfected first priority (subject to certain exceptions to be set forth in the Credit Documentation) liens on and security interests in all of the following (collectively, the “ Collateral ”):
 
(i) with respect to the US Obligations, a pledge of the capital stock of the Material Subsidiaries directly held by each US Loan Party but limited in the case of (A) capital stock of each Foreign Subsidiary that is a Material Subsidiary, (B) any direct or indirect subsidiary substantially all the assets of which consist of the capital stock and, if applicable, indebtedness of one or more CFCs (as defined below) and/or one or more CFC Holdcos (such entity, a “ CFC Holdco ”) and (C) Disregarded Domestic Persons (as defined below), to 65% of the voting capital stock and 100% of the non-voting capital stock of any such first tier Foreign Subsidiary, CFC, CFC Holdco or Disregarded Domestic Person, as applicable, and excluding the capital stock of COHR Int’l Trading C.V. and COHR Int’l Investment C.V., provided , however, that, as determined by the Administrative Agent, in lieu of a pledge of the stock of a domestic CFC Holdco or Disregarded Domestic Person, the Collateral shall include a pledge of the capital stock of each direct Subsidiary of the CFC Holdco or Disregarded Domestic Person subject to the limitations of (A), (B) and (C), and (ii) with respect to the Euro Obligations, a pledge of the capital stock of each restricted subsidiary (including, in the case of companies organized as a limited partnership ( Kommanditgesellschaft ), a pledge of the capital stock of the respective general partner) organized in a Material Jurisdiction directly held by each US Loan Party and each Euro Loan Party but limited in the case of any Foreign Subsidiary, CFC, CFC Holdco or Disregarded Domestic Person directly held by a US Loan Party, to 65% of the voting capital stock and 100% of the non-voting capital stock of any such Foreign Subsidiary, CFC, CFC Holdco or Disregarded Domestic Person, as applicable, it being understood and agreed that the Collateral with respect to the Euro Obligations shall, in any event, include a pledge of 100% of the capital stock of the Euro Borrower and each Euro Guarantor, excluding the U.S. Borrower; Coherent Investments, Inc. (65%); COHR Int’l Finance C.V. (65%); COHR Int’l Trading C.V. (66% held by COHR Int’l Finance C.V.); Coherent International LLC (65%); Coherent Canada Inc. (65%); Coherent (Thailand) Co. Ltd. (65%); Coherent Finland Oy (65%); Coherent Asia, Inc. (65%); COHR Int’l Investment C.V. (99.9% held by COHR Int’l Trading C.V.); Corelase Oy (65%); ROFIN-SINAR Technologies Europe S.L. (65%); ROFIN-BAASEL Canada Ltd. (65%); PRC Europe NV (65%); provided  that following implementation of a post-Acquisition restructuring, the foregoing exclusions from a 100% pledge of capital stock shall not apply to any Foreign Subsidiary that is 100% owned by one or more Foreign Subsidiaries that are corporations for US federal income tax purposes (ignoring any Domestic Subsidiaries that are disregarded for US federal income tax purposes and owned by a Foreign Subsidiary);
(b)      all present and future debt owed to a Borrower or any Guarantor (other than debt owed to a US Loan Party by a CFC Holdco, a Disregarded Domestic Person, any Foreign Subsidiary and any US Subsidiary that is a subsidiary of a Foreign Subsidiary);
(c)      all of the present and future property and assets, real and personal, of each Borrower and each Guarantor, including, but not limited to, machinery and equipment, inventory and other goods, accounts receivable, material fee-owned real estate, fixtures, bank accounts (subject to certain customary exceptions), general intangibles, financial assets, investment property, license rights, patents, trademarks, trade names, copyrights, other intellectual property and other general intangibles, chattel paper, insurance proceeds, contract rights, hedge agreements, documents, instruments, indemnification rights, tax refunds and cash; and
(d)      all proceeds and products of the property and assets described in clauses (a), (b) and (c) above.
 
For the avoidance of doubt, the pledge of a portion of an entity’s capital stock with respect to both the US Obligations and the Euro Obligations shall be deemed to refer to the same capital stock. The parties will cooperate in good faith in a manner consistent with the Security Principles (taking into account any applicable tax laws) with respect to any pledges of capital stock. The Collateral shall ratably secure the relevant party’s obligations in respect of the Facilities, any interest protection or other hedging arrangements with a Lender or an affiliate of a Lender and treasury management agreements with a Lender or an affiliate of a Lender.
 
All the above-described pledges, security interests and mortgages shall be created on terms, and pursuant to documentation reasonably satisfactory to the Borrower Representative and the Administrative Agent, and none of the Collateral shall be subject to any other pledges, security interests or mortgages, subject to exceptions to be agreed upon. Assets will be excluded from the Collateral in circumstances to be agreed and in circumstances where the Administrative Agent reasonably determined in consultation with the Borrower Representative that the cost of obtaining a security interest in such assets is excessive in relation to the value afforded thereby. In addition, the Administrative Agent shall not have any right to require any US Loan Party to take any steps to perfect by control any security interest noted herein in deposit, securities or commodities accounts.
Notwithstanding anything to the contrary in the Commitment Letter or any Annex thereto, the Collateral shall exclude the following:
(i)      (x) motor vehicles and other assets subject to certificates of title, (y) letter of credit rights and (z) commercial tort claims with a value of less than an amount to be agreed;
(ii)      pledges and security interests (including in respect of interests in partnerships, joint ventures and other non-wholly owned entities) to the extent prohibited by law, rule, regulation or prohibited by agreements containing anti-assignment clauses not overridden by the Uniform Commercial Code or other applicable law (such as the German Commercial Code ( Handelsgesetzbuch )) other than proceeds and receivables thereof;
(iii)      all fee owned real property with a fair market value of less than $5,000,000 and all leasehold interests;
(iv)      intent to use trademark or service mark applications;
(v)      equity interests in any person other than wholly owned subsidiaries to the extent not permitted by the terms of such subsidiary’s organizational or joint venture documents;
(vi)      any lease, license or other agreement or any property subject to a purchase money security interest, capital lease obligation or similar arrangements, in each case, to the extent permitted under the Credit Documentation to the extent that a grant of a security interest therein would violate or invalidate such lease, license or agreement, purchase money, capital lease or a similar arrangement or create a right of termination in favor of any other party thereto (other than any Loan Party) or otherwise give rise to any consent rights of any such other party or result in a default, in each case, after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or other applicable law, other than proceeds and receivables thereof, the assignment of which is expressly deemed effective under applicable law notwithstanding such prohibition;
(vii)      those assets as to which the Borrower Representative and the Administrative Agent reasonably determine results in a material adverse tax consequence to the Borrower as reasonably determined by the Borrower;
(viii)      with respect to the US Obligations, any assets owned by a CFC Holdco, Disregarded Domestic Person, CFC, Foreign Subsidiary or US Subsidiary that is owned by a Foreign Subsidiary;
(ix)      any governmental licenses or state or local franchises, charters and authorizations, to the extent security interests in such licenses franchises, charters or authorizations are prohibited or restricted thereby (in each case, except to the extent such prohibition is unenforceable after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or other applicable law)) other than proceeds and receivables thereof, the assignment of which is expressly deemed effective under the Uniform Commercial Code or other applicable law notwithstanding such prohibition;
(x)      zero balance accounts, payroll accounts, withholding and trust accounts, tax accounts, escrow or other fiduciary accounts located in the United States and other accounts customarily excluded in the other Material Jurisdictions;
(xi)      margin stock;
(xii)      other customary exclusions under applicable local law or in applicable local jurisdictions;
(xiii)      any intellectual property possessed by a US Loan Party which cannot be perfected by the filing of a UCC-1 financing statement and/or the filing of a short form intellectual property security agreement in either the United States Copyright Office or the United States Patent and Trademark Office;
(xiv)      any assets located in Non-Material Jurisdictions; and
(xv)      other exceptions to be agreed.
For purposes of the Credit Documentation, (a) “ CFC ” means a “controlled foreign corporation” within the meaning of Section 957 of the Internal Revenue Code, as amended and (b) “ Disregarded Domestic Person ” means any direct or indirect domestic subsidiary of the US Borrower that (i) is a disregarded entity or partnership for U.S. federal income tax purposes and (ii) has one or more directly owned (or owned through another Disregarded Domestic Person) Foreign Subsidiaries that are CFCs.
Conditions Precedent to Closing:
Limited to those conditions specified in (a) paragraph 5 of the Commitment Letter and (b) Annex II to the Commitment Letter.
Conditions Precedent to Each Borrowing Under the Facilities following the Closing Date:
Each borrowing or issuance or renewal of a Letter of Credit under the Facilities following the Closing Date will be subject to satisfaction of the following conditions precedent: (i) delivery of prior written notice of borrowing, (ii) all of the representations and warranties in the Credit Documentation shall be true and correct in all material respects as of the date of such extension of credit (except to the extent already qualified by materiality or material adverse effect and except to the extent such representation and warranty specifically relates to an earlier date) and (iii) no default or event of default under the Credit Documentation shall have occurred and be continuing or would result from such extension of credit.
Representations and Warranties:
Only the following representations and warranties shall apply (to be applicable to the Borrowers and their restricted subsidiaries), subject to customary and other exceptions and qualifications to be agreed consistent with the Documentation Principles: (i) existence, qualification and power; (ii) authorization, and non-contravention; (iii) government authorization and other consents; (iv) binding effect; (v) accuracy of financial statements in all material respects; (vi) no material adverse effect; (vii) litigation; (viii) no default; (ix) ownership of properties and liens; (x) environmental compliance; (xi) insurance; (xii) taxes; (xiii) ERISA compliance; (xiv) subsidiaries; (xv) Federal Reserve margin regulations and Investment Company Act; (xvi) disclosure; (xvii) compliance with laws (including OFAC, FCPA, U.S.A. PATRIOT Act and other anti-terrorism laws); (xviii) priority and perfection of security interests in Collateral (subject to permitted liens and other exceptions to be agreed); (xix) closing date solvency (defined in a manner consistent with (i) the Solvency Certificate (as defined in Annex II hereto) and (ii) the German insolvency law based on sections 17 through 19 of the German Insolvency Code, respectively); (xx) equity interests and ownership; (xxi) intellectual property (xxii) use of proceeds; (xxiii) business locations, taxpayer identification number; and (xxiv) COMI.
Covenants:
Only the following covenants shall apply (to be applicable to the Borrowers and their restricted subsidiaries), subject to customary and other exceptions, qualifications, thresholds and baskets to be agreed consistent with the Documentation Principles:
 
(a)      Affirmative Covenants :   (i) delivery of annual consolidated financial statements within the later of 90 days after the end of each fiscal year and 5 days after the date on which such financial statements are required to be filed under the rules and regulations of the SEC (after giving effect to any permitted extensions), delivery of quarterly consolidated financial statements within the later of 45 days after the end of each of the first three fiscal quarters of each fiscal year and 5 days after the date on which such financial statements are required to be filed under the rules and regulations of the SEC (after giving effect to any permitted extensions); (ii) at the time of delivery of the financial statements referenced in clause (i) above, compliance certificates; other reasonably requested information regarding the operations, business affairs and financial condition of the Borrowers and their restricted subsidiaries or compliance with the terms of the Credit Documentation; (iii) delivery of notification of default and material litigation; (iv) payment of obligations; (v) preservation of existence (subject to merger, acquisition, consolidation, amalgamation, dissolution and disposition not prohibited by the Credit Documentation); (vi) maintenance of properties (subject to casualty, condemnation and normal wear and tear and dispositions not prohibited by the Credit Documentation); (vii) maintenance of customary insurance (with ability to self-insure for healthcare matters); (viii) compliance with laws and material obligations; ERISA compliance; (ix) maintenance of books and records; (x) right of the Administrative Agent to inspect property, books and records (limited to once per year, unless an event of default has occurred and is continuing); (xi) use of proceeds; (xii) joinder of subsidiaries as guarantors (subject to the limitations set forth under the caption “Guarantors”); (xiii) pledge of capital stock and other property (subject to the limitations set forth under the caption “Security”); (xiv) further assurances in respect of collateral matters; (xv) commercially reasonable efforts to maintain ratings (but not a specific rating); (xvi) environmental compliance; (xvii) COMI; (xviii) use of proceeds; and (xiv) entering into and maintain domination and/or profit and loss sharing agreement ( Beherrschungs- und/oder Gewinnabführungsvertrag ) with the (i) Euro Borrower by subsidiaries of the Euro Borrower that are German subsidiaries or (ii) direct holding companies of such German subsidiaries.
(b)      Negative Covenants: Restrictions on:
liens (it being agreed that the negative covenant on liens will permit (A) liens securing the Facilities and any Incremental Facilities, (B) liens securing Refinancing Debt, Incremental Equivalent Debt, in each case, subject to an intercreditor agreement reasonably satisfactory to the Administrative Agent, and debt incurred pursuant to clauses (iii)(B), (E) and (F) below, (C) liens on assets of a restricted subsidiary which is not a Loan Party, (D) a general lien basket in an amount equal to the greater of (i) $50,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets (as defined below), (E) liens on assets existing at the time such assets were acquired to the extent, in the case of this clause (E), such liens do not extend to assets other than the assets so acquired and such liens were not effected in contemplation of such acquisition, (F) liens existing on the Closing Date, (G) liens on the US Borrower’s Santa Clara, California facility securing debt incurred pursuant to clause (iii)(I) below; provided  that the US Borrower receives net proceeds of such financing in an amount equal to at least 40% of the fair market value of such property and all such net proceeds are used to prepay the Term Facility and (H) permitted refinancing liens of any liens that were permitted when incurred;
(ii)      investments (it being agreed that the negative covenant on investments will permit (A) investments under the Available Amount Basket (as defined below) (subject to the restrictions set forth therein), (B) additional investments, so long as (x) no event of default shall have occurred and be continuing or would result therefrom and (y) on a pro forma basis, the Total Net Leverage Ratio shall be equal to or less than 2.50:1.00, (C) Permitted Acquisitions (as defined below), (D) intercompany investments; provided  that (x) in the case of such investments by US Loan Parties in foreign Loan Parties, such investments do not exceed $200,000,000 at any time (excluding any such investments in a “ Foreign Loan Party ” (defined herein as a Euro Loan Party other than a US Loan Party) to the extent the proceeds of such investment are invested by such Foreign Loan Party in a non-Loan Party), and (y) in the case of such investments by Loan Parties in non-Loan Parties, such investments do not exceed $100,000,000 at any time, (E) intercompany investments in unrestricted subsidiaries and joint ventures in an amount equal to the greater of (i) $30,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets, (F) re-organizations and other activities related to tax planning and re-organization set forth in a schedule to the Credit Documentation to be agreed, so long as, after giving effect thereto, the Borrower remains in compliance with the Guarantor Coverage Test, (G) the Transaction, (H) investments existing on the Closing Date, (I) a general investment basket in an amount equal to the greater of (i) $50,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets, (J) investments of a restricted subsidiary acquired after the Closing Date or of an entity merged into a Borrower or a restricted subsidiary after the Closing Date to the extent such investments were not made in contemplation of or in connection with such acquisition, merger, consolidation or amalgamation and were in existence on the date of such acquisition, merger, consolidation or amalgamation, (K) investments by any US Loan Party in any other US Loan Party, by any Euro Loan Party in any other Euro Loan Party and by any Euro Loan Party in any US Loan Party and (L) investments by any non-Loan Party in any other non-Loan Party or in any Loan Party;
(iii)      indebtedness (including cash management obligations and hedging transactions) (it being agreed that the negative covenant on indebtedness will permit (A) the Facilities, Incremental Facilities, Refinancing Debt and Incremental Equivalent Debt, (B) additional unsecured debt of Loan Parties and additional unsecured or secured debt of non-Loan Parties, in each case, in an unlimited amount so long as the pro forma Total Gross Leverage Ratio does not exceed 4.50:1.00 and no event of default shall have occurred and be continuing or would result therefrom; provided  that such debt shall not mature prior to date that is 180 days after the maturity date of, or have a shorter weighted average life than, the Term Facility, in each case in effect at the time the indebtedness was incurred, (C) indebtedness existing on the Closing Date and any permitted refinancing thereof, subject to certain conditions to be agreed, (D) intercompany indebtedness (subject to the limitations set forth in the investments covenant), (E) indebtedness of restricted subsidiaries which are not Loan Parties in an amount equal to the greater of (i) $50,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets, (F) a capital lease and purchase money debt basket in an amount equal to the greater of (i) $50,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets, (G) a general unsecured debt basket in an amount equal to the greater of (i) $75,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets, (H) any interest rate hedges consistent with those permitted by the Borrower’s foreign exchange risks policy delivered to the Lead Arrangers prior to the date of the Commitment Letter and any amendments thereto reasonably acceptable to the Administrative Agent), (I) the mortgage financing of the Borrower’s Santa Clara, California facility, so long as the proceeds of such indebtedness are used to prepay the Term Facility and (J) permitted refinancing indebtedness; provided  that notwithstanding the forgoing exceptions the aggregate amount of all debt of non-Loan Parties incurred pursuant to clauses (iii)(B), (E) and (G) above shall not exceed the greater of (i) $75,000,000 and (ii) a Corresponding Percentage of Consolidated Total Assets;
(iv)      mergers and dissolutions (it being agreed that the negative covenant on mergers and dissolutions will permit (A) Permitted Acquisitions and other permitted investments (including any merger, consolidation or amalgamation in order to effect such Permitted Acquisition or other permitted investment), (B) intercompany mergers, consolidations and amalgamations subject to certain limitations to be agreed, (C) dissolutions or changes in form if the Borrower Representative determines in good faith that such dissolution or change in form is in its best interests and is not materially disadvantageous to the Lenders and (D) certain other transactions to be mutually agreed);
(v)      dispositions of assets (it being agreed that the negative covenant on dispositions of assets will permit (A) sales of assets in the ordinary course of business and immaterial assets, (B) asset swaps, (C) dispositions of non-Collateral assets, subject to certain limitations to be agreed, (D) dispositions of non-core assets acquired in connection with a Permitted Acquisition or other permitted investment, (E) dispositions of obsolete, worn out, uneconomical, negligible or surplus assets or assets no longer useful in the business, (F) intercompany transfers, (G) dispositions of receivables and related assets in a factoring, receivables or securitization facility, (H) dispositions of any other assets on an unlimited basis for fair market value (as determined by the Borrower Representative in good faith) so long as (x) with respect to dispositions in excess of $10,000,000, at least 75% of the consideration consists of cash or Cash Equivalents (as defined below) (subject to customary and agreed upon exceptions to the cash consideration requirement, including a basket in an amount to be mutually agreed for non-cash consideration that may be designated as cash consideration) and, if in excess of $10,000,000, is subject to the terms set forth in the mandatory prepayment requirements (including the reinvestment provisions) in the Credit Documentation, (I) sale and leaseback transactions, (J) dispositions of cash or cash equivalents in the ordinary course of business, (K) dispositions of defaulted receivables in the ordinary course of business and not as part of an accounts receivables financing, (L) dispositions or abandonment of intellectual property of the Borrowers and their restricted subsidiaries determined in good faith by the management of the Borrower Representative to be no longer useful or necessary in the operation of the business of the Borrowers and their restricted subsidiaries and (M) leases, licenses, or subleases or sublicenses of any real or personal property in the ordinary course of business;
(vi)      dividends, stock repurchases and redemptions of equity interests (“ Restricted Payments ”) (it being agreed that the negative covenant on Restricted Payments will permit (A) Restricted Payments under the Available Amount Basket (subject to the restrictions set forth therein), (B) a basket for stock repurchases and redemptions in a dollar amount to be agreed, (C) additional Restricted Payments, so long as (x) no event of default shall have occurred and be continuing or would result therefrom and (y) on a pro forma basis, the Total Net Leverage Ratio shall be equal to or less than 2.25:1.00), (D) any Subsidiary of the Borrower Representative to pay dividends and make distributions to the holders of its equity interests (including any securities convertible into or exchangeable for equity interests and all warrants, options or other rights to purchase, subscribe for or otherwise acquire the foregoing or equity interests), (E) Restricted Payments in connection with the Transaction and (F) other Restricted Payments in a dollar amount to mutually be agreed;
(vii)      change in nature of business;
(viii)      change in fiscal year;
(ix)      transactions with affiliates;
(x)      use of proceeds;
(xi)      prepaying, redeeming or repurchasing subordinated or junior lien debt (“ Restricted Debt Payments ”) (it being agreed that the Credit Documentation will allow (A) Restricted Debt Payments under the Available Amount Basket (subject to the restrictions set forth therein), (B) additional Restricted Debt Payments, so long as (x) no event of default shall have occurred and be continuing or would result therefrom and (y) on a pro forma basis, the Total Net Leverage Ratio shall be equal to or less than 2.50:1.00), (C) refinancings with permitted indebtedness, (D) payment of (x) regularly scheduled interest and fees due and other non-principal payments and (y) any mandatory prepayment of principal, interest and fees and principal on the scheduled maturity date (subject, in each case, to an intercreditor agreement or other applicable subordination agreement), (E) the conversion or exchange of subordinated or junior lien debt to equity interests of the US Borrower, (F) intercompany Restricted Debt Payments and (G) other Restricted Debt Payments in an amount to be mutually agreed;
(xii)      burdensome agreements (negative pledge clauses that limit or restrict the Administrative Agent from taking or perfecting its lien in the intended Collateral, subject to exceptions to be agreed, and restrictions on dividends and distributions from subsidiaries of the Borrowers); and
(xiii)      amending or waiving (A) organizational documents in a manner that would be materially adverse to the Lenders or (B) subordinated, second lien or junior debt instruments to the extent prohibited by applicable subordination or intercreditor terms, to permit a payment not otherwise permitted hereunder or as would otherwise be materially adverse to the Lenders.
 
Among other things, the Credit Documentation will permit (a) acquisitions (each, a “ Permitted Acquisition ”) subject to (i) no event of default under the Facilities at the time of consummation of the Permitted Acquisition or resulting therefrom or, if consummated using the proceeds of an Incremental Facility, at the time of execution of the definitive agreement governing such Permitted Acquisition if agreed by the Lenders providing such Incremental Facility, (ii) the acquired entity and its subsidiaries becoming Guarantors to the extent required under “Security” above, subject to a basket to be agreed to permit acquisitions of non-Guarantors, (iii) the acquisition being approved by the board of directors, or other governing body, of the target and (iv) the acquired entity or assets being in the same, related, complimentary or ancillary line of business as the Borrowers and their subsidiaries, (b) an “ Available Amount Basket ”, which may be used for certain investments, Restricted Payments and Restricted Debt Payments subject to limitations to be agreed (including, without limitation, with respect to (x) Restricted Payments, on a pro forma basis, the Total Net Leverage Ratio being equal to or less than 2.50:1.00 and (y) Restricted Debt Payments, on a pro forma basis, the Total Net Leverage Ratio being equal to or less than 2.75:1.00) and be based on the retained portion of Excess Cash Flow (which in no event shall be less than zero) with an initial basket of $50,000,000 and (c) (x) reorganizations and other activities related to tax planning and reorganization or otherwise to achieve synergies, in each case, as set forth on a schedule to the Credit Documentation (such schedule to be provided by Borrower and deemed acceptable so long as of the date of the Credit Documentation, on a pro forma basis, after giving effect to the actions contemplated thereby (and assuming all required Guarantors have become Guarantors as of such date), the Guarantor Coverage Test would be met and the security interests of the Lenders in the Collateral, taken as a whole, would not be materially impaired), and (y) such other actions to achieve synergies in connection with the Acquisition, provided after giving effect to such actions the Guarantor Coverage Test would be met and the security interests of the Lenders in the Collateral, taken as a whole, would not be materially impaired.
Corresponding Percentage of Consolidated Total Assets ” means, with respect to any dollar basket, the amount of such dollar basket divided by the initial consolidated total assets of the Borrowers and their restricted subsidiaries giving effect to the Transaction, expressed as a percentage.
Financial Covenant :
Limited to the following (applicable each Borrower and its restricted subsidiaries):
 
Term Facility : None.
Revolving Facility : Senior Secured Net Leverage Ratio to be set at a level to be agreed (the “ Financial Covenant ”), commencing with the first full fiscal quarter after the Closing Date to be tested on the last day of each fiscal quarter. The Financial Covenant shall be set with a cushion of 30% (rounded in a manner to be mutually agreed) off Consolidated EBITDA set forth in the model projections delivered to the Lead Arrangers prior to the date of the Commitment Letter.
 
Consolidated EBITDA ” shall be defined in a manner consistent with the Documentation Precedent; provided  that the aggregate amount of all net cost savings, operating expense reductions, other operating improvements and acquisition synergies in good faith projected to be realized during such period (collectively, the “ Synergies ”) shall not exceed 20% of Consolidated EBITDA.
Secured Net Leverage Ratio ” means, as of any date of determination, the ratio of (a)(i) Total Funded Secured Indebtedness as of such date, less (ii) all unrestricted cash and Cash Equivalents (with “ Cash   Equivalents ” being defined to include investments permitted by the Borrower’s cash investment policy delivered to the Lead Arrangers prior to the date of the Commitment Letter and any amendments thereto reasonably acceptable to the Administrative Agent) of the Borrowers and the Guarantors to (b) Consolidated EBITDA for the most recently ended four-fiscal quarter period for which financial statements are available.
Senior Secured Net Leverage Ratio ” means, as of any date of determination, the ratio of (a)(i) Total Funded Senior Secured Indebtedness as of such date, less (ii) all unrestricted cash and Cash Equivalents of the Borrowers and the Guarantors to (b) Consolidated EBITDA for the most recently ended four-fiscal quarter period for which financial statements are available.
Total Funded Indebtedness ” means, if and to the extent the same would constitute indebtedness or a liability in accordance with GAAP, the sum of (without duplication) (i) the outstanding principal amount of funded indebtedness for borrowed money, (ii) unreimbursed draws under letters of credit, (iii) the outstanding principal amount of purchase money indebtedness and (iv) the outstanding principal amount of capital leases of the Borrowers and their restricted subsidiaries, subject to exceptions to be agreed.
Total Funded Secured Indebtedness ” means Total Funded Indebtedness as of such date secured by a lien, subject to exceptions to be agreed.
Total Funded Senior Secured Indebtedness ” means Total Funded Indebtedness as of such date secured by a lien (excluding any lien ranking junior to the liens securing the Facilities), subject to exceptions to be agreed.
Total Gross Leverage Ratio ” means, as of any date of determination, the ratio of (a) Total Funded Indebtedness as of such date to (b) Consolidated EBITDA for the most recently ended four-fiscal quarter period for which financial statements are available.
Total Net Leverage Ratio ” means, as of any date of determination, the ratio of (a)(i) Total Funded Indebtedness as of such date, less (ii) all unrestricted cash and Cash Equivalents of the Borrowers and the Guarantors to (b) Consolidated EBITDA for the most recently ended four-fiscal quarter period for which financial statements are available.
In the event that any additional OID or upfront fees are implemented pursuant to the “market flex” provisions of the Facilities Fee Letter, any Secured Net Leverage Ratio, Senior Secured Net Leverage Ratio, Total Gross Leverage Ratio or Total Net Leverage Ratio tests set forth in the Term Sheet shall be adjusted as mutually agreed to account for the additional interest expense or additional indebtedness and maintain the agreed cushion taking into account such additional interest expense or additional indebtedness.
Unrestricted Subsidiaries:
The Credit Documentation will contain provisions pursuant to which, subject to customary limitations on investments, loans, advances to, and other investments in, unrestricted subsidiaries, the Borrower Representative will be permitted to designate any existing or subsequently acquired or organized subsidiary as an “unrestricted subsidiary” and, in each case, subsequently re-designate any such unrestricted subsidiary as a “restricted subsidiary” so long as, after giving effect to any such designation or re-designation, (i) no event of default shall have occurred and be continuing or would result from any such designation and (ii) the Borrowers shall be in pro forma compliance with the Financial Covenant. Unrestricted subsidiaries will not be subject to the mandatory prepayment, representation and warranty, affirmative or negative covenant or event of default provisions of the Credit Documentation, and the cash held by, results of operations, indebtedness and interest expense of unrestricted subsidiaries will not be taken into account for purposes of determining any financial ratio or covenant contained in the Credit Documentation. The designation of any subsidiary as an unrestricted subsidiary after the Closing Date shall constitute an investment by the relevant Borrower or its subsidiary (as applicable) at the date of designation in an amount equal to the fair market value of the Borrower’s or its subsidiaries’ (as applicable) investment therein.
Events of Default:
Only the following events of default shall apply (to be applicable to the Borrowers and their restricted subsidiaries), with grace periods, baskets and materiality to be agreed consistent with the Documentation Principles: (i) nonpayment of principal; nonpayment of interest with a grace period of three business days and nonpayment of fees or other amounts with a grace period of five business days; (ii) any representation or warranty proving to have been inaccurate in any material respect when made or confirmed; (iii) failure to perform or observe covenants set forth in the Credit Documentation (subject, in the case of certain affirmative covenants, to a grace period of 30 days); (iv) cross-defaults to other indebtedness in an amount to be agreed; (v) bankruptcy, insolvency defaults (with a 60 day grace period for involuntary proceedings in case of US Loan Parties and customary grace periods in other jurisdictions) and, in case of the Euro Loan Parties, is illiquid ( zahlungsunfähig)  pursuant to section 17 of the German Insolvency Code, imminent illiquid ( drohend   zahlungsunfähig ) pursuant to Section 18 of German Insolvency Code or over-indebted ( überschuldet ) pursuant to Section 19 of German Insolvency Code; (vi) monetary judgment defaults to the extent not covered by indemnities or insurance above an amount to be agreed; (vii) invalidity of guarantees or other loan documents; (viii) change of control; and (ix) ERISA defaults.
Notwithstanding the foregoing and the provisions under “Waivers and Amendments” below, (i) only Lenders holding at least a majority of the Revolving Loan commitments and Revolving Loans shall have the ability to amend the Financial Covenant, waive a breach of the Financial Covenant or accelerate the Revolving Credit Facility and (ii) a breach of the Financial Covenant shall not constitute an event of default with respect to the Term Facility or trigger a cross-default under the Term Facility until the date on which the Revolving Loans (if any) have been accelerated or the Revolving Loan commitments have been terminated, in each case, by the Lenders in accordance with the terms of the Revolving Credit Facility.
Assignments and Participations:
Each Lender will be permitted to make assignments (except to Disqualified Institutions) in minimum amounts to be agreed to other entities approved by (x) the Administrative Agent (y), so long as no payment or bankruptcy event of default has occurred and is continuing, the Borrower Representative, and (z) with respect to commitments under the Revolving Credit Facility, the Swingline Lender and the Issuing Bank, each such approval not to be unreasonably withheld or delayed; provided, however , that (i) no approval of the Borrower Representative shall be required in connection with assignments to other Lenders or any of their affiliates, (ii) the Borrower Representative shall be deemed to have given consent to an assignment if it shall have failed to respond to a written notice thereof within ten business days and (iii) no approval of the Administrative Agent shall be required in connection with assignments (x) under the Term Facility to other Lenders or any of their affiliates or approved funds or (y) under the Revolving Credit Facility to other Lenders under the Revolving Credit Facility or any of their affiliates or approved funds. Each Lender will also have the right, without consent of the Borrower Representative or the Administrative Agent, to assign as security all or part of its rights under the Credit Documentation to any Federal Reserve Bank.
 
Lenders will be permitted to sell participations (except to Disqualified Institutions, if the list of Disqualified Institutions has been provided to all Lenders) with voting rights (a) limited to matters in respect of (i) increases in commitment amount of such participant, (ii) reductions of principal, interest or fees payable to such participant, (iii) extension of scheduled maturities or times for payment of amounts payable to such participant and (iv) releases of all or substantially all of the Collateral or value of the guarantees and (b) for clarification purposes, which shall not include the right to vote on waivers of defaults or events of default and the sale of such participations shall not require the approval of the Borrower Representative or the Administrative Agent.
An assignment fee in the amount of $3,500 will be charged with respect to each assignment unless waived by the Administrative Agent in its sole discretion.
 
Notwithstanding anything herein or in the Credit Documentation to the contrary, (i) in the case that after the date of the Commitment Letter the Borrower Representative supplements the list of Disqualified Institutions, such supplement from the  Borrower Representative  may not retroactively disqualify any person that previously acquired an assignment or participation in the Facilities and (ii) the Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions hereof relating to Disqualified Institutions.  Without limiting the generality of the foregoing, the Administrative Agent shall not ‎(x) be obligated to ascertain, monitor or inquire as to whether any Lender or participant or prospective Lender or participant is a Disqualified Institution or (y) have any liability with respect to or arising out of any assignment or participation of loans, or disclosure of confidential information, to, or the restrictions on any exercise of rights or remedies of, any Disqualified Institution.

 
Subject to the Documentation Principles, assignments of loans under the Term Facility to the Borrowers or any of their subsidiaries shall be permitted subject to satisfaction of conditions to be set forth in the Documentation Precedent.
Waivers and Amendments:
Amendments and waivers of the provisions of the Credit Documentation will require the approval of Lenders holding loans and commitments representing more than 50% of the aggregate advances and commitments under the Facilities (the “ Required Lenders ”), except that (a) the consent of each Lender directly and adversely affected thereby will also be required with respect to, among other things, (i) increases in commitment amount of such Lender (it being understood that a waiver of any condition precedent or the waiver of any default or mandatory prepayment shall not constitute an increase in any commitment of any Lender), (ii) reductions of principal, interest, or fees payable to such Lender (other than waivers of default interest, a default or an event of default or mandatory prepayment); provided  that any change in the definitions of any ratio used in the calculation of any rate of interest or fees (or the component definitions) shall not constitute a reduction in any rate of interest or fees, (iii) extensions of scheduled maturities or times for payment of amounts payable to such Lender (it being understood and agreed that the waiver of any mandatory prepayment, default interest, default or event of default shall only require the consent of the Required Lenders), (iv) releases of all or substantially all of the Collateral or value of the guarantees (other than in connection with permitted asset sales, dispositions, mergers, liquidations or dissolutions or as otherwise permitted), (v) changes that impose any restriction on the ability of such Lender to assign any of its rights or obligations, (vi) the definition of Required Lenders, (vii) pro rata/sharing provisions and (viii) re-denominations of currency and (b) tranche voting will be required for certain matters.
Notwithstanding the foregoing, (i) amendments and waivers of the Financial Covenant shall only require the approval of Lenders holding more than 50% of the aggregate amount of the commitments under the Revolving Credit Facility and (ii) amendments to affect a Repricing Transaction which reduced the interest rate shall only require the approval of Lenders directly and adversely affected thereby.
 
Subject to the Documentation Principles, the Credit Documentation shall contain defaulting lender provisions and “yank-a-bank” provisions substantially consistent with the Documentation Precedent.
If the Administrative Agent and the Borrower Representative shall have jointly identified an obvious error or any error or omission of a technical nature in the Credit Documentation, then the Administrative Agent and the Borrower Representative shall be permitted to amend such provision without further action or consent of any other party so long as the Required Lenders do not object thereto within 10 business days following receipt of notice thereof.
Notwithstanding anything to the contrary set forth herein, the Credit Documentation shall provide that the Borrower Representative may at any time and from time to time request that all or a portion of any loans under the Facilities be converted to extend (i) the scheduled maturity date of any payment of principal with respect to all or a portion of any principal amount of such loans and (ii) the scheduled termination date of any commitments pursuant to the Revolving Credit Facility (any such loans which have been so converted, “ Extended Loans ”) and upon such request of the Borrower Representative any individual Lender shall have the right to agree to extend the maturity date of its outstanding loans or the termination date of its commitments without the consent of any other Lender; provided that all such requests shall be made pro rata to all Lenders within the applicable Facility. The terms of Extended Loans shall be identical to the loans of the existing class from such Extended Loans are converted except for interest rates, fees, amortization, final maturity date or final termination date, provisions requiring optional and mandatory prepayments to be directed first to the non-extended loans prior to being applied to Extended Loans and certain other customary provisions to be agreed.
Any applicable intercreditor agreement may be amended solely with the consent of the Administrative Agent and, if a party thereto, the Borrowers and the Guarantors, to give effect thereto or to carry out the purposes thereof.
Indemnification:
The Borrowers will indemnify the Administrative Agent, the Syndication Agent, the Lead Arrangers, each Swingline Lender and Issuing Bank, and the Lenders and their respective affiliates, and the officers, directors, employees, affiliates, agents, advisors and controlling persons of the foregoing (each an “ Indemnified Person ”), and hold them harmless from and against all costs, expenses (including, without limitation, reasonable fees, disbursements and other charges of counsel) and liabilities of any such Indemnified Person arising out of or relating to any claim or any litigation or other proceeding (regardless of whether any such Indemnified Person is a party thereto or whether such claim, litigation, or other proceeding is brought by a third party or by the Borrowers or any of its affiliates, creditors or shareholders) that relate to the Credit Documentation, provided  that no Indemnified Person will be indemnified for any cost, expense or liability (x) to the extent determined by a court of competent jurisdiction in a final non-appealable judgment to have resulted from the gross negligence, bad faith, willful misconduct of such Indemnified Person or any of such Indemnified Person’s controlled or controlling affiliates or any of its or their respective officers, directors, employees, agents, advisors or controlling persons, (y) arising from a material breach of such Indemnified Person’s (or any of their respective affiliates, successors and assigns and the officers, directors, employees, agents, advisors and controlling persons) obligations under the definitive loan documentation (as determined by a court of competent jurisdiction in a final non-appealable judgment), or (z) arising from any claim, actions, suits, inquiries, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its affiliates and that is brought by an Indemnified Person against any other Indemnified Person (other than any claim, actions, suits, inquiries, litigation, investigation or proceeding against the Administrative Agent, the Syndication Agent, the Issuing Bank, any Lead Arranger or any Commitment Party in its capacity as such).
Governing Law:
New York.
Expenses:
The Borrowers shall pay (a) all reasonable and documented out-of-pocket expenses of the Administrative Agent, the Syndication Agent, the Lead Arrangers, each Swingline Lender and Issuing Bank associated with the syndication of the Facilities and the preparation, execution, delivery and administration of the Credit Documentation and any amendment or waiver with respect thereto (including, without limitation, the reasonable fees, disbursements and other charges of one firm of counsel for all such persons, taken as a whole, one local counsel for all such persons, taken as a whole, in each relevant state and in each Material Jurisdiction, in each case retained by the Lead Arrangers (each such counsel subject to the Borrower Representative’s reasonable consent (such consent not to be unreasonably withheld, delayed or conditioned)) and (b) all reasonable and documented or invoiced out-of-pocket expenses of the Administrative Agent, the Syndication Agent, the Lead Arrangers, each Swingline Lender and Issuing Bank, and the Lenders (including, without limitation, the fees, disbursements and other charges of counsel) in connection with the enforcement of the Credit Documentation.
Counsel to the Commitment Parties:
Weil, Gotshal & Manges LLP.
Miscellaneous:
Each of the parties shall (i) waive its right to a trial by jury and (ii) submit to exclusive New York jurisdiction. The Credit Documentation shall contain customary “defaulting lender” provisions.


ANNEX II
CONDITIONS PRECEDENT TO CLOSING
Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Annex II is attached.
The initial extensions of credit under the Facilities on the Closing Date will be subject to satisfaction (or waiver by the Lead Arrangers with the consent of the Commitment Parties) of the following conditions precedent:
(i) The terms of the Acquisition Agreement will be reasonably satisfactory to the Lead Arrangers (it being understood that the execution version of the Acquisition Agreement, dated as of March 16, 2016 is reasonably satisfactory to the Lead Arrangers). The Acquisition shall have been or shall substantially concurrently be, consummated in accordance with the terms of the Acquisition Agreement without giving effect to any amendment, change or supplement or waiver of any provision thereof (including any change in the purchase price) in any manner that is materially adverse to the interests of the Lenders or the Lead Arrangers without the prior written consent of the Lead Arrangers (which consent shall not be unreasonably withheld or delayed); provided that (x) (i) any reduction in purchase price for the Acquisition shall not be deemed to be material and adverse to the interests of the Lenders or the Lead Arrangers so long as there is a concurrent reduction in the aggregate principal amount of the commitments in respect of the Term Facility and (ii) any increase in purchase price for the Acquisition shall not be deemed to be material and adverse to the interests of the Lenders or the Lead Arrangers so long as the purchase price is not funded with additional indebtedness (it being understood and agreed that no purchase price, working capital or similar adjustment provisions set forth in the Acquisition Agreement shall constitute a reduction or increase in purchase price) and (y) any amendment, change or supplement or waiver of the definition of “Company Material Adverse Effect” set forth in the Acquisition Agreement shall be deemed to be material and adverse to the interests of the Lenders.
(ii) Notwithstanding anything in this Commitment Letter (including, for the avoidance of doubt, Annexes I, II and III), the Fee Letters, the Credit Documentation or any other letter agreement or other undertaking concerning the financing of the Transaction to the contrary, the only representations and warranties the accuracy of which shall be a condition to the initial availability of the Facilities shall be (A) the Acquisition Agreement Representations (as defined below) and (B) the Specified Representations (as defined below). “ Acquisition Agreement Representations ” shall mean the representations made by or with respect to the Acquired Business and its subsidiaries in the Acquisition Agreement as are material to the interests of the Lenders (in their capacities as such), but only to the extent that the breach of any such representations results in you or any of your affiliates having the right to terminate your or its obligations under the Acquisition Agreement (after giving effect to any applicable notice and cure period) or results in the failure of a condition precedent to your obligation to consummate the Acquisition pursuant to the Acquisition Agreement. “ Specified Representations ” shall mean the representations and warranties in the Credit Documentation relating to (in each case, subject to applicable materiality qualifiers and the Documentation Principles): (i) (A) corporate status of you and the Guarantors and (B) corporate power and authority to enter into the Credit Documentation by you and the Guarantors, (ii) due authorization, execution and delivery by you and the Guarantors and enforceability of the Credit Documentation against you and the Guarantors, (iii) no conflicts with charter documents by you and the Guarantors as it relates to the entry into and performance of the Credit Documentation, (iv) compliance by you and the other Guarantors with Federal Reserve margin regulations, U.S.A. Patriot Act, not using proceeds in violation of OFAC, FCPA and other anti-terrorism laws and the Investment Company Act, (v) solvency of you and your subsidiaries on a consolidated basis on the Closing Date immediately after giving effect to the consummation of the Transaction (such representations to be substantially identical to those set forth in the Solvency Certificate attached as Annex III to the Commitment Letter (the “ Solvency Certificate ”)), and (vi) the creation, validity and perfection of the security interests granted in the Collateral by you and the other Guarantors on the Closing Date substantially concurrently with the initial funding of the Facilities.
(iii) Since the date of the Acquisition Agreement, there shall not have occurred or arisen any Company Material Adverse Effect (as defined below) that is continuing. For purposes hereof, “ Company Material Adverse Effect ” means any fact, event, violation, inaccuracy, circumstance, change or effect (any such item, an “ Effect ”) that, individually or when taken together with all other Effects that exist or have occurred prior to or at the date of determination of the occurrence of the Company Material Adverse Effect, is or is reasonably likely to be materially adverse to the business, operations, financial condition or results of operations of the Company and its Subsidiaries taken as a whole; provided, however , that in no event shall any Effect directly or indirectly resulting from any of the following, either alone or in combination, be taken into account when determining whether a Company Material Adverse Effect has occurred or may, would or could occur:
(i)
general economic, regulatory, business or political conditions in the United States or any other country or region in the world (or changes therein);
(ii)
conditions in the industries in which the Company or any of its Subsidiaries conduct business;
(iii)
changes in Applicable Law or GAAP or the interpretations thereof;
(iv)
acts of war, terrorism or sabotage or any escalation or worsening of acts of war or terrorism;
(v)
earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides, wild fires or other natural disasters, weather conditions and other force majeure events in the United States or any other country or region in the world;
(vi)
the public announcement or pendency of the Acquisition Agreement, the Merger or any other transactions contemplated by the Acquisition Agreement, including by reason of the identity of Parent or any communication by Parent regarding the plans or intentions of Parent with respect to the conduct of the business of the Company or any of its Subsidiaries and including the impact of any of the foregoing on any relationships, contractual or otherwise, with customers, suppliers, distributors, collaboration partners, stockholders, lenders, employees or regulators (including without limitation, any cancellations of or delays in customer agreements, any reduction in sales, any disruption in supplier, distributor, partner or similar relationships or any loss of employees);
(vii)
any failure by the Company to meet published analysts’ estimates, projections or forecasts of revenues, earnings or other financial or business metrics, in and of itself, and or any failure by the Company to meet any internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations or the issuance of revised projections that are not as optimistic as those in existence as of March 16, 2016 (it being understood that the underlying cause(s) of any such failure may be taken into consideration unless otherwise prohibited by this definition of “Company Material Adverse Effect”);
(viii)
any decline in the market price or change in the trading volume of Company Common Stock, in and of itself (it being understood that the underlying cause(s) of any such failure may be taken into consideration unless otherwise prohibited by this definition of “Company Material Adverse Effect”);
(ix)
any action taken that is required by the terms of the Acquisition Agreement or taken at the written request of Parent or with the prior written consent or approval of Parent;
(x)
any Legal Proceedings made or brought by any of the current or former Company Stockholders (on their own behalf or on behalf of the Company) against the Company, arising out of the Merger or in connection with any other transactions contemplated by the Acquisition Agreement; and
(xi)
the availability or cost of equity, debt or other financing to Parent, Merger Sub or the Surviving Corporation, or any changes, events or occurrences in financial, credit, banking or securities markets (including any disruption thereof and any decline in the price of any security or market index) or any interest rate or exchange rate changes or general financial or capital market conditions, including interest rates, or changes therein;
(except, in the case of each of clauses (i) through (v) above, to the extent that such Effect has had a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the industries in which the Company and its Subsidiaries operate). All capitalized terms used in this paragraph (iii) and the definition of “Company Material Adverse Effect” and not defined herein shall have the meaning assigned thereto in the Acquisition Agreement (as in effect on March 16, 2016) for purposes of the definition of “Company Material Adverse Effect”.
(iv) The Administrative Agent under each Facility shall have received the Solvency Certificate from the chief financial officer of the US Borrower (or, at the US Borrower’s option, a solvency opinion from an independent investment bank or valuation firm of nationally recognized standing that is addressed to the Administrative Agent and the Lenders and dated as of the Closing Date) with respect to solvency of you and your subsidiaries on a consolidated basis on the Closing Date immediately after giving effect to the consummation of the Transaction.
(v) The Administrative Agent under each Facility shall have received (A) customary opinions of counsel to the US Borrower and the Guarantors, (B) customary corporate resolutions, customary closing date officer’s certificates certifying as to the satisfactions of the conditions precedent to the Facilities, customary secretary’s and/or officer’s certificates appending such resolutions, commercial register excerpts (not older than 14 days), shareholders lists, charter documents, good standing certificates and incumbency certificate and information necessary for the Lead Arrangers to perform customary lien searches prior to closing, (C) subject in all respects to the Funds Certain Provisions, all documents and instruments (including schedules to security documentation) required to create and perfect the Administrative Agent’s senior priority security interest in the Collateral shall have been executed and delivered by the US Borrower, the Euro Borrower and the Guarantors (or, where applicable, the US Borrower and the Guarantors shall have authorized the filing of financing statements under the Uniform Commercial Code) and, if applicable, be in proper form for filing and (D) a customary borrowing notice.
(vi) The Lead Arrangers shall have received: (A) the audited consolidated balance sheets and related consolidated statements of operations, cash flows and shareholders’ equity of each of the US Borrower and the Acquired Business for the three most recently completed fiscal years of the US Borrower and the Acquired Business, respectively, ended at least 60 days before the Closing Date, accompanied by an unqualified report thereon by their respective independent registered public accountants; (B) the unaudited consolidated balance sheets and related statements of operations and cash flows of each of the US Borrower and the Acquired Business for each subsequent fiscal quarter of the US Borrower and the Acquired Business, respectively, ended at least 40 days before the Closing Date; and (C) pro forma consolidated balance sheet and related statement of operations of the US Borrower as of and for the periods for which audited and unaudited financial statements are required by clauses (A) and (B) above, and, other than a fiscal year end, as of and for the twelve-month period ended on the last day of the most recently completed four fiscal quarter period at least 40 days before the Closing Date, in each case after giving effect to the Transaction (the “ Pro Forma Financial Statements ”), all of which financial statements shall be prepared in accordance with Regulation S-X under the Securities Act (except that it is understood and agreed that the Pro Forma Financial Statements for any last twelve-month period that does not correspond with a fiscal year end may not comply with Regulation S-X only insofar as Regulation S-X contemplates fiscal year and interim period pro forma financial statements rather than “last twelve-month” pro forma financial statements).
(vii) The Lead Arrangers shall have been afforded a period of at least 21 consecutive calendar days (or such shorter period reasonably acceptable to the Lead Arrangers) following receipt of the Information Memorandum prior to the Closing Date; provided that such period shall (x) exclude the period from July 1, 2016 through and including July 4, 2016 and from November 23, 2016 through and including November 27, 2016, and (y) either conclude on or prior to August 19, 2016 or commence no earlier than September 6, 2016 and on or prior to December 23, 2016 or commence no earlier than January 3, 2017.
(viii) All fees due to the Administrative Agent, the Lead Arrangers and the Lenders under the Fee Letters and the Commitment Letter to be paid on the Closing Date, and all expenses to be paid or reimbursed under the Commitment Letter to the Administrative Agent and the Lead Arrangers on the Closing Date that have been invoiced at least three business days prior to the Closing Date, shall have been paid, in each case, from the proceeds of the initial funding under the applicable Facilities.
(ix) The Refinancing shall have been, or shall concurrently with the initial funding of the Facilities be consummated and all guarantees of such indebtedness shall be released and, to the extent applicable, all liens and security interests securing such indebtedness shall be discharged.
(x) So long as requested at least ten business days prior to the Closing Date, the Administrative Agent shall have received, at least three business days prior to the Closing Date, all documentation and other information with respect to the Borrowers and the Guarantors that is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the U.S.A. PATRIOT Act.

ANNEX III
FORM OF SOLVENCY CERTIFICATE
[      ], 201[_]
This SOLVENCY CERTIFICATE (this “ Certificate” ) is delivered in connection with that certain Credit Agreement dated as of [______], 201[_] (as amended, supplemented, amended and restated, replaced, or otherwise modified from time to time, the “ Credit Agreement” ), by and among COHERENT, INC., a Delaware corporation (the “ US Borrower ”), COHERENT HOLDING GMBH, a German company with limited liability (the “ Euro Borrower ”), BARCLAYS BANK PLC, as administrative agent and collateral agent (the “ Administrative Agent ”), and the financial institutions from time to time party thereto as lenders. Capitalized terms used herein without definition have the same meanings as in the Credit Agreement.
I, [●], the [ Chief Financial Officer/equivalent officer ] of the US Borrower, in such capacity and not in an individual capacity and without personal liability, hereby certify on behalf of the US Borrower that, to my knowledge, as of the date hereof, immediately after giving effect to the consummation of the Transaction, including the incurrence of the obligations under the Credit Agreement and the use of proceeds thereof:
1.      The fair value of the assets of the Company (as used herein “ Company ” means the Borrowers and their subsidiaries, on a consolidated basis) is more than its debts and liabilities, subordinated, contingent or otherwise.
2.      The present fair saleable value of assets of the Company is more than the amount that will be required to pay the probable liability, on a consolidated basis, of its debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured.
3.      The Company is able to pay its debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured.
4.      The Company is not engaged in, and is not about to engage in, business for which it has “unreasonably small capital”.
For purposes of this Certificate, the amount of any contingent liability at any time shall be computed as the amount that would reasonably be expected to become an actual and matured liability.
[Signature page follows]

IN WITNESS WHEREOF, I represent the foregoing information is provided to the best of my knowledge and belief and execute this Certificate as of the date first above written.

By:
        
Name: [●]    
Title: [
Chief Financial Officer/equivalent officer ]    






TRANSITION SERVICES AGREEMENT
This Transition Services Agreement (“Agreement”) is made and entered into as of February /s/ 22, 2016 (the “Agreement Date”) by and between Coherent, Inc., a Delaware corporation having its principal offices at 5100 Patrick Henry Drive, Santa Clara, CA 95054 (“Company”) and Helene Simonet (“Ms. Simonet”).
On September 23, 2015, Ms. Simonet, as the Company’s Executive Vice President and Chief Financial Officer (CFO), informed the Company of her intent to retire effective as of February 1, 2016 and ensure an orderly transition of her services. Ms. Simonet agreed to extend her tenure as the Company’s Executive Vice President and Chief Financial Officer through February 21, 2016 and continues to want to ensure an orderly transition of her services.
The Company desires to retain Ms. Simonet as a special advisor to the Company’s Chief Executive Officer as a non-executive employee helping with the transition from February 22, 2016 through April 4, 2016 and as an independent contractor consultant thereafter through December 30, 2016 to perform consulting services for the Company and Ms. Simonet is willing to perform such services in order to ensure an orderly transition, on terms set forth more fully below.
In consideration of the mutual promises contained herein, the parties agree as follows:

1. SPECIAL ADVISOR TO CHIEF EXECUTIVE OFFICER SERVICES AND COMPENSATION
Ms. Simonet during the period from February 22, 2016 through April 4, 2016 (“Special Advisor Transition Period”) shall continue as an employee of the Company as a special advisor to the Chief Executive Officer and shall remain subject to the same compensatory arrangements during the Special Advisor Transition Period as in effect on the Agreement Date. Ms. Simonet shall remain an employee of the Company during the Special Advisor Transition Period, but shall cease to be an executive officer of the Company effective immediately prior to the beginning of the Special Advisor Transition Period.

2. CONSULTING SERVICES AND COMPENSATION
2.1     Services . Ms. Simonet agrees to provide financial, accounting and other assistance to the Company on a consulting basis (“ Services ”) for the period from April 5, 2016 through December 30, 2016 or such earlier termination date of the Agreement Term set forth in Section 5 of this Agreement (“Consulting Period”) in order to ensure an orderly transition. Unless expressly agreed to by the Company in writing, Ms. Simonet shall have no authority to act as an agent of the Company or represent or obligate the Company in any manner during the Consulting Period. Unless expressly agreed to by Ms. Simonet in writing, the Company shall not require Ms. Simonet to provide more than twenty (20) hours of assistance during any calendar month during the Consulting Period. Ms. Simonet agrees that during the term of the Agreement Ms. Simonet shall continue to be subject to the Company’s Business Conduct Policy and acknowledges receipt of a copy and her understanding thereof.
2.2     Fees . Company agrees to pay to Ms. Simonet $11,111.11 per calendar month (or portion thereof) during the Consulting Period for the performance of Services, which payment will be made no later than the tenth day of the calendar month following the calendar month during which Ms. Simonet performed Services under this Agreement. Pursuant to the terms of Ms. Simonet’s outstanding equity awards under the Company’s 2011 Equity Incentive Plan, Ms. Simonet will continue to vest in such outstanding equity awards during the Agreement Term, including, without limitation, the Consulting Period. For the avoidance of doubt, no pro rata portion of this amount shall be made for any partial months of Service during the Consulting Period.
2.3     Reports . If requested by the Company (which for the avoidance of doubt, such request shall be made by the Company’s Chief Executive Officer), Ms. Simonet will from time to time during the Consulting Period or any extension thereof keep the Company advised as to Ms. Simonet’s progress in performing the Services hereunder.
3.      NO CONFLICTING OBLIGATIONS .

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 1



Ms. Simonet certifies that Ms. Simonet has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Ms. Simonet from complying with the provisions hereof, and further certifies that Ms. Simonet will not enter into any such conflicting agreement during the term of this Agreement.
4.      CONFIDENTIALITY
4.1     Definition . “Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not limited to, research and product plans, products, services, customers, customer lists, markets, software, developments, inventions, processes, formulas, technology, designs, drawings, hardware configuration information, marketing, finance or other business information, disclosed to Ms. Simonet either directly or indirectly in writing, orally or otherwise during employment or consulting.
4.2     Non-Use and Non-Disclosure . Ms. Simonet will not, during or subsequent to the term of this Agreement, use Confidential Information for any purpose whatsoever other than the performance of the Services on behalf of the Company, or disclose Confidential Information to any third party. Ms. Simonet agrees that Confidential Information will remain the sole property of the Company. Ms. Simonet further agrees to take all reasonable precautions to prevent any unauthorized disclosure of Confidential Information. Notwithstanding the above, Ms. Simonet’s obligation under this Section 4.2 relating to Confidential Information will not apply to information that (i) is known to Ms. Simonet at the time of first disclosure (either while Ms. Simonet was an employee or independent contractor with respect to the Company) to Ms. Simonet by the Company as evidenced by written records of Ms. Simonet, (ii) has become publicly known and made generally available through no wrongful act of Ms. Simonet or her agents, or (iii) has been rightfully received by Ms. Simonet from a third party authorized to make such disclosure.
4.3     Third Party Information . Ms. Simonet recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Ms. Simonet agrees that Ms. Simonet owes the Company and such third parties, during the term of this Agreement and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out the services for the Company consistent with the Company’s agreement with such third party.
4.4     Classified Material . Ms. Simonet will not undertake any work involving access to classified information, or remove any classified material from Company’s facilities (including computers and products), until the express written approval of the appropriate government agency has been obtained from Company’s General Counsel. Ms. Simonet will not disclose any classified information or material to any unauthorized person.
4.5     Return of Information . Upon the termination of this Agreement, or upon the Company’s earlier request, Ms. Simonet will deliver to the Company all of the Company’s property relating to, and all tangible embodiments of, Confidential Information in Ms. Simonet’s possession or control.
4.6     No Export . Ms. Simonet acknowledges that Confidential Information or other information disclosed in connection with the Services might be considered technical data that is subject to compliance with the export control laws and regulations of the United States, and hereby agrees to comply with such laws.
5.      OWNERSHIP
5.1     Assignment . Ms. Simonet acknowledges that all information (including, without limitation, business plans and/or business information), technology, know-how, copyrightable works, drawings, materials, notes, records, designs, ideas (whether or not patentable), inventions, improvements, devices, developments, discoveries, compositions, trade secrets, processes, methods and/or techniques conceived, reduced to practice or made by Ms. Simonet alone or jointly with others during the term of this Agreement, which relate in any manner to the business of the Company, as well as all deliverables, (collectively, “Work Product”) are the sole property of the Company, and that all Work Product will be deemed a work made for hire, to the extent allowable under applicable law. To the extent the Work Product is not deemed a work made for hire, Ms. Simonet does hereby and will assign to the Company all right,

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 2



title and interest in and to such Work Product and any copyright, patent, trade secret, and other intellectual property rights related thereto. Ms. Simonet acknowledges that the Company will have the sole right, but not the obligation, to prosecute and maintain patent applications and patents worldwide with respect to Work Product.
5.2     Further Assurances . Ms. Simonet will assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Work Product and any copyrights, patents, or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company deems necessary in connection therewith.
5.3     Pre-Existing Materials . If in the course of performing services under this Agreement, Ms. Simonet incorporates into any Work Product developed hereunder any invention, improvement, development, concept, discovery or other proprietary information owned by Ms. Simonet or in which Ms. Simonet has an interest: (i) Ms. Simonet will inform the Company, in writing before incorporating such invention, improvement, development, concept, discovery or other proprietary information into any Work Product; and (ii) Ms. Simonet hereby grants the Company, under all of Ms. Simonet’s rights therein, a nonexclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made, use, sell, import, reproduce, distribute, perform, display, and prepare derivative works of, same as part of or in connection with such Work Product.
5.4     Third Party or Public Source Materials . Ms. Simonet will not incorporate into any Work Product any: (i) invention, improvement, development, concept, discovery or other proprietary information owned by any third party; or (ii) any open source or public domain material.
5.5     Attorney in Fact . Ms. Simonet agrees that if the Company is unable because of Ms. Simonet’s unavailability, mental or physical incapacity, or for any other reason, to secure Ms. Simonet’s signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering any Work Product, then Ms. Simonet hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Ms. Simonet’s agent and attorney-in-fact, to act for and in Ms. Simonet’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of patents and copyright registrations thereon with the same legal force and effect as if executed by Ms. Simonet.
5.6     Warranty . Ms. Simonet hereby represents and warrants that (i) all Work Product will be the original work of Ms. Simonet; (ii) to Ms. Simonet’s knowledge, the Work Product and the use thereof as contemplated hereunder will not infringe the copyright, patent, trade secret, or any other intellectual property right of any third party; (iii) the Work Product will not be obscene, libelous, or violate the right of privacy or publicity of any third party; (iv) the Work Product will not contain any virus, trap door, worm, or any other device that is injurious or damaging to software or hardware used in conjunction with the Work Product; (v) any software or data portions of the Work Product will operate correctly and consistently upon dates occurring on or after January 1, 2000; and (vi) the Work Product and all Services will comply with all applicable government security regulations.
6.      TERM AND TERMINATION
The Agreement Term will commence on February 22, 2016 and will continue until the earlier of (i) December 30, 2016; or (ii) such earlier termination as provided below. The Company may terminate this Agreement immediately upon notice if, in the Company’s reasonable determination, Ms. Simonet is in material breach of any material provision of this Agreement (other than due to Ms. Simonet’s disability), without further compensation. This Agreement shall terminate automatically on the occurrence of bankruptcy or insolvency of either party, by death of Ms. Simonet or by assignment of this Agreement except as provided under Section 9.2.

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 3



Upon termination of this Agreement, all rights and duties of the parties hereunder will cease except:
(i) Sections 4 (Confidentiality), 5 (Ownership), 6 (Term and Termination), 7 (Independent Contractor), 8 (Arbitration and Equitable Relief) and 9 (General) will survive termination of this Agreement. Upon termination of this Agreement other than because of Ms. Simonet’s material breach, the fee set forth in Section 2.2 for Services for the month of termination shall be paid in accordance with Section 2.2.
(ii) Upon the termination of this Agreement. or upon the Company’s earlier requests Ms. Simonet will deliver to the Company all property relating to, and all tangible embodiments of, Work Product in Ms. Simonet’s possession or control.
7.      INDEPENDENT CONTRACTOR .
7.1     Status . Nothing in this Agreement will in any way be construed to constitute Ms. Simonet as an agent, employee or representative of the Company during the Consulting Period. Ms. Simonet will perform the Services hereunder during the Consulting Period as an independent contractor. It is the express intention of the parties that during the Consulting Period Ms. Simonet is an independent consultant and not an employee, agent, representative, joint venturer or partner of the Company. Nothing in this Agreement shall be interpreted or construed as creating or establishing the relationship of employer and employee between the Company and Ms. Simonet during the Consulting Period. Ms. Simonet acknowledges and agrees that Ms. Simonet is obligated to report as income all compensation received by Ms. Simonet pursuant to this Agreement. Ms. Simonet will be issued a Form 1099 by the Company for any payments hereunder with respect to the Consulting Period and Ms. Simonet will be responsible for paying any applicable taxes for such payments. If applicable, Ms. Simonet will provide the Company a complete and accurate W-9. Ms. Simonet agrees to and acknowledges the obligation to pay all self-employment and other taxes thereon including applicable federal, state and local income taxes, unemployment insurance, workers’ compensation insurance, disability insurance, Social Security taxes and other charges. Ms. Simonet acknowledges that Ms. Simonet will receive no Company-sponsored benefits from the Company either as a consultant or employee for the Consulting Period, where benefits include without limitation paid vacation, sick leave, medical insurance, and 401K and employee stock purchase plan participation; provided that this sentence does not limit the rights that Ms. Simonet has under any such plans with respect to the period while Ms. Simonet was an employee, the right to continue vesting in equity awards under the Company’s 2011Equity Incentive Plan as set forth in Section 2.2 of this Agreement, or any COBRA rights that Ms. Simonet or her family may have because of her retirement from the Company. If Ms. Simonet is reclassified by a state or federal authority as an employee for the Consulting Period, Ms. Simonet will become a reclassified employee and will receive no benefits except those mandated by state or federal law, even if by the terms of the Company’s benefit plans in effect at the time of such reclassification Ms. Simonet would otherwise be eligible for such benefits. Without limitation on the foregoing, Ms. Simonet specifically acknowledges that she will cease to be a participant under the Company’s Change of Control Severance Plan on April 4, 2016. The Company and Ms. Simonet acknowledge that the Indemnification Agreement by and between the Company and Ms. Simonet dated as of March 27, 2003 remains in effect according to its terms.
7.2     Equipment, Instruments, Documentation and Specifications . Ms. Simonet shall supply all equipment, instruments, documentation and specifications required to perform Services during the Consulting Period, except that Ms. Simonet may continue to use the laptop computer and cellphone provided by the Company and the Company shall continue to pay for maintenance and service and applicable data/cell plans of such computer and cellphone during the term of the Agreement. Such computer and cellphone shall at all times remain the property of the Company and Ms. Simonet shall return such laptop computer and cellphone within 15 day following the termination of this Agreement. The Company shall prior to the termination of this Agreement use its best efforts to facilitate a transfer to Ms. Simonet of the cell phone number currently used by Ms. Simonet.
7.3     Time, Places and Methods of Providing Services . As long as Ms. Simonet delivers acceptable services to the Company in a timely fashion, Ms. Simonet shall generally have the discretion to determine the location and times of rendering services as well as the method of accomplishing Ms. Simonet’s Services during the Consulting Period.

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 4



7.4     Disclosure . The Company shall not issue or permit to be issued any press release or other public announcement regarding Ms. Simonet or the terms of Ms. Simonet’s engagement under this Agreement without first providing Ms. Simonet an opportunity to review such press release or other public announcement and considering in good faith any changes requested by Ms. Simonet. Notwithstanding the foregoing nothing in this Section 7.4 shall delay the Company from making any disclosures required by law, including the rules and regulations adopted by the SEC.
8.      ARBITRATION AND EQUITABLE RELIEF .
8.1     Arbitration . The Company and Ms. Simonet agree that any dispute or controversy arising out of, in relation to, or in connection with this Agreement, or the making, interpretation, construction, performance or breach thereof, will be finally settled by binding arbitration in San Francisco, California under the then current rules of JAMS by one (1) arbitrator appointed in accordance with such rules. The arbitrator may grant injunctive or other relief in such dispute or controversy. The decision of the arbitrator, will be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court of competent jurisdiction. The parties agree that, any provision of applicable law notwithstanding, they will not request and the arbitrator will have no authority to award, punitive or exemplary damages against any party. The costs of the arbitration, including administrative and arbitrator’s fees, will be shared equally by the parties. Each party will bear the cost of its own attorneys’ fees and expert witness fees.
8.2     Equitable Relief . The parties may apply to any court of competent jurisdiction for a temporary restraining order, preliminary injunction, or other interim or conservatory relief, as necessary, without breach of this Agreement and without abridgment of the powers of the arbitrator.
8.3     Acknowledgement . MS. SIMONET HAS READ AND UNDERSTANDS THIS SECTION 8. MS. SIMONET UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, MS. SIMONET WILL BE OBLIGATED TO SUBMIT ANY CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE, BREACH OR TERMINATION THEREOF, TO BINDING ARBITRATION, EXCEPT AS PROVIDED IN SECTION 8.2, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF MS. SIMONET’S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF THE RELATIONSHIP BETWEEN THE PARTIES.
9.      GENERAL
9.1     Notices . Any required notice will be given in writing and will be deemed given when delivered or, if delivery is not accomplished by reason or some fault of the addressee, when tendered.
9.2     Assignment . Ms. Simonet acknowledges that the Company has chosen Ms. Simonet to perform services based on Ms. Simonet’s reputation and skills. Accordingly, neither this Agreement nor any right hereunder or interest herein may be assigned or transferred by Ms. Simonet without the express written consent of the Company. Any assignment in violation of the foregoing will be null and void. The Company may assign this Agreement to an entity that succeeds to substantially all of the business or assets of the Company.
9.3     Governing Law . This Agreement will be governed by, and construed and interpreted under, the laws of the State of California without reference to conflicts of laws principles.
9.4     Severability . In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision, provided that no such severability will be effective if it materially changes the economic benefit of this Agreement to either the Company or Ms. Simonet.

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 5



9.5     Modification; Waiver . This Agreement may not be altered, amended or modified in any way except by writing signed by both parties. Waiver of any term or provision of this Agreement or forbearance to enforce any term or provision by either party will not constitute a waiver as to any subsequent breach or failure of the same term or provision or a waiver of any other term or provision of this Agreement.
9.6     Entire Agreement and Negotiation Thereof . The parties hereto acknowledge that this Agreement and the Exhibits hereto set forth the entire agreement and understanding of the parties as to the subject matter hereof, and supersedes all prior discussion, agreements and writings in respect hereto. The Company shall reimburse Ms. Simonet for reasonable legal fees and expenses in an amount up to $2,000 incurred in connection with negotiating this Agreement.
9.7     Counterparts . This Agreement may be executed in counterpart, each of which will be deemed an original, but both of which together will constitute one and the same instrument.
9.8     Compliance with Laws . Ms. Simonet agrees to comply with all applicable Federal, State and local laws and regulations issued pursuant thereto, including without limitation any applicable anti-corruption laws, such as the Foreign Corrupt Practices Act. Ms. Simonet will not discriminate against any of its employee or applicant for employment because of race, color, religion, sex, age, national origin, veteran status or physical/mental handicap. Any hazardous material is shipped pursuant to the Services must be classified, packed, marked, labeled and in proper condition for carriage by motor or air according to current DOT and IATA restricted article regulations.  Ms. Simonet agrees to comply with the Safe Harbor regulations of the US Department of Commerce for any and all services performed hereunder. This shall apply to any personal related data received and/or processed for the Company as of the date hereof regardless of the date of receipt of such data.  Ms. Simonet shall indemnify and hold harmless the Company from and against any and all damage caused by any non-compliance by Ms. Simonet..
9.9     Debarment Certification . Ms. Simonet represents and warrants that she has not ever been, is not currently, nor is the subject of a proceeding that could lead to that party becoming, as applicable, debarred, suspended, proposed for debarment, exclusion or disqualified under the nonprocurement common rule, or otherwise declared ineligible from receiving Federal contracts, certain subcontracts and certain Federal assistance and benefits (“Debarred”). Ms. Simonet covenants that in the event that she becomes Debarred, Ms. Simonet shall immediately notify the Company and the Company shall have the right to immediately terminate this Agreement without penalty.
9.10     Terms of Use . Ms. Simonet agrees that it shall abide by the terms of use attached hereto as Exhibit A.

IN WITNESS WHEREOF, the undersigned are duly authorized to execute this Agreement on behalf of the Company and Ms. Simonet, as applicable.
"MS. SIMONET"
 
COHERENT, INC.
 
 
 
By: /s/ Helene Simonet
 
By: /s/ John Ambroseo
 
 
 
Print Name: Helene Simonet
 
Print Name: John Ambroseo
 
 
 
 
 
Title: President and Chief Executive Officer



 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 6



EXHIBIT A
Terms of Use
Purpose
These terms of use set forth the acceptable use and expectations with any person with access to Coherent technical resources – including telephones (mobile and desk), desktop and portable computer systems, fax machines, Internet and World Wide Web (Web) access, voice mail, electronic mail (email), instant messaging (IM), and the Coherent intranet.
Scope
These Terms of Use apply to all people with access to or through Coherent networks and/or email, computer systems, fax machines, phones (mobile and desk), Internet and World Wide Web (Web) access, voice mail, electronic mail (email), instant messaging (IM) and the Coherent intranet. All communications and internet use conducted through Coherent technical resources should not be considered private. The nature of electronic communication is inherently unsecured and is typically captured at various levels by protocols used in the transmission of data.
Compliance with this agreement is mandatory of all Coherent employees, contractors, consultants, contingent workers, or anyone with email and/or internet access through Coherent networks.
Failure to comply with the Terms of Use will result in disciplinary action up to and including termination. In addition, Coherent may advise appropriate legal officials of any violations.
Detailed Standards, Procedures and Guidelines that impact Acceptable Use are included in:
Data Retention / Backup Policy
Email Management Procedure
Network / Infrastructure Operations Procedure
Security Incident Response Procedure
All rules and policies of acceptable conduct as outlined in the Employee Handbook and other HR Policies and Procedures apply to all communication and content created, viewed and/or accessed while using Coherent technical resources.
1.
Acceptable Use – Coherent's technical resources are provided for the benefit of Coherent and its customers, vendors, and suppliers. These resources are provided for use in the pursuit of Company business and are to be reviewed, monitored, and used only in that pursuit, except as otherwise provided in this policy.
Employees and contractors are permitted to use Coherent's technical resources for occasional, non-work purposes with permission from their direct Supervisor/Manager. Nevertheless, Employees and contractors have no right of privacy as to any information or file maintained in or on Coherent's property or transmitted or stored through Coherent's computer, messaging (including but not limited to IM, email, and voicemail), or telephone systems.
2.
Unacceptable Use – Activities that are not permissible through Coherent networks include, but are not limited to: downloading any video and/or audio files, streaming audio and/or video (e.g., YouTube, news websites, on-line radio, podcasts, etc.), social networking sites, web logging (blogging), video blogging, accessing or being a part of peer-to-peer (P2P) networks and/or systems, and any website that violates HR Policies as outlined in the Employee Handbook.

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 7



Coherent's information systems should not be used for personal gain or the advancement of individual views. Employee postings are not permitted on Coherent's intranet or unauthorized bulletin board systems, blogs, or public folders. Solicitation for any non-Company business or activities using Company resources is strictly prohibited. Use of Coherent's information systems must not interfere with productivity, the productivity of any other Employee, or the operation of Coherent's systems. Employees and contractors may not play games on Coherent's computers and other technical resources during work time.
Sending messages or other communications that either mask the user’s identity or indicate that someone else sent them is prohibited. Never access any information systems using another Employee's password. Similarly, only access the libraries, files, data, programs, and directories that are related to work duties. Unauthorized review, duplication, dissemination, removal, installation, damage, or alteration of files, passwords, computer systems or programs, or other property of Coherent, or improper use of information, is prohibited.
Sending, saving, or viewing offensive material is prohibited. Messages stored and/or transmitted by computer, voice mail, email, or telephone systems must not contain content that may reasonably be considered offensive to any Employee, customer or business partner of Coherent. Offensive material includes, but is not limited to, sexual comments, jokes or images, racial slurs, gender-specific comments, or any comments, jokes or images that would offend someone on the basis of his or her race, color, creed, sex, age, national origin or ancestry, physical or mental disability, veteran status, marital status, medical condition, sexual orientation, as well as any other category protected by federal, state, or local laws. Any use of the Internet/World Wide Web or intranet to harass or discriminate is unlawful and strictly prohibited by Coherent. Violators will be subject to discipline, up to and including termination of employment.
3.
Access to Information – Coherent asks you to keep in mind that when you are using Coherent's computers you are creating Company documents using a Company asset. Coherent respects the individual privacy of its Employees. However, that privacy does not extend to an Employee's work-related conduct or to the use of Company-provided information systems or supplies.
Coherent's computer, messaging and communication systems, and the data stored on them are and remain at all times the property of Coherent. All information, including messages and files, that are created, sent, or retrieved over Coherent's technical resources is the property of Coherent, and should not be considered private or confidential. Information or files transmitted or stored through Coherent's computer, messaging or communication systems are the property of Coherent. Any electronically stored information that you create, send to, or receive from others or retrieve and review, must serve the legitimate business interests and obligations of Coherent.
Employees and contractors should also be aware that, even when a file or message is erased or a visit to an Internet or Web site is closed; it is still possible to recreate the message or locate the Web site. Coherent reserves the right to monitor use of its information systems at any time.
All individuals, employees, as well as contractors, may have access from time to time to network resources, such as Agile or Oracle systems. No individual employee or contractor who has such access may use their access in any manner which is harmful to Coherent or any other individual or entity.
4.
Copyrighted Materials – It is unlawful to copy and distribute copyrighted material (e.g., software, database files, documentation, articles, graphics files, audio, video, and/or downloaded information) through messaging systems or by any other means unless advanced approval is obtained from appropriate sources that Coherent has the right to copy and/or distribute the material. Failure to observe a copyright may result in disciplinary action by Coherent as well as legal action by the copyright owner. Any questions concerning these rights should be directed to your Supervisor/Manager.

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 8



5.
Confidential Information – Messaging and Internet/Web access are inherently unsecure by virtue of the technical protocols used in the transmission of data. Others outside Coherent may also be able to monitor your messaging and Internet/Web access. For example, Internet sites maintain logs of visits from users; these logs identify which company, and even which particular person, accessed the service. In order to protect Coherent from viruses and security breaches, accessing outside messaging services, while on a Coherent technical resource, is prohibited.
When transferring messages and files electronically, Coherent’s systems should be used. Coherent’s internal systems use secured networks and are under the control of the IT Department. If you should require a higher level of data security (e.g., transmitting engineering diagrams or privacy protected data), contact the IT Department for assistance.
All Employees and contractors must safeguard Coherent's confidential information, as well as that of customers and business partners, from disclosure. Do not access messages with others present, unless you know the information in the message can be disclosed to the person/people present. Messages containing confidential information should not be left visible while you are away from your work area. In order to protect Coherent from viruses and security breaches, accessing outside messaging services, while on a Coherent technical resource, is prohibited.
6.
Security of Information – Although you may have passwords to access computer and messaging systems, these technical resources belong to Coherent, are to be accessible at all times by Coherent, and are subject to audit/inspection by Coherent. Never share passwords and never access any system using another person’s password.
In order to facilitate Coherent's access to information on its technical systems, do not encrypt or encode any messages, communication or any other files or data stored or exchanged on Company systems without the express prior written permission from the IT Department and your Supervisor/Manager. As part of this approval, the IT Department will indicate how to securely deliver encryption key/code or software to the IT Department so that the encrypted/encoded information can be accessed if necessary.
7.
Software Policy – All software and hardware must be approved and installed by the IT Department. Employees and contractors are prohibited from installing any software or using any hardware on Company information system resources that have not been approved by the IT Department.
8.
Employee Responsibility – Each Employee and contractor is responsible for the content of all text, audio, video, images, and/or messages that they place or send over Coherent's technical resources. Employees and contractors may access only files, data, applications, or programs that they have explicit permission to use (electronic or written).
By signing below, I hereby acknowledge that I have read the foregoing terms of use and hereby agree that I will strictly follow the terms of use.
SIGNATURE: /s/ Helene Simonet    
PRINT NAME: Helene Simonet    
TITLE:     
DATE: February 22, 2016    

 
 
 
 
COHERENT TRANSITION SERVICES AGREEMENT
 
Page 9


Exhibit 31.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 
I, John R. Ambroseo, certify that:
 
1.                                       I have reviewed this quarterly report on Form 10-Q of Coherent, Inc.;
 
2.                                       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.                                       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.                                       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)          Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)         Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.                                       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 
Date:
May 11, 2016
 
 
 
 
 
/s/: JOHN R. AMBROSEO
 
John R. Ambroseo
 
President and Chief Executive Officer
 







Exhibit 31.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
 
I, Kevin Palatnik, certify that:
 
1.                                       I have reviewed this quarterly report on Form 10-Q of Coherent, Inc.;
 
2.                                       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.                                       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.                                       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)          Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)         Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.                                       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 
Date:
May 11, 2016
 
 
 
 
 
/s/: KEVIN PALATNIK
 
Kevin Palatnik

 
Executive Vice President and Chief Financial Officer
 
 












Exhibit 32.1
 
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the As Sarbanes-Oxley Act of 2002
 
I, John R. Ambroseo, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Coherent, Inc. on Form 10-Q for the fiscal quarter ended April 2, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Coherent, Inc.
 
Date:
May 11, 2016
 
 
 
 
 
/s/: JOHN R. AMBROSEO
 
John R. Ambroseo
 
President and Chief Executive Officer
 
 







Exhibit 32.2
 
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the As Sarbanes-Oxley Act of 2002
 
I, Kevin Palatnik, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Coherent, Inc. on Form 10-Q for the fiscal quarter ended April 2, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Coherent, Inc.
 
Date:
May 11, 2016
 
 
 
 
 
/s/: KEVIN PALATNIK
 
Kevin Palatnik

 
Executive Vice President and Chief Financial Officer